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Transcription in eukaryotes takes place in the context of a repressive chromatin template.  
Access to the DNA is facilitated by histone modifying enzymes and ATP-dependent chromatin 
remodeling complexes, which modify chromatin structure.  The activities of chromatin 
modifying proteins are often coordinated by nonenzymatic accessory factors that interact with 
actively transcribing RNA Polymerase II (Pol II).  One such factor is the Saccharomyces 
cerevisiae Paf1 transcription elongation complex.  This complex, which is minimally composed 
of Paf1, Ctr9, Rtf1, Cdc73, and Leo1, physically interacts with Pol II and localizes to the coding 
regions of active genes. 
The Rtf1 subunit of the Paf1 complex performs several cotranscriptional functions:  it 
facilitates recruitment of the chromatin remodeling enzyme Chd1, promotes covalent 
modification of specific lysine residues in histones H2B and H3, and mediates association of 
other Paf1 complex subunits.  Using a collection of internal deletion mutations that remove 20 to 
50 amino acid segments across the length of Rtf1, I demonstrated that Rtf1's known functions are 
mediated by nonoverlapping regions, implying that the multiple functions of this protein are not 
completely interrelated.  Deletion of the regions of Rtf1 that are required for promoting histone 
modification or its association with active genes resulted in the strongest transcription-related 
phenotypes, which suggested that promoting cotranscriptional histone modification is a critical 
means by which Rtf1 exerts its effects on transcription.  Detailed analysis of the region of Rtf1 
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required for histone modification determined that it is sufficient to promote Rtf1-dependent 
histone modifications and that this function is dependent on several highly conserved residues. 
Additionally, a screen for factors that become essential in the absence of Rtf1 uncovered 
mutations in the first two enzymes of the inositol polyphosphate (IP) signaling pathway:  Plc1 
and Arg82.  The IP signaling pathway has been linked to the function of several chromatin 
remodeling complexes.  I uncovered strong genetic interactions between Arg82, Paf1, and 
mutations in the SWI/SNF and INO80 chromatin remodeling complexes and demonstrated that 
the expression of several target genes was strongly impaired by mutations in these factors.  
Together, these data suggest that transcription elongation, IP signaling, and chromatin 
remodeling cooperate to coordinate proper gene expression. 
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1.0  INTRODUCTION 
The genomes of eukaryotes are intricately packaged into a nucleoprotein material known as 
chromatin by association with the histone proteins; this arrangement facilitates their efficient 
storage and organization within the comparatively small cell nucleus.  However, this storage 
system imposes a significant impediment to processes that require access to the genetic material, 
such as DNA repair and replication, recombination, and transcription.  Eukaryotic cells have, 
therefore, developed several methods to counter the repressive nature of chromatin structure, 
including covalent modification of the histone proteins and disassembly or remodeling of 
nucleosomes, which represent the basic unit of chromatin. 
 The studies described in this dissertation were performed using the yeast Saccharomyces 
cerevisiae as a model system to explore the mechanisms underlying chromatin modification 
during the transcription of messenger RNA. Therefore, the information provided in this chapter 
is specifically tailored toward detailing the current understanding of these processes in S. 
cerevisiae.   
Chromatin modification during transcription appears to be an ongoing process that is 
tightly regulated throughout the transcription cycle.  This careful control is necessary to ensure 
proper levels of gene expression and to prevent aberrant initiation from cryptic promoter 
sequences present in active open reading frames (ORFs) that become exposed when chromatin 
structure has been perturbed by the passage of RNA polymerase II (Pol II).  The regulation of 
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chromatin modification during transcription depends, in part, upon accessory factors that interact 
with actively transcribing Pol II and coordinate the recruitment of chromatin-modifying factors 
to active genes and, in some cases, stimulate their enzymatic activity. 
1.1 THE EUKARYOTIC GENOME IS PACKAGED INTO CHROMATIN 
Eukaryotic cells condense and organize large genomes within the relatively small confines of 
their nuclei.  The genome of S. cerevisiae, which represents one of the simplest eukaryotic 
genomes, totals nearly 13,000,000 base pairs (bp) in length and contains nearly 6,000 genes 
(GOFFEAU et al. 1996).   The S. cerevisiae haploid genome consists of 16 linear chromosomes of 
varying size which must be packaged into a nuclear space that measures approximately 3µm3 
(JORGENSEN et al. 2007). 
Organization and compaction of eukaryotic DNA molecules is achieved through their 
association with the histone proteins.  The histones are a class of small, highly conserved 
proteins that interact with each other to form an octamer containing two copies each of histones 
H2A, H2B, H3, and H4 (LUGER et al. 1997).  The histones are positively charged, leading to a 
tight interaction between the histone octamer and the negatively-charged phosphodiester 
backbone of a DNA molecule. 
Approximately every 200 bp along the length of a eukaryotic chromosome, a 146 bp 
length of DNA coils nearly two revolutions around a histone octamer to form a structure known 
as a nucleosome (Figure 1) (LUGER et al. 1997).  The resulting nucleoprotein material, known as 
chromatin, resembles “beads on a string” and represents the first order of chromosome 
organization (KORNBERG and THOMAS 1974).  The genome can be further compacted through 
 3 
the formation of higher-order chromatin structures which require, in part, a fifth histone protein 
(histone H1) which contacts both the proteins in the histone octamer and DNA present in the 
linker region between adjacent nucleosomes (ISHIMI et al. 1981).  Highly compact chromatin 
domains, known as heterochromatin, often contain important structural elements such as 
telomeres or centromeres.  The remainder of the genome is referred to as euchromatin, which is 
largely composed of coding regions for both active and inactive genes. 
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Figure 1.  The crystal structure of the nucleosome. 
The crystal structure of the nucleosome was solved at 2.8A resolution.  Models for the structure of 146 bp of DNA 
wrapped around a histone octamer are shown (Reprinted by permission from Macmillan Publishers Ltd: [Nature] 
LUGER et al. 1997, copyright 1997).  Two copies each of H2A (orange), H2B (pink), H3 (blue), and H4 (green) can 
be seen in the model on the left.  In addition to the alpha-helical histone core domains, several histone “tails” can be 
seen protruding from the nucleosome core in both models.  Two coils of DNA around the histone octamer can be 
seen clearly in the model on the right.   
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1.2 CHROMATIN STRUCTURE IS DYNAMICALLY REGULATED BY SEVERAL 
MECHANISMS 
The arrangement of eukaryotic chromosomes into chromatin is an efficient means of storing the 
genetic material in a highly organized fashion.  However, organization of the genome into 
chromatin impacts DNA-based processes such as DNA repair, DNA replication, recombination, 
and transcription, by introducing structural constraints and occluding the recognition sites of 
DNA-binding proteins.  Specifically, nucleosomes are known to impede Pol II processivity along 
ORFs of active genes, often resulting in stalling or arrest of the polymerase (KIREEVA et al. 
2005).  Eukaryotic cells have, therefore, developed a number of mechanisms to modify 
chromatin structure in order to facilitate the proper execution of DNA-based processes.  The 
most common mechanisms of chromatin modification in yeast, including chromatin disassembly, 
incorporation of histone variants, covalent histone modification, and ATP-dependent chromatin 
remodeling, are described in more detail in the following sections.  Higher eukaryotes also 
regulate chromatin modification through heritable methylation of the DNA, although this 
mechanism appears to be largely absent from the S. cerevisiae genome. 
1.2.1 Nucleosome disassembly and the incorporation of histone variants 
Chromatin assembly is closely linked to genome replication.  Expression of the histone genes 
takes place specifically during the S phase of the cell cycle and histones are incorporated into 
newly synthesized DNA immediately following the passage of DNA polymerase (TABANCAY 
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and FORSBURG 2006).  Histone octamers are assembled from free H2A/H2B and H3/H4 dimers.  
Incorporation of new nucleosomes into DNA takes place in a stepwise fashion in which two 
H3/H4 dimers are incorporated first, followed by the addition of two H2A/H2B dimers 
(SCHULTZ et al. 1997). 
 Nucleosome positioning is not entirely random; nearly 70% of the S. cerevisiae genome 
is incorporated into well-positioned nucleosomes that consistently occupy a 140 bp length of 
DNA (YUAN et al. 2005).  Additionally, chromatin structure assumes a characteristic pattern 
over the bodies of yeast genes.  Many yeast gene promoters contain an approximately 200 bp 
length of DNA that is devoid of nucleosomes.  This nucleosome free region (NFR) is succeeded 
into the ORF by several well-positioned nucleosomes (MAVRICH et al. 2008; YUAN et al. 2005).  
In many cases, the precise location of nucleosomes becomes less well-defined as distance from 
the promoter increases, suggesting the NFR may function as a nucleosome positioning signal. 
 The NFR is known to be flanked by two well-positioned nucleosomes that contain the 
histone variant H2A.Z in place of canonical H2A.  Histone variants are differentiated from 
canonical histones largely by their continued expression outside of S phase and their primarily 
replication-independent incorporation into chromatin (LI et al. 2007a).  H2A.Z, encoded by the 
HTZ1 gene, shares only about 60% sequence similarity with canonical H2A, which implies an 
early evolutionary divergence between these two proteins (ZLATANOVA and THAKAR 2008).  
H2A.Z containing nucleosomes appear to be destabilized more easily than their canonical H2A 
containing counterparts (ZHANG et al. 2005). The presence of H2A.Z in nucleosomes flanking 
promoters may, therefore, facilitate transcription initiation by promoting efficient eviction of 
nucleosomes that occlude transcription factor binding sites or inhibit the ability of the 
transcription machinery to assemble on gene promoters. 
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 The presence of nucleosomes in the bodies of genes impedes the processivity of Pol II 
(KIREEVA et al. 2005).  Therefore, chromatin must be disassembled during active transcription to 
ensure efficient gene expression.  Removal of a single H2A/H2B dimer from each nucleosome 
appears to be sufficient to allow the passage of Pol II in vitro (KIREEVA et al. 2002).  
Translocating Pol II is believed to induce positive supercoiling of the DNA template ahead of its 
position, which may be adequate to dislodge an H2A/H2B dimer (LEVCHENKO et al. 2005).  
However, chromatin is also believed to be actively disassembled by the activity of numerous 
histone chaperones including the CAF-I complex, Nap1, Spt6, and the yeast FACT complex; 
these histone chaperone complexes also play important roles in reassembling chromatin 
following the passage of Pol II (ARMSTRONG 2007).  Chromatin reassembly is critical to prevent 
aberrant initiation from cryptic promoters present within ORFs (KAPLAN et al. 2003). 
1.2.2 Histone modification 
Changes in chromatin structure can also be elicited through modification of the histone proteins.  
The crystal structure of the nucleosome demonstrates that each histone protein contains an alpha- 
helical core domain, which interacts with other histones and the DNA backbone; however, 
unstructured amino- and carboxy-terminal tails are also apparent (Figure 1) (LUGER et al. 1997).  
Histone modifications primarily occur on these histone tails, although modifications in the core 
domains have also been identified. 
Histones can be posttranslationally modified by the phosphorylation of serines, the 
acetylation, ubiquitylation, or sumoylation of lysines, and the methylation of lysines and 
arginines (Figure 2); additional modifications, such as isomerization, ADP-ribosylation and 
deimination, have also been identified (KOUZARIDES 2007; KREBS 2007).  Many histone 
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modifications are conserved throughout eukaryotes, which emphasizes the importance of 
modifying chromatin structure for normal cellular function. 
 9 
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Figure 2.  Posttranslational histone modifications in yeast. 
The four core histones are represented; hexagons symbolize core domains and the sequences of amino- and/or 
carboxy-terminal tails are provided.  By convention, histone H2A is numbered from the methionine at position 1, 
which is cleaved posttranslationally; all other histones are numbered according to the first amino acid present in the 
mature protein.  Modifications on the C-terminal tails of histones H3 and H4 have not been identified; the C-
terminal tails have, therefore, been omitted for simplicity.   Known covalent histone modifications in yeast are 
indicated; acetylation (Ac) is shown in green; phosphorylation (P) is shown in purple; monoubiquitylation (Ub) is 
shown in blue; and methylation (Me) is shown in red.  In several instances, the same residue is known to be 
modified by both acetylation and methylation; these modifications are mutually exclusive.  For simplicity, only the 
most common modification or the modification most relevant to the data contained in this document is shown.   
Select histone modifying enzymes that are of particular relevance to this thesis are illustrated in proximity to their 
sites of action.  Rad6 and Bre1 cooperate to monoubiquitylate histone H2B at K123; Ubp8 and Ubp10 are ubiquitin 
proteases that remove this modification.  Set1, Set2, and Dot1 are histone lysine methyltransferases that catalyze the 
methylation of histone H3 at lysines 4, 36, and 79, respectively.  The same enzyme catalyzes mono-, di-, and 
trimethylation of the particular lysine that it modifies.  The four core histones are also known to be sumoylated, but 
specific sites of sumoylation have not been identified.  This illustration is an adaptation of Figure 1 from KREBS 
2007. 
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Specific enzymes that mediate each type of histone modification have been identified.  In 
many cases, enzymes have also been identified that reverse or remove these modifications.  The 
existence of these classes of enzymes underscores the extreme flexibility of this mode of 
chromatin modification.  Furthermore, the reversibility and complexity of histone modification 
suggests that chromatin, which is generally believed to repress DNA-based processes, is also 
utilized by eukaryotic cells in a regulatory capacity. 
The placement and removal of histone modifications is tightly regulated, both spatially 
and temporally.  This results in the establishment of distinct patterns and combinations of histone 
modifications at specific chromosomal landmarks, such as genes, telomeres, or areas of DNA 
damage.  These carefully crafted domains of histone modification patterns have, therefore, been 
postulated to represent a “histone code” in which specific histone modification patterns elicit 
distinct effects on different DNA-dependent processes (STRAHL and ALLIS 2000). 
Histone modifications are believed to impact chromatin structure in at least three ways:  
the attachment of functional groups to the histones inherently alters their structure, acetylation of 
lysines is believed to weaken histone-DNA interactions by neutralizing the positive charge of 
this residue, and the presence of histone modifications can introduce binding sites for additional 
factors that further modify chromatin structure.  The establishment and consequences of three of 
the most well-studied classes of histone modifications, (acetylation, ubiquitylation, and 
methylation) are described in more detail in the following sections. 
1.2.2.1 Histone Acetylation 
Histone acetylation was the first covalent histone modification to be identified and it 
remains the most common.  The four core histone proteins, H2A, H2B, H3, and H4, are 
acetylated at multiple residues in vivo (Figure 2) and the histone variant H2A.Z is also known to 
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be acetylated.  Histones are acetylated almost exclusively on their amino-terminal tails; although, 
modifications within the histone core domain have also been identified. 
Acetylation of histones is carried out by a group of enzymes known as histone 
acetyltransferases (HATs); individual HATs often possess the ability to modify multiple histone 
lysine residues.  In vitro experiments have demonstrated that HATs often require association 
with additional factors to facilitate acetylation of histones that are incorporated into a 
nucleosomal template.  At least four major HAT-containing complexes have been identified in 
yeast:  SAGA, ADA, NuA3, and NuA4.  The activities of these complexes are carried out by the 
Gcn5 (SAGA and ADA), Esa1, and Sas3 HATs, respectively (ALLARD et al. 1999; GRANT et al. 
1997; JOHN et al. 2000).  Gcn5 specifically acetylates histone H2B at lysines 11 and 16 and 
histone H4 at lysines 9, 14, 18, and 23; Esa1 primarily acetylates histone H4 at lysines 5, 8, 12, 
and 16, but also displays some activity toward lysine 7 of histone H2A; and Sas3 exclusively 
acetylates histone H3 at lysines 14 and 23 (MILLAR and GRUNSTEIN 2006; STERNER and BERGER 
2000).  Several additional HATs, including Hpa3, Hat1, Elp3, Sas2, and Rtt109, have also been 
identified in yeast (KLEFF et al. 1995; OSADA et al. 2001; TSUBOTA et al. 2007; WITTSCHIEBEN 
et al. 1999; YOW et al. 2004). 
 HAT-containing complexes are frequently transcriptional coactivators, which are 
specifically recruited to gene promoters to facilitate gene expression.  It is, therefore, not 
surprising that histone acetylation, primarily of histones H3 and H4, is predominantly associated 
with promoter regions and is almost exclusively linked to transcription activation (KOUZARIDES 
2007; LI et al. 2007a; STERNER and BERGER 2000).  Acetylation has been proposed to weaken 
histone-DNA contacts due to its ability to neutralize the positive charge of the lysine residue to 
which it is attached (HONG et al. 1993).  This idea is supported by the observation that acetylated 
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histones can be evicted from chromatin more easily than their unmodified counterparts (CHANDY 
et al. 2006; ERKINA and ERKINE 2006; GOVIND et al. 2007; WILLIAMS et al. 2008).  Because 
histones are acetylated at multiple residues, it is likely that charge neutralization has a 
cumulative effect whereby histone-DNA contacts are affected more significantly as multiple 
modifications accumulate on a single histone tail.  Histone acetylation has also been postulated 
to promote transcription activation by hindering the compaction of chromatin into higher-order 
structures (KOUZARIDES 2007; SHOGREN-KNAAK et al. 2006).  Many HATs have also been 
implicated in telomeric silencing, chromatin assembly, and DNA repair (COUTURE and TRIEVEL 
2006; MILLAR and GRUNSTEIN 2006). 
 Another function that has been identified for histone acetylation is the recruitment of 
additional chromatin modifying factors.  Acetylated histones are the binding sites for proteins 
that contain bromodomains, which are typically found in ATP-dependent chromatin remodeling 
factors (described in more detail in Section 1.2.3) and other proteins that impact chromatin 
structure (ZENG and ZHOU 2002).  Histone acetylation, therefore, represents a means to target 
additional enzymatic activities to specific locations in the genome. 
 Histone acetylation is actively reversed by enzymes known as histone deacetylases 
(HDACs).  These proteins generally function as gene repressors (KOUZARIDES 2007).  
Additionally, low levels of histone acetylation have been identified within gene coding regions.  
Accumulation of histone acetylation within ORFs can allow aberrant initiation from cryptic 
promoters that become exposed when chromatin structure has been modified to allow the 
passage of Pol II (CARROZZA et al. 2005; JOSHI and STRUHL 2005; LI et al. 2007b).  Histone 
acetylation within coding regions is removed by the Rpd3 HDAC by a mechanism described in 
detail in Section 1.2.2.3. 
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1.2.2.2 Histone Ubiquitylation 
Histones in S. cerevisiae are known to be ubiquitylated on lysine 123 in the carboxy-
terminal tail of histone H2B (H2B K123 Ub) (Figure 2) (ROBZYK et al. 2000).  This modification 
is conserved in higher eukaryotes, which also possess the ability to ubiquitylate histone H2A at 
K119 (NICKEL and DAVIE 1989).  These modifications are primarily limited to 
monoubiquitylation, which is reversible and is believed to signal for involvement in non-
degradation associated functions.  A recent study indicates that histone H2B may also be 
polyubiquitylated, which likely signals for its degradation (GENG and TANSEY 2008). 
 Ubiquitylation of H2B K123 in S. cerevisiae is performed by the Rad6 ubiquitin 
conjugating-enzyme and the Bre1 ubiquitin ligase (Figure 2) (HWANG et al. 2003; ROBZYK et al. 
2000; WOOD et al. 2003a).  An additional factor, Lge1, is found in a complex with Rad6 and 
Bre1 and is also required for H2B K123 Ub, but its role is not clearly defined (HWANG et al. 
2003).  H2B K123 Ub is found along the promoters and coding regions of active genes (Figure 
3), where the enzymes involved in this modification are known to localize; Bre1 is recruited to 
gene promoters by interaction with transcriptional activator proteins, which leads to the 
subsequent recruitment of Rad6 (HWANG et al. 2003; WOOD et al. 2003a; WOOD et al. 2003b; 
XIAO et al. 2005).  However, recruitment alone is not sufficient for Bre1 and Rad6 activation.  
Rad6 associates with Pol II when it transitions to an elongation-competent form and remains 
associated along the entirety of the ORF; this interaction and the presence of a Pol II-associated 
transcription accessory complex, known as the Paf1 complex (described in greater detail in 
Section 1.4.2.1), are required for Rad6 to become catalytically active (XIAO et al. 2005).  
Additionally, in vitro experiments demonstrated that, in addition to Pol II and the Paf1 complex, 
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Rad6 requires the presence of NTPs to transition to an active form, suggesting that transcription 
itself is also required for H2B K123 Ub (PAVRI et al. 2006). 
 16 
 
Figure 3.  Distribution of H2B K123 ubiquitylation and H3 K4, K36, and K79 methylation at a 
typical active yeast gene. 
The open reading frame (ORF) and promoter of a model yeast gene are illustrated at the top.  A typical yeast gene 
contains higher total histone levels in the ORF than at the promoter or immediately downstream of the ORF.  The 
relative abundance of total histones or each of the indicated histone modifications are indicated by the height of the 
curved lines.  Me3 = trimethylation; Me2 = dimethylation; Me1 = monomethylation.  H3 K79 Me refers to all methyl-
lysine states for this residue.  This figure is adapted from Figure 1 in LI et al. 2007a. 
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H2B K123 Ub is rapidly reversed by deubiquitylating enzymes.  In yeast, this activity is 
mediated by the ubiquitin specific proteases Ubp8 and Ubp10 (DANIEL et al. 2004; EMRE et al. 
2005; GARDNER et al. 2005; HENRY et al. 2003).  While the activities of Ubp8 and Ubp10 are 
partially redundant (GARDNER et al. 2005), unique functions have been identified for each of 
these enzymes.  Ubp8 is a component of the SAGA transcriptional coactivator complex, which is 
recruited to gene promoters and also contains HAT activity; integrity of the SAGA complex is 
required for Ubp8 activity (DANIEL et al. 2004; HENRY et al. 2003).  Ubp10 functions 
independently of SAGA and has instead been shown to associate with Sir4, a protein involved in 
establishing transcriptional silencing at the telomeres and rDNA loci (described in more detail in 
Section 1.3).  Accordingly, Ubp10 is required for normal telomeric and rDNA silencing 
(KAHANA and GOTTSCHLING 1999; OSLEY 2006). 
 The exact function of H2B K123 Ub remains unknown, although several models have 
been proposed.  Ubiquitin, a 76 amino acid protein, likely represents a bulky attachment to 
histone H2B, which itself is only 132 amino acids in length.  The presence of a monoubiquitin 
moiety on H2B has, therefore, been postulated to function as a “wedge” that might loosen the 
interaction of the histone octamer with DNA or prevent tight packing of adjacent chromatin 
fibers, thereby making the underlying DNA more accessible to the transcription machinery 
(MURATANI and TANSEY 2003).  It has also been reported that deubiquitylation of H2B K123 Ub 
is required for association of the Ctk1 kinase with transcribing Pol II (WYCE et al. 2007).  Ctk1 
phosphorylates Pol II during transcription elongation at specific sites on an unstructured domain 
at the C-terminus of the largest subunit (JONES et al. 2004).  Ctk1-mediated phosphorylation of 
Pol II is known to stimulate the association of numerous factors involved in chromatin 
modification and mRNA maturation with active Pol II (AHN et al. 2004; LI et al. 2003; 
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LICATALOSI et al. 2002).  Because the association of Ctk1 with Pol II is inhibited until H2B 
K123 Ub is removed, it has been suggested that this modification may function to impose a 
checkpoint during transcription elongation (WEAKE and WORKMAN 2008).  Additionally, H2B 
K123 Ub is known to be a prerequisite for the subsequent methylation of histone H3 at lysines 4 
and 79 (BRIGGS et al. 2002; SUN and ALLIS 2002).  These histone methylation events (described 
in more detail in the following section) are believed to prevent aberrant silencing of 
transcriptionally active regions (NG et al. 2003c); H2B K123 Ub is, therefore, also implicated in 
this process. 
1.2.2.3 Histone Methylation 
Histones can also be modified by the enzymatic addition of methyl groups to arginine and 
lysine residues on histones H3 and H4.  Histone arginine residues can be mono- or dimethylated; 
dimethylation may occur in symmetric or asymmetric configurations (Figure 4; bottom).  The 
arginine residue at position 2 of histone H3 is known to be methylated in S. cerevisiae; this 
modification is typically associated with inactive genes (KIRMIZIS et al. 2007).  To date, enzymes 
that remove histone arginine methylation have not been identified. 
Histone lysine methylation occurs in mono-, di-, or trimethylated forms (Figure 4; top); 
all three methyl-lysine states are mediated by the same enzyme.  Nucleosomes present in the 
bodies of active genes in S. cerevisiae are frequently methylated on histone H3 at lysines 4, 36, 
and 79 (K4, K36, and K79); these modifications are mediated by the Set1, Set2, and Dot1 
methyltransferases, respectively (Figure 2) (BERNSTEIN et al. 2002; LI et al. 2007a; SANTOS-
ROSA et al. 2002; XIAO et al. 2005).  The activity of Set1 and Set2 is carried out by a conserved 
catalytic motif known as a SET domain.  This domain is named for the Drosophila melanogaster 
gene regulators Su(var) 3-9, Enhancer of zeste, and Trithorax, which represent the first proteins 
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in which this domain was identified (JONES and GELBART 1993; TSCHIERSCH et al. 1994).  SET 
domains, which have since been documented in numerous histone lysine methyltransferases 
throughout eukaryotes, were originally characterized by their involvement in heterochromatin 
formation, a process that has subsequently been demonstrated to be highly dependently on global 
patterns of histone modifications (RUSCHE et al. 2003).  Dot1 represents the only known histone 
methyltransferase that lacks a SET domain (FENG et al. 2002).  K4 and K36 are located in the H3 
amino-terminal tail; while K79 is present on the outer surface of the H3 core domain.  The 
different localization of their substrates may account for the unique catalytic motifs present in the 
SET-domain containing histone methyltransferases and Dot1. 
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Figure 4.  The states of methylation on histone lysine and arginine residues. 
Top; Histones can be mono-, di-, or trimethylated on lysine residues.  Bottom; Histones can be mono- or 
dimethylated on arginine residues.  Arginine dimethylation can occur in symmetric or asymmetric configurations.  
This figure is an adaptation of Figure 1 from SHILATIFARD 2006. 
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While Set2 and Dot1 appear to function independently of binding partners, Set1 acts in 
the context of COMPASS (complex of proteins as
Histone H3 lysine methylation occurs in distinct patterns across the bodies of active 
genes.  H3 K4 methylation displays a graded pattern across ORFs in which a peak of 
trimethylation is present at the 5’ end of a gene, dimethylation is enriched in the center of a gene, 
and the 3’ end is marked by monomethylation (Figure 3) (LI et al. 2007a; POKHOLOK et al. 
2005).  H3 K36 di- and tri-methylation are distributed across the coding regions of active genes 
with a slight bias toward the 3’ end (Figure 3); no distinct pattern has been identified for 
monomethylation of H3 K36.  H3 K79 methylation marks nearly all histone H3 in euchromatin, 
which accounts for 90% of the yeast genome (VAN LEEUWEN et al. 2002).  This modification is 
found in the coding regions of active genes, although no particular distribution of individual 
methyl-lysine states is apparent (LI et al. 2007a; POKHOLOK et al. 2005). 
sociated with Set1), which is conserved 
throughout eukaryotes.  In addition to Set1, COMPASS contains Cps60, Cps50, Cps40, Cps35, 
Cps30, Cps25, and Cps15 (MILLER et al. 2001; NAGY et al. 2002; ROGUEV et al. 2001).  
Association of Set1 with other COMPASS subunits is required for its enzymatic activity and 
unique subunits have distinct effects on the fate of COMPASS and the methyl-lysine states that 
can be achieved at H3 K4 (DEHE and GELI 2006; MUELLER et al. 2006; ROGUEV et al. 2001; 
SCHNEIDER et al. 2005):  Cps50 and Cps30 are required for Set1 stability and COMPASS 
integrity and are, therefore, required for all H3 K4 methyl states; loss of Cps25 and/or Cps60 
decreases H3 K4 dimethylation and eliminates H3 K4 trimethylation; and Cps40 specifically 
affects H3 K4 trimethylation, potentially by influencing Set1 stability.  Cps35, which has also 
been found to associate with the RNA 3’ end formation machinery, is essential for cell viability 
(DEHE and GELI 2006; ROGUEV et al. 2001). 
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These distinct patterns of individual histone H3 lysine methylation marks are established 
through several mechanisms.  Set1 and Set2 are specifically recruited to the coding regions of 
active genes through a physical interaction with Pol II itself.  Rpb1, the largest subunit of Pol II, 
features an unstructured “tail” at its carboxy-terminus, which is composed of 26 repeats of a 
tyrosine-serine-proline-threonine-serine-proline-serine (YSPTSPS) consensus heptapeptide 
repeat (ALLISON et al. 1985).  Pol II is phosphorylated on this unstructured domain, known as the 
carboxy-terminal domain (CTD), in a distinct pattern as it transcribes an mRNA.  The serine at 
position 5 (Ser5) of the heptapeptide repeat is phosphorylated during early transcription 
elongation.  Ser5 phosphorylation is erased as Pol II approaches the 3’ end of a gene, while 
phosphorylation of the serine at position 2 (Ser2) concomitantly accumulates (PALANCADE and 
BENSAUDE 2003).  Set1 is known to interact with the Ser5 phosphorylated form of Pol II 
(KROGAN et al. 2003) and Set2 contains a motif that binds directly to the CTD when it is 
phosphorylated at Ser2 (KIZER et al. 2005).  Dot1 is not known to physically interact with Pol II, 
but instead is likely recruited to chromatin through an interaction with a basic patch on the 
surface of histone H4 (FINGERMAN et al. 2007). 
In addition to targeted recruitment of their corresponding histone methyltransferases, H3 
K4 and K79 di- and tri-methylation are also confined to discrete spatial domains through a trans-
histone modification pathway; H2B K123 Ub is a prerequisite for the subsequent di- and 
trimethylation of H3 at these sites (BRIGGS et al. 2002; NG et al. 2002; SUN and ALLIS 2002; 
WOOD et al. 2003b).  Monomethylation of H3 at K4 and K79 does not require H2B K123 Ub 
(DEHE et al. 2005; SHAHBAZIAN et al. 2005).  In vitro studies have demonstrated that 
monoubiquitylation of K120 of human H2B, which corresponds to H2B K123 of S. cerevisiae,  
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leads to methylation of H3 K79 by the human homolog of Dot1 within the same nucleosome 
(MCGINTY et al. 2008).   
Several models have been proposed to explain the mechanism by which H2B K123 Ub 
controls di- and trimethylation of histone H3 at K4 and 79.  In the simplest model, the addition of 
ubiquitin to H2B at K123 decondenses chromatin structure to allow better access of the Set1 and 
Dot1 methyltransferases to their corresponding substrates.  Additionally, a recent study 
demonstrated that H2B K123 Ub is necessary for the recruitment of the COMPASS subunit 
Cps35 to active genes and that this interaction is required for normal di- and trimethylation of H3 
K4 (LEE et al. 2007).  Interestingly, the same study identified a physical interaction between 
Cps35 and Dot1, suggesting that a similar mechanism may also control Dot1’s ability to catalyze 
di- and trimethylation.  The proteasomal ATPases Rpt4 and Rpt6 and the Ccr4-Not mRNA 
production and processing complex are also involved in the steps linking H2B K123 Ub to H3 
K4 and K79 di- and trimethylation, but the mechanism by which these factors participate in this 
process is unclear (EZHKOVA and TANSEY 2004; LARIBEE et al. 2007). 
Histone lysine methylation is a relatively stable mark; it endures for several hours at 
recently transcribed yeast genes despite dissociation of the histone lysine methyltransferases 
from coding regions coincident with cessation of transcription (NG et al. 2003c).  It was, 
therefore, believed that histone lysine methylation was not actively removed and was instead 
turned over slowly as a passive result of the incorporation of unmodified histones during 
subsequent rounds of genome replication.  However, multiple enzymes have recently been 
discovered that possess the ability to enzymatically remove specific methyl marks from histones.  
Two classes of histone lysine demethylases, which utilize unique catalytic mechanisms, have 
been identified:  the first class, represented by LSD1 (lysine specific demethylase 1; originally 
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identified in humans) can remove mono- and dimethylation of H3 K4 (SHI et al. 2004); the 
second class is composed of multiple proteins containing a Jumonji domain.  Histone lysine 
demethylases containing Jumonji domains have been shown to catalyze the removal of di- and 
trimethylation from specific histone lysine residues (KIM and BURATOWSKI 2007; TSUKADA et 
al. 2006).  In spite of the discovery of histone demethylases, histone methylation remains a 
persistent mark.  This suggests that histone lysine demethylases function to fine tune histone 
lysine methylation domains and do not catalyze their complete erasure.  While the effects of 
histone demethylases on global histone methylation levels and transcription are relatively subtle, 
they have been demonstrated to have roles in development in higher eukaryotes (AGGER et al. 
2008). 
Histone lysine methylation is conserved throughout evolution, suggesting that it serves an 
important purpose and experimental evidence implies that these modifications are linked to 
several processes.  H3 K4 and K79 methylation have been proposed to function as a 
transcriptional memory mechanism (NG et al. 2003c).  Because these modifications are present 
on the bodies of active genes and persist for an extended period of time in the absence of 
transcription, histone lysine methylation may represent a means of maintaining recently 
transcribed genes in a state that is poised for reactivation.  The presence of histone lysine 
methylation in recently transcribed coding genes is also known to prevent the spread of 
transcriptional silencing into areas of active gene expression (described in detail in Section 1.3.) 
Additionally, histone lysine methylation is known to introduce binding sites for several 
classes of enzymes that contain chromo-, Tudor, or PHD domains (KREBS 2007).  These histone 
methyl-lysine binding proteins can sometimes discriminate among different methylation states, 
implying that unique stages of methylation can lead to distinct downstream effects.  Proteins 
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containing histone methyl-lysine binding motifs are often found in multisubunit complexes that 
contain enzymatic activity, thus functioning as a mechanism to tether catalytic activity to specific 
sites in the genome.  For example, H3 K36 di- and trimethylation are known to function as 
binding sites for the chromodomain containing Eaf3 protein, a subunit of the Rpd3(S) complex 
(CARROZZA et al. 2005; JOSHI and STRUHL 2005; LI et al. 2007b).  Rpd3 is an HDAC and its 
targeted recruitment to domains where H3 K36 di- and trimethylation are present leads to the 
removal of acetylation from histones present in the bodies of active genes.  Deacetylation of 
histones in coding regions by this mechanism prevents aberrant initiation from cryptic promoters 
present within open reading frames. 
1.2.3 ATP-Dependent Chromatin Remodeling 
An additional method of modifying chromatin is to reposition or restructure nucleosomes to 
facilitate or restrict access to the underlying DNA.  This is achieved through the activity of 
several families of multisubunit complexes, called chromatin remodeling complexes, that contain 
a catalytic subunit with homology to the super family 2 (SF2) of DEAD/H-box nucleic acid-
stimulated ATPases (EISEN et al. 1995).  Although the SF2 family of enzymes includes DNA 
helicases, chromatin remodeling enzymes do not possess helicase activity.   
Chromatin remodeling enzymes are likely recruited to chromatin through interactions that 
are mediated by regulatory subunits present within their respective complexes; the ATPase 
subunits themselves do not appear to possess any sequence specific DNA-binding activity and 
are instead believed to interact with DNA nonspecifically through the phosphodiester backbone.  
Chromatin remodeling enzymes utilize the energy derived from ATP hydrolysis to disrupt the 14 
points of contact between a histone octamer and the DNA backbone (LUGER et al. 1997).  In 
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some cases, disrupting the interactions between histones and DNA is sufficient to permit access 
of DNA-binding proteins to the underlying DNA or to allow the passage of RNA or DNA 
polymerase.   
However, chromatin remodeling complexes do not typically cause only transient 
disruptions in histone-DNA contacts, but rather result in the repositioning, eviction, or 
restructuring of entire nucleosomes.  The current model for how chromatin remodeling enzymes 
facilitate these effects on nucleosome positioning is believed to involve a mechanism of 
intranucleosomal looping (GANGARAJU and BARTHOLOMEW 2007; VAN VUGT et al. 2007).  
Chromatin remodeling enzymes are thought to contact DNA at two points and spool the DNA 
from one contact point through its active site, while holding the other point of contact stationary, 
resulting in the formation of an intranucleosomal loop (Figure 5).  The force of translocating the 
DNA is likely sufficient to disrupt histone-DNA contacts. 
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Figure 5.  Potential mechanism of intranucleosomal looping and nucleosome repositioning induced 
by chromatin remodeling enzymes. 
A chromatin remodeling enzyme (pink) may contact nucleosomal DNA nonspecifically through the phosphodiester 
backbone at two points.  The energy derived from ATP hydrolysis might lead to a shifting of one DNA contact point 
while the second point of contact is held stationary.  This would result in an intranucleosomal loop, as depicted in 
the center illustration.  A nucleosome could be repositioned if the histone octamer forms stable contact with the 
DNA that was translocated into proximity with the histones during formation of the intranucleosomal loop (shown 
in orange).  Propagation of the intranucleosomal loop could then result in shifting of the DNA at the other end of the 
nucleosome (shown in purple).  For simplicity, only one revolution of DNA around the histone octamer is shown.  
This figure is adapted from Figure 5 in GANGARAJU and BARTHOLOMEW 2007. 
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Individual complexes create different lengths of intranucleosomal loops.  It is likely that 
the size of intranucleosomal loop created by a particular complex is responsible for the 
characteristic style of activity by which that complex functions, such as the incorporation of 
histone variants or the formation of regularly spaced nucleosome arrays.  The mechanism by 
which a particular chromatin remodeling complex functions is generally thought to determine 
whether it facilitates or restricts access to the underlying DNA. 
S. cerevisiae contains 8 known chromatin remodeling complexes, which range in 
complexity from 2 to 17 subunits.  Homologs of S. cerevisiae chromatin remodeling complexes 
have been identified in all eukaryotes.  These complexes are split into 4 families, which are 
classified by similarities in their ATPase subunits (GANGARAJU and BARTHOLOMEW 2007).  
SWI2/SNF2-type complexes are characterized by bromodomains, which bind acetylated lysines, 
in their catalytic subunit; ISWI-type complexes contain catalytic subunits that contain SANT and 
SLIDE domains, which facilitate histone tail and DNA binding, respectively, CHD-type 
chromatin remodeling proteins harbor chromodomains that are believed to interact with 
methylated lysines on histones, and INO80-type complexes contain DNA-binding DBINO 
domains in their catalytic subunits.   
In yeast, the SWI2/SNF2 family is represented by the SWI/SNF and RSC complexes; the 
ISWI family is represented by the ISW1a, ISW1b, and ISW2 complexes, the INO80 family is 
represented by the INO80 and SWR1 complexes, and Chd1 is the sole CHD-type chromatin 
remodeling enzyme.  With the exception of the essential RSC complex, different chromatin 
remodeling complexes appear to be somewhat redundant, although each complex also appears to 
fulfill its own unique roles.  Each of these complexes is described in more detail in the following 
subsections. 
 29 
1.2.3.1 SWI/SNF 
SWI/SNF was the first chromatin remodeling complex discovered in yeast.  Mutations in 
genes encoding the members of this complex were identified in independent genetic screens for 
factors that could not activate mating type switching (SWI = mating type swi
The product of the SNF2 gene was found to encode a protein with similarity to the SF2 
family of DEAD/H-box nucleic acid-stimulated ATPases (CAIRNS et al. 1994; VAN VUGT et al. 
2007).  Snf2 was purified as a member of a 12 subunit complex that also contains the products of 
many other SWI and SNF genes (CAIRNS et al. 1994; PETERSON et al. 1994).  This complex was, 
therefore, named SWI/SNF and was found to be present at about 100-200 copies per cell 
(GHAEMMAGHAMI et al. 2003).  In addition to its ATPase domain, Snf2 also contains 
bromodomains and other subunits of SWI/SNF contain ARID, SWIRM, and SANT domains 
which participate in interactions with DNA and histones (GANGARAJU and BARTHOLOMEW 
2007).  SWI/SNF has subsequently been shown to disrupt nucleosome structure and increase 
DNA accessibility to activators in an ATP-dependent manner (COTE et al. 1994); additional 
tching defect) or 
use sucrose as a carbon source (SNF = sucrose non-fermenting) (WINSTON and CARLSON 1992).  
SWI and SNF mutations were discovered to affect overlapping sets of factors.  The likely cause 
of the defects in SWI and SNF mutants was the inability to induce expression of the gene 
encoding the mating type switching HO endonuclease or SUC2, which encodes a sucrose 
hydrolyzing enzyme; these observations suggested SWI and SNF mutants resulted in a general 
defect in transcription activation.  Suppressors of SWI and SNF mutations were generally found 
to relieve the repressive nature of chromatin (LAURENT et al. 1991; PETERSON and HERSKOWITZ 
1992), suggesting a role for factors encoded by SWI and SNF genes in gene activation through 
effects on chromatin structure. 
 30 
biochemical analysis indicates that SWI/SNF functions at individual nucleosomes to create large 
intranucleosomal loops that are approximately 50 bp in length (ZOFALL et al. 2006).  SWI/SNF 
is strongly required for expression of only about 5% of genes in rich medium (SUDARSANAM et 
al. 2000).  However, it is likely that there is a requirement for this complex during activation of 
many genes; this idea is supported by the initial identification of SWI/SNF subunits as 
participating in HO and SUC2 activation.  In addition to its known role in transcription 
activation, less well-defined roles for SWI/SNF have also been identified in rDNA and telomeric 
silencing, nucleotide excision repair, and double strand break repair (VAN VUGT et al. 2007). 
1.2.3.2 RSC 
RSC, which stands for Remodels the Structure of Chromatin, is an additional member of 
the SWI/SNF family of chromatin remodeling complexes in S. cerevisiae.  This complex is 
present in the cell at a 10-fold greater abundance than SWI/SNF (GHAEMMAGHAMI et al. 2003).  
The catalytic component of RSC, Sth1, was identified based on sequence homology to Snf2 
(LAURENT et al. 1992).  Sth1 contains a similar domain composition as Snf2 and creates similar-
sized intranucleosomal loops (VAN VUGT et al. 2007).  RSC is a 17-member complex that exists 
in two isoforms that are defined by the presence or absence of the Rsc3 and Rsc30 subunits; 10 
of the 17 subunits of RSC, including Sth1, are essential for cell viability (CAIRNS et al. 1999).  
This is likely due to a general requirement for RSC in global transcription; 40% of all yeast 
genes are strongly affected by depletion of Sth1 (VAN VUGT et al. 2007). 
RSC likely functions in concert with histone acetylation to maintain global transcriptional 
activity.  Multiple bromodomains are found in the Rsc1, Rsc2, and Rsc4 subunits of RSC, in 
addition to those in the Sth1 ATPase.  Together, the bromodomains present in RSC account for 7 
of the 15 known bromodomains in yeast (VAN VUGT et al. 2007).  The abundance of 
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bromodomains contained in the RSC complex may suggest that RSC is recruited to genes 
through an interaction with acetylated histones.  This idea is supported by the observation that 
RSC stimulates the passage of Pol II through nucleosomes most efficiently in the presence of the 
SAGA and NuA4 histone acetyltransferase complexes (CAREY et al. 2006).  In addition to its 
role in transcription regulation, RSC has also been implicated in sister chromatin cohesion, 
chromosome stability, and DNA repair (VAN VUGT et al. 2007). 
1.2.3.3 ISW1 
The Imitation SWItch, or ISWI, family of chromatin remodeling complexes in yeast is 
represented by ISW1a, ISW1b, and ISW2; these ATPases are present in the cell at approximately 
1500 copies each (GHAEMMAGHAMI et al. 2003).  The ISWI ATPases, Isw1 and Isw2, are very 
similar in structure to SWI/SNF-type ATPases except that they lack bromodomains.  The SANT 
domains of ISWI-type ATPases, known as SLIDE domains (SANT-like ISWI domain) mediate 
the DNA-binding activity of ISWI-family members and are necessary for their full catalytic 
activity (GANGARAJU and BARTHOLOMEW 2007).  The full activity of these enzymes also 
requires interaction with the same basic patch on histone H4 that interacts with the histone lysine 
methyltransferase Dot1 (CLAPIER et al. 2002). 
ISWI-containing complexes are the smallest chromatin remodeling complexes identified; 
the 4 known ISWI-containing complexes in yeast contain only 2 to 4 subunits.  ISW1a is 
composed of Isw1 and Ioc3 and functions primarily at promoters to repress gene expression; 
ISW1b contains Isw1, Ioc2, and Ioc4 and is believed to restore nucleosomes within ORFs, and 
is, therefore, also typically associated with inhibition of transcription (VAN VUGT et al. 2007).  
However, the repositioning of nucleosomes into ORFs by ISW1b may also function to assist in 
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promoter clearance of Pol II during transcription initiation, which suggests that this complex may 
also have a positive impact on transcription (MORILLON et al. 2003). 
ISW1a and ISW1b move nucleosomes in opposite directions in vitro, suggesting that 
regulatory subunits impart directionality to the catalytic subunit (GANGARAJU and 
BARTHOLOMEW 2007; VAN VUGT et al. 2007).  ISW1a creates regularly spaced nucleosome 
arrays (SIF 2004), which are believed to inhibit transcription by restricting access to the 
underlying DNA.  ISWI-type ATPases result in the formation of considerably smaller 
intranucleosomal DNA loops than SWI/SNF family members; the loops created by ISWI-type 
ATPases appear to measure only about 10 bp in length (ZOFALL et al. 2006). 
1.2.3.4 ISW2 
The Isw2 ATPase forms a complex with Itc1, Dbp4, and Dls1, which is believed to have 
a role in maintenance of telomeric silencing and in preventing inappropriate antisense 
transcription (WHITEHOUSE et al. 2007) (IIDA and ARAKI 2004).  A complex consisting of only 
Isw2 and Itc1 has also been identified; this two subunit complex appears to be recruited to gene 
promoters through interaction with the transcriptional repressor Ume6 and functions in parallel 
with the Rpd3(L) histone deacetylase complex to repress gene expression (VAN VUGT et al. 
2007). 
Isw2-containing complexes are thought to function in a primarily repressive capacity, 
similar to their Isw1-containing counterparts.  Isw2 also functions to create regularly spaced 
nucleosome arrays, although the activity of this enzyme does not appear to be as tightly regulated 
as that of Isw1.  Isw2 results in the spacing of nucleosomes approximately every 200 bp, while 
Isw1-positioned nucleosomes are about 175 bp apart (GANGARAJU and BARTHOLOMEW 2007). 
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1.2.3.5 CHD1 
Chd1 is the sole representative of the CHD (chromodomain helicase DNA-binding)-type 
ATPase in yeast cells.  It shares significant domain similarity to Snf2, but also contains two 
chromodomains, which recognize methyl-lysine residues on histones (WOODAGE et al. 1997).  
The presence of chromodomains suggests that Chd1 might be targeted to active chromatin 
through a physical interaction with methylated H3 K4, but conflicting data regarding this 
interaction have been reported in yeast (OKUDA et al. 2007; PRAY-GRANT et al. 2005).  The 
normal expression of about 2-4% of all yeast genes requires Chd1, which is present at about 
1600 copies per cell (GHAEMMAGHAMI et al. 2003; TRAN et al. 2000).  This chromatin 
remodeling enzyme demonstrates the ability to reposition nucleosomes, but does not create large 
stretches of free DNA like those created by SWI/SNF (TRAN et al. 2000). 
Chd1 interacts with chromatin throughout the yeast genome (SIMIC et al. 2003; TRAN et 
al. 2000).  It is known to associate with the SAGA transcriptional coactivator/histone 
acetyltransferase complex, implying a potential role in transcription activation (PRAY-GRANT et 
al. 2005).  However, yeast Chd1 also physically interacts with the Paf1 and Spt4/Spt5 
transcription elongation complexes and human CHD1 co-immunoprecipitates the FACT histone 
chaperone/transcription elongation complex (SIMIC et al. 2003; SIMS et al. 2007); these 
interactions strongly suggest a role for Chd1 in transcription elongation. 
1.2.3.6 INO80 
The INO80 family of chromatin remodeling proteins is the most recently identified class 
of these factors in yeast.  The catalytic components (Ino80 and Swr1) of these complexes 
(INO80 and SWR1) are characterized by a split ATPase domain that contains a large spacer 
region (GANGARAJU and BARTHOLOMEW 2007).  The INO80 complex, which is composed of 15 
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subunits, is present at about 7000 copies per cell and is necessary for normal transcription of 
about 150 genes (GHAEMMAGHAMI et al. 2003; JONSSON et al. 2001).   
Ino80 contains Rvb1 and Rvb2; these proteins share homology with the bacterial 
Holliday junction helicase RuvB and impart 3’-5’ helicase activity to the INO80 complex (SHEN 
et al. 2000).  Additionally, the INO80 complex contains actin and three actin-related proteins 
(ARPs), Arp4, Arp5, and Arp8.  While the exact mechanism by which ARPs participate in 
chromatin remodeling is not understood, they have been hypothesized to interact with histones or 
components of the nuclear matrix (SIF 2004; VAN VUGT et al. 2007). 
In addition to its known role in regulating a subset of yeast genes, the INO80 complex 
has also been implicated in DNA repair.  Mutations in INO80 complex members result in an 
increased sensitivity to DNA-damaging agents (MORRISON et al. 2004; VAN ATTIKUM et al. 
2004).  INO80 is targeted to DNA double stranded breaks through an interaction of the Arp4 
subunit with H2A that is phosphorylated on serine 129 in response to DNA damage (DOWNS et 
al. 2004).  However, the exact mechanism by which INO80 participates in the repair of DNA 
double strand breaks is not well understood. 
1.2.3.7 SWR1 
The SWR1 (SWI-related) complex, which is composed of 15 subunits, is present at about 
700 copies per cell (GHAEMMAGHAMI et al. 2003; KOBOR et al. 2004; VAN VUGT et al. 2007).  
The catalytic component of this complex, Swr1, participates in the only known example of ATP-
dependent chromatin remodeling that results in the incorporation of a histone variant.  Swr1 
physically interacts with H2A.Z and catalyzes the replacement of canonical H2A/H2B dimers 
with H2A.Z/H2B dimers (KOBOR et al. 2004; MIZUGUCHI et al. 2004).  This exchange happens 
primarily at gene promoters (ZHANG et al. 2005).  H2A.Z/H2B dimers are more easily displaced 
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from chromatin than their canonical counterparts and are, therefore, believed to poise genes for 
activation (ZHANG et al. 2005).  Although the exact mechanism by which the SWR1 complex is 
targeted to promoters is not entirely understood, its recruitment may be facilitated by interaction 
of two bromodomains within the Bdf1 subunit with acetylated histones (VAN VUGT et al. 2007).  
In addition to its effects on transcription through H2A.Z incorporation, the SWR1 complex is 
also known to have roles in DNA repair and preventing the spread of telomeric silencing 
(GANGARAJU and BARTHOLOMEW 2007). 
1.3 TELOMERIC SILENCING IS CONTROLLED BY GLOBAL PATTERNS OF 
HISTONE MODIFICATION 
Structural segments of linear chromosomes, such as telomeres and centromeres, are assembled 
into compact, transcriptionally silent heterochromatin domains.  Compaction of these areas of the 
genome is believed to protect their structural integrity, in part, by excluding the transcription 
machinery and other DNA-based enzymes from accessing the genomic material in these regions.  
In S. cerevisiae, rDNA repeats and the mating type loci are also actively silenced to properly 
control their expression.  Because transcriptional silencing of the telomeres is the category of 
silencing that is most relevant to the data presented in this document, the remainder of this 
section focuses specifically on establishment and maintenance of this type of silencing.  
However, silencing of rDNA repeats and the mating type loci are carried out by similar, though 
not identical, mechanisms (RUSCHE et al. 2003). 
Telomeric DNA is composed of repetitive sequences that contain binding sites for the 
sequence specific DNA binding protein Rap1 (CONRAD et al. 1990).  The silent information 
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regulator (Sir) proteins Sir4 and Sir2 form a complex that is recruited to the telomeres by a 
physical interaction between Rap1 and Sir4 (MORETTI et al. 1994).  Sir2 is an HDAC that 
functions to deacetylate the amino-terminal tails of histones H3 and H4 in nearby telomeric 
nucleosomes (LANDRY et al. 2000; SMITH et al. 2000).  Hypoacetylated histone H3 and H4 tails 
are bound tightly by Sir4 and also recruit a third Sir family member, Sir3 (HECHT et al. 1995).  
Recruitment of Sir4 to hypoacetylated H3 and H4 tails results in the arrival of additional 
molecules of Sir2 as part of the Sir4-Sir2 complex.  Multiple cycles of Sir2-dependent histone 
deacetylation followed by recruitment of Sir3 and the Sir4-Sir2 complex leads to the spreading 
of these factors over several kilobases of DNA.   
Telomere-associated Sir proteins bind tightly to each other, leading to compaction of the 
underlying DNA.  This creates a dense and highly ordered arrangement of nucleosomes in 
telomeres.  The tightly packed Sir proteins and closely spaced nucleosomes create a barrier that 
results in inaccessibility of the underlying genomic DNA to DNA-binding proteins. 
Transcriptional silencing of the telomeres is highly dependent on global histone 
modification patterns.  In addition to the absence of histone H3 and H4 acetylation, telomeric 
nucleosomes also lack H2B K123 Ub and H3 K4 and K79 methylation (BERNSTEIN et al. 2002; 
NG et al. 2003a; SANTOS-ROSA et al. 2004; VAN LEEUWEN et al. 2002).  H2B K123 Ub is likely 
excluded from histones in the telomeres due to the known physical interaction between the 
Ubp10 deubiquitylating enzyme and Sir4 (GARDNER et al. 2005; KAHANA and GOTTSCHLING 
1999).  Because H2B K123 Ub is a prerequisite for H3 K4 and K79 methylation, the active 
exclusion of H2B K123 Ub from telomere-associated histones likely prevents H3 K4 and K79 
methylation in these nucleosomes.  H3 K4 and K79 methylation that was present when silencing 
was established is likely eliminated by histone replacement during subsequent rounds of genome 
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replication.  However, it is also possible that histone demethylases are involved in the removal of 
H3 K4 and K79 methylation from telomeric nucleosomes. 
The enzymes required for H2B K123 Ub and H3 K4 and K79 methylation are necessary 
for normal telomeric silencing (HUANG et al. 1997; KROGAN et al. 2002a; VAN LEEUWEN et al. 
2002).  The absence of these enzymes leads to an abundance of hypomodified histone tails 
throughout the genome, which results in titration of the Sir proteins away from the telomere (NG 
et al. 2003b).  If the Sir proteins are not present at a high enough concentration in telomeric 
regions, DNA compaction is not achieved thereby allowing the transcription machinery and 
other DNA-binding proteins to access the underlying DNA.  Because H2B K123 Ub and H3 K4 
and K79 methylation inhibit the formation of silenced chromatin, it is likely that a major function 
of the specific targeting of these modifications to the bodies of actively transcribed genes is to 
protect areas of ongoing or recent gene activity from being silenced incorrectly. 
1.4 TRANSCRIPTION BY RNA POLYMERASE II IS HIGHLY REGULATED BY 
ACCESSORY PROTEINS 
The genetic information contained in DNA is copied into RNA by the activity of RNA 
polymerases.  Three major RNA polymerases exist in eukaryotic cells:  Pol I, Pol II, and Pol III.  
Pol I transcribes ribosomal RNA (rRNA); Pol III primarily transcribes transfer RNA, but also 
transcribes 5S rRNA.  Transcription of protein coding genes into messenger RNA (mRNA) is 
carried out by Pol II; this enzyme also catalyzes the expression of several species of noncoding 
RNAs, including small nuclear RNAs and small nucleolar RNAs.   
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Pol II is a highly conserved 550 kDa complex that is composed of 12 subunits (CRAMER 
2004).  Structural studies of Pol II indicate that it adopts a “crab claw”-like configuration.  The 
upper and lower “jaws” are composed primarily of the two largest subunits of Pol II:  Rpb1 and 
Rpb2 (Figure 6) (CRAMER et al. 2000; KETTENBERGER et al. 2004).  Template DNA is funneled 
through this cleft, where the Watson and Crick strands are separated and brought into contact 
with the active site of the polymerase.  Individual nucleotides enter the active site through a 
channel (CRAMER et al. 2000) and base pair with the template strand where Pol II catalyzes the 
formation of a phosphodiester bond between the arriving nucleotides.  The “bubble” introduced 
between the Watson and Crick strands of the DNA can accommodate an RNA-DNA hybrid that 
measures approximately 8 nucleotides in length (KETTENBERGER et al. 2004).   
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Figure 6.  The crystal structure of RNA Polymerase II. 
The crystal structure of Pol II was solved in complex with template DNA and a short RNA product (Reprinted from  
KETTENBERGER et al. 2004, Copyright 2004, with permission from Elsevier).  Two views (left = side view; right = 
top view) are shown.  Pol II subunits 1-12 (Rpb1-Rpb12) are colored according to the key shown between the two 
structural representations.  Template DNA, nontemplate DNA, and product RNA are shown in blue, cyan, and red, 
respectively; downstream DNA is shown in light pink. 
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As the length of the RNA chain increases, it exits the polymerase through a channel that 
emerges near the carboxy-terminus of Rpb1 (KETTENBERGER et al. 2004).  This places the 
growing RNA in close proximity to the Rpb1 carboxy-terminal domain (CTD) (KETTENBERGER 
et al. 2004).  In yeast, the CTD is composed of 26 repeats of the heptapeptide consensus 
sequence YSPTSPS, which are unstructured in crystallographic studies (ALLISON et al. 1985).  
The CTD is highly conserved throughout eukaryotes, although the number of repeats increases 
with the complexity of the organism.  The CTD is a unique feature of Pol II that is not present on 
the largest subunits of Pols I and III. 
Removal or substantial truncation of the Rpb1 CTD results in lethality in yeast (WEST 
and CORDEN 1995), which likely reflects its critical role in coordinating the cotranscriptional 
processing of nascent RNAs.  Transcription of an mRNA consists of distinct initiation, 
elongation, and termination stages.  The CTD of Rpb1 is phosphorylated in a characteristic 
pattern as Pol II progresses through each transcriptional stage (Figure 7), which influences the 
association of unique classes of RNA processing factors with the CTD; at a minimum, these 
factors participate in adding a 5’ cap and 3’ polyadenylated (poly(A)) tail to an emerging pre-
mRNA to produce a mature mRNA.  The importance of the CTD in coordinating 
cotranscriptional pre-mRNA processing is further supported by the identification of over 100 
yeast proteins that interact with the CTD (PHATNANI et al. 2004).  The emergence of the nascent 
RNA from a channel near the CTD places it in close proximity to processing factors that bind to 
the polymerase through this domain; this likely facilitates the coupling of transcription to pre-
mRNA processing. 
The association of pre-mRNA processing factors is influenced by the phosphorylation 
state of the CTD, which changes dynamically during the transcription cycle (Figure 7) (BENTLEY 
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2005; KOMARNITSKY et al. 2000; PALANCADE and BENSAUDE 2003; PRELICH 2002).  During 
transcription initiation, when Pol II is recruited to a gene promoter, the CTD is un- or 
hypophosphorylated.  Coincident with the release of Pol II into the ORF at the onset of 
transcription elongation, CTD repeats become phosphorylated specifically on the serine at 
position 5 (Ser5) by the protein kinase Kin 28.  Ser5-phosphorylated CTD repeats facilitate the 
binding of enzymes that participate in processing of the pre-mRNA 5’ end, including the 7-
methyltransferase Abf1, the guanylyltransferase Ceg1, and the RNA triphosphatase Cet1 which 
catalyze the addition of a methylguanosine cap to the pre-mRNA at the 5’ end.  Capping of the 
pre-mRNA appears to positively influence transcription elongation, suggesting that checkpoints 
exist throughout the transcription cycle to ensure an emerging RNA is properly maturing. 
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Figure 7.  Phosphorylation of the CTD is dynamically regulated throughout the transcription cycle. 
The predominant form of Pol II recruited to the promoter during PIC formation is un- or hypomodified on the Rpb1 
CTD.  Coincident with promoter escape and the transition to early elongation, CTD repeats become phosphorylated 
on Ser5 by Kin28; this facilitates the recruitment of the pre-mRNA capping enzymes, which catalyze the addition of 
a methylguanosine cap to the 5’ end of the emerging RNA (shown in orange).  As transcription continues, Ser5 
phosphorylation is removed from the CTD repeats by Ssu72, and the CTD is concomitantly phosphorylated on Ser2 
by the Ctk1 kinase.  Ser2 phosphorylated CTD repeats are essential for the recruitment of many cleavage, 
polyadenylation, and termination factors; the association of these factors peak during late elongation and as Pol II 
traverses the poly(A) site.  Downstream of the poly(A) site, CTD phosphorylation at Ser2 is removed by the Fcp1 
phosphatase and the polymerase dissociates from the template.  Dephosphorylation of Pol II renders it competent to 
initiate another round of transcription.  This figure is an adaptation of Figure 1 in PRELICH 2002. 
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As transcription progresses, Ser5 phosphorylation is removed by the Ssu72 phosphatase, 
resulting in a graded pattern of Ser5 phosphorylation across the ORF in which it is highest at the 
5’ end.  Conversely, CTD repeats are phosphorylated on the serine at position 2 (Ser2) by the 
Ctk1 kinase beginning in early elongation and intensifying as the polymerase reaches the 3’ end 
of the ORF.  The activity of Ctk1, therefore, results in a Ser2 phosphorylation pattern that is 
inverse to that of Ser5 phosphorylation.  Phosphorylation of CTD repeats at Ser2 facilitates the 
recruitment of factors involved in late transcriptional events including 3’ end processing, 
transcript termination, and mRNA export (described in more detail in Sections 1.4.3 and 1.4.4).  
As Pol II encounters the polyadenylation site, Ser2 phosphorylation is removed by the Fcp1 
phosphatase.  This restores the CTD to its unmodified form, thus rendering the polymerase 
competent to reinitiate transcription of additional RNAs once it dissociates from the template. 
In addition to the CTD-interacting factors described here, a plethora of additional 
proteins participate in transcription.  These factors facilitate recruitment of Pol II to gene 
promoters, modification of the chromatin template during transcription, reactivation of stalled 
polymerases, 3’ end formation of the RNA, transcript termination, and export of mRNA to the 
cytoplasm for translation.  Factors that play prominent roles in these processes are detailed in the 
following sections. 
1.4.1 Promoter Binding and Transcription Initiation 
Genes are divided into coding regions and control regions.  Coding regions contain the 
DNA sequence information necessary to instruct production of the gene’s RNA or protein 
product.  Control regions, or promoters, are composed of various DNA sequence elements that 
direct the binding and positioning of transcriptional activators, coactivators, and the basal 
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transcription machinery.  Approximately 20% of eukaryotic promoters contain an element 
known as a TATA box, which generally conforms to the consensus sequence 
TATA(A/T)A(A/T)N and is found approximately 40 to 120 bases upstream of the transcription 
start site in S. cerevisiae (BASEHOAR et al. 2004; BUCHER 1990; STRUHL 1989).  The TATA box 
is involved in assembly and positioning of the preinitiation complex (PIC), which is composed of 
Pol II and several general transcription factors (GTFs).   
Eukaryotic promoters contain several additional conserved sequence elements that 
contribute to transcription initiation.  The initiator (Inr) element defines the transcription start site 
and generally contains an adenosine at the transcription start site, a cytosine at the -1 position, 
and several neighboring pyrimidines (SMALE and KADONAGA 2003).  Many TATA-less 
promoters in higher eukaryotes also contain a downstream promoter element (DPE).  This 
element contains sequences that interact with the GTFs TFIID and TFIIB to define the site of 
PIC assembly in the absence of a TATA box (KUTACH and KADONAGA 2000; SMALE and 
KADONAGA 2003).  Many gene promoters also contain upstream activating sequences (UASs) or 
upstream repressing sequences (URSs); these sequence elements frequently contain binding sites 
for sequence-specific transcriptional activators or repressors. 
1.4.1.1 Assembly of the Preinitiation Complex  
Pol II is insufficient to initiate transcription on its own and requires interaction with the 
GTFs to stably associate with gene promoters (HA et al. 1993).  In vitro experiments 
demonstrated that the GTFs assemble sequentially into the PIC during transcription activation 
(Figure 8) (BURATOWSKI et al. 1989; FANG and BURTON 1996; HA et al. 1993).  The first step in 
PIC assembly is binding of the TATA binding protein (TBP) to the TATA box.  TBP, which is 
encoded by the SPT15 gene in S. cerevisiae, is a component of the GTF TFIID.  In addition to 
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TBP, TFIID also contains at least 12 TBP-associated factors, or TAFs, which interact with 
promoter sequences other than the TATA box, as well as activators and coactivators, to enhance 
or restrict interaction of TBP with the TATA box (WOYCHIK and HAMPSEY 2002).  At TATA-
less promoters, the TAFs and the GTF TFIIB are critical for positioning the PIC through 
association with other promoter elements.  Binding of TFIID to the TATA box is enhanced by 
the subsequent association of TFIIA (ORPHANIDES et al. 1996).  PIC formation continues with 
the recruitment of TFIIB, which interacts asymmetrically with the DNA upstream and 
downstream of TATA-associated TFIID.  Transcription generally initiates from a PIC in only 
one direction, and the asymmetrical binding of TFIIB is thought to impart this directionality 
(NOGALES 2000).  TFIIB physically interacts with a complex of TFIIF and Pol II, which is 
unmodified on its CTD, and recruits it to the promoter (FLORES et al. 1989).  The association of 
Pol II-TFIIF stabilizes the interaction of TFIIB and TFIID with promoter DNA and facilitates the 
recruitment of TFIIE (BURATOWSKI et al. 1989; FLORES et al. 1989).  TFIIE appears to assist 
closure of Pol II around the DNA template and to stimulate TFIIH’s catalytic activities 
(NOGALES 2000; WOYCHIK and HAMPSEY 2002).  TFIIH, the final GTF recruited to the PIC, 
contains at least two known catalytic functions.  It contains two helicases of opposite polarity, 
Rad3 and Rad25, which are believed to unwind the DNA template to facilitate Pol II binding 
(GUZMAN and LIS 1999; WOYCHIK and HAMPSEY 2002).   
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Figure 8.  Assembly of the preinitiation complex. 
The preinitiation complex (PIC) is composed of Pol II and several general transcription factors (GTFs).  In vitro, the 
GTFs and Pol II are recruited in a stepwise fashion, as described in the text; the order of GTF and Pol II recruitment 
is illustrated.  Following promoter escape, a subset of GTFs remains at the promoter to facilitate additional rounds of 
transcription.  This figure is an adaptation of Figure 1 in MARTINEZ 2002. 
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Although PIC assembly is complete upon the association of TFIIH, in vitro experiments 
have demonstrated that Pol II does not immediately transition to an elongation-competent form.  
Initially, Pol II remains associated with the promoter as it generates short 8-10 bp transcripts; a 
phenomenon known as abortive initiation.  The exact trigger that releases Pol II from the 
promoter is not entirely understood, but it appears to involve a stable association with the 
template DNA and the availability of necessary cofactors and nucleotides (DVIR 2002).  
Additionally, Pol II becomes phosphorylated at Ser5 coincident with promoter escape; this 
activity is mediated by the Kin28 kinase, which is a subunit of TFIIH (MARTINEZ 2002; PRELICH 
2002).  Whether Ser5 phosphorylation precedes or immediately follows promoter escape is 
unknown.  Upon promoter clearance, a subset of the GTFs remain assembled at the promoter, 
often in contact with activator and coactivator proteins, which facilitates reinitiation during 
subsequent rounds of transcription of the same gene (MARTINEZ 2002; YUDKOVSKY et al. 2000). 
The stepwise model of PIC assembly was determined through in vitro experiments.  It 
has also been proposed that the PIC may be recruited to gene promoters as a “holoenzyme” in 
which Pol II is preassembled with the GTFs and coactivator proteins (BURATOWSKI 2000).  In 
vivo PIC formation likely proceeds by a mechanism that is intermediate to the stepwise and 
holoenzyme models and that the precise pathway of PIC formation is likely to differ at individual 
promoters.  
1.4.1.2 Transcriptional activators and coactivators 
The PIC is sufficient to support basal transcription from a promoter, but the level of gene 
expression must often be enhanced or reduced to meet the physiological needs of the cell.  The 
intensity and timing of gene expression is generally controlled through the regulated binding of 
sequence-specific DNA binding proteins, known as transcriptional activators or repressors, to 
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sites within the gene promoter.  Transcriptional activators, such as Gal4, Gcn4, and Swi5 in S. 
cerevisiae, are typically composed of a DNA binding domain and an activation domain.  The 
DNA binding domain of a transcriptional activator interacts with a binding site in the promoters 
of its target genes.  Activation domains enhance transcription by physically interacting with the 
basal transcription machinery and facilitating its association with the promoter or by recruiting 
coactivators (discussed in more detail in the following paragraph).  Transcriptional repressors 
generally function to antagonize assembly of the PIC, block the access of transcriptional 
activators to their binding sites, or interfere with the downstream functions of activators by 
physically interacting with activation domains. 
Coactivators, which are generally thought to lack sequence-specific DNA-binding 
activity, are typically recruited to promoters through physical interactions with transcriptional 
activators.  Coactivators usually function either to establish a physical link between the 
transcriptional activator and Pol II or to modify chromatin structure at the promoter; both of 
these modes of functionality are believed to assist PIC formation.  Coactivator proteins that are 
known to influence the structure of promoter chromatin include the SWI/SNF chromatin 
remodeling complex and the SAGA HAT complex.  These proteins appear to stimulate 
transcription by creating a more accessible chromatin structure at the promoter that facilitates 
binding of the GTFs and Pol II.  Mediator, which is composed of 20 subunits, is the most 
recognizable representative of coactivators that function to facilitate and stabilize the binding of 
Pol II at gene promoters.  This complex, which is believed to function at the majority of yeast 
promoters, physically interacts with many transcriptional activators and with Pol II (KORNBERG 
2005).  Mediator has also been demonstrated to interact with several transcriptional repressors to 
inhibit transcription initiation.  Several of the TAFs associated with TFIID also function as co-
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activators that appear to stabilize TBP binding through interaction with transcriptional activators 
and promoter elements (FEATHERSTONE 2002; WOYCHIK and HAMPSEY 2002). 
1.4.2 Transcription Elongation 
Once Pol II clears the promoter, it enters the ORF and begins incorporating free nucleotides into 
a growing RNA chain during the elongation phase of the transcription cycle.  Transcription 
elongation is a highly regulated process which requires numerous accessory factors.  
Crystallographic studies have demonstrated that the structure of Pol II is modified in several 
ways following the initiation to elongation transition (GNATT 2002); these structural 
modifications may generate new protein-protein interaction surfaces which function to recruit 
transcription elongation factors to the transcribing polymerase.  Transcription elongation factors 
have been identified that physically interact with Pol II to coordinate cotranscriptional 
modification of the nascent mRNA or chromatin and to reactivate Pol II that has stalled or 
arrested within the ORF.  Additional factors are known to associate directly with the chromatin 
template to modulate its structure during transcription.  Four yeast transcription elongation 
factors with particular relevance to the data presented in this document, the Paf1 complex, the 
Spt4/Spt5 complex, TFIIS, and yFACT, are described in more detail in the following sections. 
1.4.2.1 Paf1 complex 
The S. cerevisiae Paf1 complex, minimally composed of Paf1, Ctr9, Rtf1, Cdc73, and 
Leo1, colocalizes with Pol II from the transcription start site to the poly(A) site of actively 
transcribed genes (KAPLAN et al. 2005; KROGAN et al. 2002b; MUELLER and JAEHNING 2002; 
POKHOLOK et al. 2002; SIMIC et al. 2003; SQUAZZO et al. 2002).  In the absence of Rtf1 or 
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Cdc73, the remaining Paf1 complex subunits remain physically associated with each other, but 
are not recruited to genes and no longer interact with Pol II (MUELLER et al. 2004).  Paf1, Cdc73, 
and Rtf1 are present in the cell at about 25,000 copies each, which is roughly equivalent to the 
expression level of Rpb3 (the 3rd largest subunit of Pol II) (MUELLER et al. 2004; PORTER et al. 
2005); this suggests that there is a Paf1 complex available for interaction with every Pol II in an 
individual cell.  Consistent with this idea, the Paf1 complex has been found to associate with 
every active ORF that has been tested. 
Despite their ubiquitous association with active genes, the subunits of the Paf1 complex 
are not essential for cell viability.  However, deletion of genes encoding the Paf1 complex results 
in numerous phenotypes.  Deletion of CTR9 and PAF1 result in a severe growth defect, deletion 
of CDC73 causes an intermediate growth phenotype, and deletion of RTF1 or LEO1 cause only 
minor or undetectable effects on cell growth (BETZ et al. 2002).  This pattern of mutational 
severity (paf1∆ = ctr9∆ > cdc73∆ > rtf1∆ = leo1∆) is reflected in several other phenotypes 
caused by deletion of the genes encoding the Paf1 complex.  These phenotypes include genetic 
interaction with CTD truncations or deletion of the gene encoding the H3 K36 methyltransferase 
Set2 and sensitivity to the base analog 6-azauracil (6-AU) (CHU et al. 2007; SQUAZZO et al. 
2002).  These observations suggest that individual subunits of the Paf1 complex are necessary 
for distinct functions. 
Microarray and other gene expression analyses have determined that the Paf1 complex 
affects the expression of a subset of genes.  Most genes whose expression is affected by the Paf1 
complex are involved in cell wall biosynthesis, rRNA maturation, and cell cycle progression 
(KOCH et al. 1999; PENHEITER et al. 2005; PORTER et al. 2005).  Accordingly, deletion of PAF1 
causes phenotypes associated with cell wall defects and a decreased tolerance to cell stress (BETZ 
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et al. 2002).  These phenotypes include sensitivity to high temperature, caffeine, and SDS.  
Interestingly, 68% of genes who expression is downregulated in a paf1∆ strain are essential, and 
many of these genes are also downregulated in the absence of Ctr9 (PENHEITER et al. 2005).  
These observations likely account for the severe growth defects observed in paf1∆ and ctr9∆ 
cells.   
The severity of phenotypes caused by loss of Paf1 or Ctr9 may also be accounted for by 
the observation that these subunits are required for normal levels of Rtf1, Cdc73, and Leo1, 
while the reverse effect is not observed (MUELLER et al. 2004; PORTER et al. 2005).  Intriguingly, 
Paf1 and Ctr9 appear to retain functionality even when they are not associated with active genes 
or Pol II (MUELLER et al. 2004); this observation is supported by the less severe growth defect 
observed in rtf1∆ or cdc73∆ strains, in which the remaining Paf1 complex subunits are no longer 
associated with chromatin, as compared to the extreme slow growth of paf1∆ and ctr9∆ strains. 
The Paf1 complex has been linked to the initiation, elongation, and termination stages of 
transcription.  Database analyses indicate that the subunits of the Paf1 complex contain no 
recognizable functional motifs or domains suggestive of catalytic activity in their primary amino 
acid sequences.  Instead, the Paf1 complex may represent a recruitment platform for other factors 
that positively stimulate transcription. 
Paf1 and Cdc73 were initially purified in association with a component of the GTF TFIIH 
and Rpb1 that is unphosphorylated on its CTD (the predominant form of Pol II found in the PIC) 
(SHI et al. 1997).  However, subsequent studies have demonstrated that a significantly greater 
amount of Paf1 complex interacts with Rpb1 that is phosphorylated at Ser5 or Ser2 of the CTD 
(MUELLER et al. 2004; QIU et al. 2006).  This observation suggests that the Paf1 complex 
predominantly associates with elongating polymerase.  Additionally, expression of luciferase 
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was unaffected by the deletion of Paf1 in strains where the gene encoding luciferase was placed 
under the control of promoters from genes that depend on the Paf1 complex for normal 
expression (PENHEITER et al. 2005).  These observations suggest that the Paf1 complex does not 
play a major role in transcription initiation. 
The presence of the Paf1 complex across the entirety of active ORFs implies that this 
complex functions during transcription elongation.  An initial link between the Paf1 complex and 
transcription elongation was suggested by the results of a screen for factors that become essential 
in the absence of the Paf1 complex subunit Rtf1.  This screen identified mutations in the CTD 
Ser2 kinase Ctk1, the CTD Ser2 phosphatase Fcp1, and the Pob3 component of the yFACT 
histone chaperone/transcription elongation complex (COSTA and ARNDT 2000); these factors all 
have established roles in transcription elongation.  The Rtf1 subunit of the Paf1 complex is also 
known to physically interact with the Chd1 chromatin remodeling enzyme, which has been 
linked to transcription elongation, and this interaction is necessary for normal recruitment of 
Chd1 to active genes (SIMIC et al. 2003). 
Additional subunits of the Paf1 complex have subsequently been implicated in 
transcription elongation.  Deletion of the genes encoding subunits of the Paf1 complex results in 
genetic interaction with mutations in known elongation factors (Spt4, Spt5, and TFIIS) and  
sensitivity to the base analog 6-AU (SQUAZZO et al. 2002).  Exposure to 6-AU results in 
reduction of intracellular nucleotide pools (EXINGER and LACROUTE 1992); this is believed to 
increase polymerase stalling and arrest and result in a greater dependence on elongation factors 
for normal transcription.  Therefore, sensitivity to 6-AU is a hallmark of defects in transcription 
elongation.  Physical interactions have been identified between the Paf1 complex and other 
protein complexes which are known to affect transcription elongation, including the Spt4/Spt5 
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and yFACT complexes (Figure 9) (SQUAZZO et al. 2002).  Additionally, the Spt4/Spt5 and 
Bur1/Bur2 transcription elongation complexes are necessary for normal recruitment of the Paf1 
complex to active genes (LARIBEE et al. 2005; QIU et al. 2006). 
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Figure 9.  Physical interactions and functions of the Paf1 complex. 
The Paf1 complex physically interacts with the Spt4/Spt5 and yFACT transcription elongation complexes.  The 
Spt4/Spt5 and Bur1/Bur2 complexes are required for association of the Paf1 complex with active genes; a physical 
interaction between the Paf1 and Bur1/Bur2 complexes has not been demonstrated.  The Paf1 complex is required 
for normal levels of Ser2 CTD phosphorylation, which is necessary for normal recruitment of the H3 K36 
methyltransferase Set2 and several factors involved in RNA 3’ end formation.  Rtf1 is known to physically interact 
with Chd1 and mediate its full recruitment to active ORFs.  Subunits of the Paf1 complex are also required for 
normal association of the Rad6 ubiquitin conjugating enzyme and the COMPASS complex (which contains the Set1 
H3 K4 methyltransferase) with active genes.  In addition to its role in the recruitment of histone modifying enzymes, 
the Paf1 complex affects multiple covalent histone modifications:  H2B K123 Ub and methylation of H3 at K4, 
K36, and K79.  The Paf1 complex affects only trimethylation of H3 K36.  S2P = Ser2 phosphorylation 
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A known Paf1 complex-dependent function associated with transcription elongation is 
the covalent modification of specific lysine residues on histones H2B and H3 (Figure 9).  
Monoubiquitylation of histone H2B at lysine 123 (K123) by the ubiquitin-conjugating enzyme 
Rad6 and the ubiquitin-protein ligase Bre1 is eliminated in strains lacking Rtf1 or Paf1 (NG et al. 
2003b; WOOD et al. 2003b).  This modification is a prerequisite for the methylation of histone 
H3 on K4 and K79 by the methyltransferases Set1 and Dot1, respectively (BRIGGS et al. 2002; 
SUN and ALLIS 2002).  Therefore, Rtf1 and Paf1 are also required for histone H3 K4 and K79 
methylation (KROGAN et al. 2003; NG et al. 2003b; NG et al. 2003c).  Interestingly, low levels of 
monomethylation at H3 K4 are still detected in rtf1∆ and paf1∆ cells, suggesting that the Paf1 
complex controls the processivity of Set1 (DEHE et al. 2005).  Rtf1 is likely the primary 
component of the Paf1 complex that regulates these modifications because Rtf1 levels are 
significantly reduced in strains lacking Paf1, while Paf1 levels remain unchanged in the absence 
of Rtf1 (MUELLER et al. 2004; PORTER et al. 2005).   
H2B K123 ubiquitylation and H3 K4 methylation are enriched in the coding regions of 
active genes (BERNSTEIN et al. 2002; SANTOS-ROSA et al. 2002; XIAO et al. 2005).  Rad6 and 
Set1 are recruited to ORFs coincident with gene activation and modify histones during 
transcription.  Rtf1 colocalizes with these histone modifying enzymes on active genes and is 
required for their optimal recruitment and activation (KROGAN et al. 2003; NG et al. 2003c; XIAO 
et al. 2005).  Rtf1-dependent histone modifications are required for normal Sir-mediated 
silencing (HUANG et al. 1997; KROGAN et al. 2002a; VAN LEEUWEN et al. 2002).  Consistent with 
this observation, mutations in the Paf1 complex lead to defects in telomeric and rDNA silencing 
(KROGAN et al. 2003; MUELLER et al. 2006; NG et al. 2003b). 
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The Paf1 complex also has additional roles in histone modification.  Histone H3 is also 
methylated on lysine 36 (K36) by the Set2 methyltransferase (STRAHL et al. 2002).  The 
trimethyl state of this modification is severely reduced by the deletion of PAF1 or CTR9 and is 
decreased in the absence of CDC73; mono- and dimethylation of this residue are unaffected 
(CHU et al. 2007).  Interestingly, deletion of RTF1, which has severe effects on H3 K4 and K79 
methylation, has no effect on methylation of K36.  Chromatin immunoprecipitation analysis 
demonstrated that H3 K36 trimethylation was severely reduced in the coding regions of several 
genes and that this reduction was greater at the 5’ end of the ORF than at the 3’ end of the ORF. 
The decrease in H3 K36 trimethylation caused by loss of Paf1 correlates with an increase 
in acetylation of histones H3 and H4 (CHU et al. 2007).  Histone acetylation and H3 K36 
methylation have previously been linked; Set2-mediated H3 K36 methylation results in 
recruitment of the Rpd3(S) histone deacetylase complex, which removes histone acetylation 
from coding regions to prevent aberrant initiation from cryptic promoters (CARROZZA et al. 
2005; JOSHI and STRUHL 2005; LI et al. 2007b).  Interestingly, deletion of SET2 does not result 
in increased acetylation at the 5’ ends of coding regions, as is seen in paf1∆ strains (CHU et al. 
2007).  Additionally, a paf1∆ set2∆ strain results in a significant increase in cryptic initiation 
from the FLO8 ORF than is observed in either single mutant.  These observations suggest the 
Paf1 complex functions to control cryptic initiation and histone acetylation in the bodies of 
active genes by a mechanism that is redundant with the function of Set2. 
The Paf1 complex is also connected to the termination stage of transcription through 
several recognized roles in RNA 3’ end formation.  Components of the Paf1 complex are 
necessary for normal Ser2 phosphorylation of the Rpb1 CTD (MUELLER et al. 2004).  This 
modification is necessary for the cotranscriptional recruitment of numerous cleavage, 
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polyadenylation, and termination factors to transcribing Pol II.  Specifically, the Paf1 complex is 
known to be required for association of the cleavage factors Cft1 and Pcf11 with active genes 
(MUELLER et al. 2004; NORDICK et al. 2008).  A physical interaction has also been identified 
between the Paf1 complex and Hpr1, a subunit of the TREX transcription elongation and mRNA 
export complex (CHANG et al. 1999).  Consistent with a role in pre-mRNA cleavage and 
polyadenylation, mutations in the Paf1 complex are known to affect poly(A) site selection and 
result in the shortening of poly(A) tails from the normal length of 75 nucleotides to 65 
nucleotides (MUELLER et al. 2004; PENHEITER et al. 2005).  These effects on RNA 3’ end 
formation can lead to nonsense mediated decay of the resulting transcripts and it has been 
demonstrated that the decreased mRNA levels observed for some Paf1 complex-dependent genes 
are a result of mRNA instability and not reduced gene expression (PENHEITER et al. 2005). 
The Paf1 complex also affects 3’ end formation of several nonpolyadenylated transcripts.  
Deletion of genes encoding subunits of the Paf1 complex leads to transcriptional readthrough of 
the SNR13 and SNR47 snoRNA genes, resulting in the production of hybrid transcripts that 
extend into the neighboring gene (SHELDON et al. 2005).  snoRNAs are not polyadenylated; 
instead, their 3’ ends are generated through the function of the Nab3 and Nrd1 heterologous 
nuclear ribonucleoproteins and the nuclear exosome (STEINMETZ et al. 2001).  The role of the 
Paf1 complex in 3’ end formation of nonpolyadenylated RNAs can, therefore, likely be 
attributed to its involvement in the recruitment of Nab3 and Nrd1 to snoRNA genes (SHELDON et 
al. 2005).   
Despite the evidence linking it to transcription termination through its roles in 3’ end 
formation, the Paf1 complex is primarily considered an elongation factor.  While a direct role for 
the Paf1 complex in transcription termination cannot be ruled out, it is known to dissociate from 
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Pol II at the poly(A) site and has not been found to associate with RNA (KAPLAN et al. 2005); 
these observations make it unlikely that the Paf1 complex participates directly in 3’ end 
formation or transcription termination.  The known roles for the Paf1 complex in 3’ end 
formation or transcription termination can largely be attributed to the role of this complex in 
facilitating phosphorylation of Rpb1 CTD repeats on Ser2, which occurs during transcription 
elongation.  
Although there is considerable genetic and biochemical evidence linking the Paf1 
complex to transcription elongation, the absence of Paf1 complex subunits appears to have 
relatively minor effects on the distribution of Pol II throughout the genome.  However, Pol II 
levels were assessed at constitutively active genes in many of these studies.  Recent reports have 
demonstrated that Pol II levels are reduced at the 5’ end of the galactose-inducible GAL1 gene 
shortly after activation in strains lacking Paf1 complex subunits (MARTON and DESIDERIO 2008; 
XIAO et al. 2005).  Additionally, the sensitivity of strains lacking Paf1 complex subunits to heat 
and caffeine suggests that this complex may be involved in the cellular stress response, which is 
largely mediated by rapid gene induction.  These results may imply that the Paf1 complex is 
necessary to efficiently promote optimal gene expression during the pioneering rounds of 
transcription and that it may become less important during the maintenance of steady-state gene 
expression.  This hypothesis is consistent with the known roles for the Paf1 complex in creating 
a more permissible chromatin structure in ORFs through it roles in histone modification.   
Further supporting the idea that the Paf1 complex contributes to a more accessible 
chromatin structure, several studies have demonstrated that histone H3 levels are elevated in 
ORFs in the absence of Paf1 complex subunits (DEHE et al. 2005; MARTON and DESIDERIO 
2008).  Interestingly, deletion of genes encoding the subunits of the Paf1 complex often cause 
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more severe phenotypes than mutation of the histone modifying enzymes that mediate Paf1 
complex-dependent histone modifications.  This suggests that the function of the Paf1 complex is 
not solely mediated through its effects on histone modification.  The role of Rtf1 in recruiting 
Chd1 to ORFs, or an as-yet-unidentified function for the Paf1 complex, may also contribute to 
modifying chromatin structure upon gene activation. 
The subunits of the Paf1 complex are conserved throughout eukaryotes and they have 
been demonstrated to carry out many of the same functions as their S. cerevisiae counterparts.  
Deletion or multiplication of the genes encoding the human homologs of Paf1 complex subunits 
have been implicated in the etiology of numerous cancers, and the homologs of Drosophila 
melanogaster (fly) Paf1 complex subunits are involved in Wnt and Notch signaling (AKANUMA 
et al. 2007; CHAUDHARY et al. 2007; TENNEY et al. 2006).  Interestingly, while Rtf1 is conserved 
throughout eukaryotes, it is absent from the human and fly Paf1 complex equivalents 
(CHAUDHARY et al. 2007; YART et al. 2005; ZHU et al. 2005).   Additionally, the human Paf1 
complex has incorporated the Ski8 component of the human SKI complex, which cooperates 
with the exosome to mediate 3’–5’ mRNA decay (ZHU et al. 2005).  This observation implies 
that the human Paf1 complex has incorporated additional functions. 
1.4.2.2 Spt4/Spt5 complex 
Spt4 physically associates with the essential Spt5 protein in vivo to form the Spt4/Spt5 
transcription elongation complex in S. cerevisiae (HARTZOG et al. 1998).  This complex is 
conserved in higher eukaryotes, where it is known as DSIF (DRB sensitivity-inducing factor).  
Human DSIF was identified as a factor that induced Pol II pausing in conjunction with the 
transcription inhibitor 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) (WADA et al. 
1998).  The Spt4/Spt5 complex is recruited to the ORFs of active genes and is known to 
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physically interact with Pol II and multiple elongation factors including TFIIS, yFACT, the Paf1 
complex, and Spt6 (KROGAN et al. 2002b; LINDSTROM et al. 2003; MUELLER and JAEHNING 
2002; SQUAZZO et al. 2002).  Spt5 shares a region of homology with the bacterial elongation 
factor NusG (WADA et al. 1998).  These observations suggested a role for the Spt4/Spt5 complex 
in transcription elongation and it has been demonstrated to affect this process both positively and 
negatively (HARTZOG et al. 1998; WADA et al. 1998).  Mutations in SPT4 and SPT5 cause 
growth defects when combined with CTD truncations or mutations in CTD kinases, suggesting 
that the Spt4/Spt5 complex affects transcription through a pathway that functions in parallel to 
the CTD of Rpb1 (LINDSTROM and HARTZOG 2001).  Despite the experimental evidence linking 
the Spt4/Spt5 complex to transcription elongation, the mechanism by which it participates in this 
process remains unknown and the subunits of this complex are not predicted to function 
enzymatically. 
The Spt4/Spt5 complex is also known to interact with transcription initiation factors, 
RNA processing factors, and mRNA capping enzymes and to affect polyadenylation of mRNA 
(CUI and DENIS 2003; LINDSTROM et al. 2003).  Additionally, Spt4 and Spt5 associate with Pol I 
and are necessary for normal expression of rRNA (SCHNEIDER et al. 2006).  These observations 
suggest that the function of the Spt4/Spt5 complex is not restricted specifically to transcription 
elongation by Pol II.   
1.4.2.3 TFIIS 
Pol II is known to stall or arrest as it translocates across an ORF during transcription 
(KIREEVA et al. 2005).  Pausing or arrest of Pol II can be induced by chromatin structure or by 
interaction with unfavorable nucleotide sequences.  Arrested Pol II can be reactivated by the 
conserved transcription elongation factor TFIIS, which is encoded by the DST1 gene 
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(KETTENBERGER et al. 2003; RUDD et al. 1994; WEILBAECHER et al. 2003).  Deletion of DST1 
results in growth defects when strains harboring this deletion are grown in the presence of 6-AU 
or are combined with deletion in genes encoding other elongation factors, including components 
of the Paf1, Spt4/Spt5, and the yFACT complexes (COSTA and ARNDT 2000; HARTZOG et al. 
1998; ORPHANIDES et al. 1999).  These observations implicate TFIIS in transcription elongation. 
TFIIS is known to physically interact with Pol II and the structure of this interaction has 
been solved (KETTENBERGER et al. 2004).  TFIIS binds to the surface of Pol II near the pore 
through which nucleotides enter the active site.  A hairpin loop extending from TFIIS inserts into 
the pore where it stimulates an intrinsic cleavage activity of Pol II.  This activity repositions the 
new RNA 3’ end properly in the Pol II active site and stimulates the resumption of transcription. 
1.4.2.4 yFACT 
The FACT (FA
yFACT is also known to physically interact with histones and has been demonstrated to 
possess histone chaperone activity (ORPHANIDES et al. 1998).  yFACT can stimulate the 
cilitates Chromatin Transcription) complex was first identified in HeLa 
cell nuclear extracts as a factor that stimulates transcription on a chromatin template in vitro 
(ORPHANIDES et al. 1998).  This complex was found to be conserved in yeast (yFACT), where it 
is composed of the Spt16, Pob3, and Nhp6 subunits.  ChIP analyses have demonstrated that 
yFACT associates with the coding regions of active genes and mutations in subunits of yFACT 
genetically interact with mutations in the transcription elongation factors TFIIS and Spt4 
(MASON and STRUHL 2003; ORPHANIDES et al. 1998).  Furthermore, yFACT is known to 
physically interact with the Chd1 chromatin remodeling enzyme, which has been linked to 
transcription elongation, and the Paf1 complex (KROGAN et al. 2002b; SQUAZZO et al. 2002).  
Together, these observations implicated yFACT in transcription elongation. 
 64 
displacement of an H2A/H2B dimer from a nucleosome, which is sufficient to permit the 
passage of Pol II (BELOTSERKOVSKAYA et al. 2003).  These activities of yFACT are strongly 
enhanced in vitro by the addition of the Paf1 complex and H2B K123 Ub (PAVRI et al. 2006).  
The histone chaperone activity of yFACT has also been linked to the reassembly of chromatin 
following cessation of transcription (BELOTSERKOVSKAYA et al. 2003).  These observations 
suggest that yFACT facilitates transcription elongation by creating a chromatin environment that 
allows Pol II to navigate the template more easily; yFACT then functions to reassemble 
chromatin once transcription has ceased.  
1.4.3 3’ End Formation and Transcription Termination at Protein Coding Genes 
The final steps in production of a functional mRNA are cleavage and polyadenylation of the 3’ 
end of the transcript.  These processes are tightly coupled to dissociation of Pol II from the DNA 
template.  The factors involved in these processes are frequently essential and many associate 
with Pol II on active genes through an interaction with Ser2 phosphorylated CTD repeats.  
Cleavage and polyadenylation take place in yeast at a site downstream of the coding region that 
contains 3 characteristic DNA sequence elements (Figure 10) (ZHAO et al. 1999).  The most 5’ 
component of the cleavage and polyadenylation signal is a UA-rich efficiency element, which 
functions to activate a nearby A-rich positioning element.  Cleavage of the pre-mRNA typically 
takes place about 20 nucleotides downstream of the positioning element at a PyAn (Py = 
pyrimidine) consensus site. 
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Figure 10.  Factors involved in RNA 3’ end formation. 
Cleavage of a pre-mRNA requires two multisubunit complexes, CFI and CFII, which bind to the RNA.  Two 
sequence elements, the efficiency element (EE) and the positioning element (PE), are involved in positioning of the 
cleavage complex.  Cleavage takes place at a PyAn (Py = pyrimidine) element that is usually found about 20 
nucleotides downstream of the PE.  Association of a third multisubunit complex (polyadenylation factor = PF), 
results in the addition of approximately 75 adenines to the new 3’ OH on the pre-mRNA that was generated by the 
cleavage reaction.  The addition of the poly(A) tail is catalyzed by poly(A) polymerase (Pap1).  The activity of Pap1 
is opposed by poly(A) nuclease (PAN).  poly(A) binding protein (Pab1) coats the poly(A) tail to help stabilize the 
transcript.  This figure is an adaptation of Figure 4 in ZHAO et al. 1999. 
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Transcript cleavage is carried out by cleavage factor I (CFI; composed of Rna14, Rna15, 
Pcf11, Clp1, and Hrp1) and cleavage factor II (CFII; composed of Cft1, Cft2, Brr5, and Pta1) 
(ZHAO et al. 1999).  The exact sites at which CFI and CFII bind RNA are unknown, but these 
complexes are known to crosslink to RNA (MINVIELLE-SEBASTIA et al. 1998).  The efficiency 
element and positioning element are believed to interact with CFI and CFII to direct cleavage 
activity to the PyAn site.  Although the identity of the endonuclease that carries out the cleavage 
reaction remains unknown, recent evidence suggests the Cft2 subunit of CFII may perform this 
activity (RYAN et al. 2004).   
Following cleavage, polyadenylation factor (PF; composed of Fip1, Pap1, Yth1, Pfs1, 
and Pfs2), is recruited to the RNA through physical interaction with CFII and directs the addition 
of a poly(A) tail to the free 3’ OH of the RNA at the cleavage site through the catalytic activity 
of Pap1 (poly(A) polymerase) (PREKER et al. 1997; ZHAO et al. 1999).  The action of Pap1 is 
opposed by poly(A) nuclease (PAN) (LOWELL et al. 1992); together, the antagonism between 
these enzymes results in the formation of a poly(A) tail that typically measures 75 nucleotides in 
length (BLOCH et al. 1978).  The poly(A) tail is coated by poly(A) binding protein (Pab1), which 
protects the mature mRNA transcript from degradation in both the nucleus and cytoplasm (ZHAO 
et al. 1999).   
Transcription termination at protein coding genes in yeast does not appear to take place at 
a consensus sequence, but instead occurs stochastically downstream of the poly(A) site.  
Eukaryotic transcription has been proposed to take place by two mechanisms:  the “anti-
terminator model” and the “torpedo model”.  Experimental evidence supports both hypotheses, 
suggesting that distinct mechanisms may operate downstream of specific genes.  In the anti-
terminator model, the addition of the poly(A) tail to the transcript may lead to the displacement 
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of a positive elongation factor or the association of a negative elongation factor (BURATOWSKI 
2005; LOGAN et al. 1987).  This may lead to increased stalling and pausing of the polymerase, 
making it more prone to dissociate from the DNA template.  Interestingly, the Paf1 complex is 
known to dissociate from Pol II near the poly(A) site and deletion of genes encoding Paf1 
complex subunits lead to shortened poly(A) tails (KAPLAN et al. 2005; MUELLER et al. 2004). 
Alternatively, the torpedo model of transcription termination proposes that cleavage of 
the transcript at the poly(A) site introduces a new 5’ RNA end that is not capped; this may create 
a loading point for an exonuclease or helicase that tracks along the transcript until it reaches the 
polymerase and facilitates its dissociation from the DNA template (BURATOWSKI 2005).  This 
model is supported by the physical interaction of the Rat1 5’ to 3’ exonuclease with Rtt103, a 
phospho-Ser2 CTD binding protein that is thought to play a role in mRNA 3’ end formation and 
transcription termination (KIM et al. 2004b). 
1.4.4 mRNA export 
Before a mature mRNA can be translated into protein, it must be exported to the cytoplasm.  
mRNA is exported to the cytoplasm in association with proteins as a messenger 
ribonucleoprotein particle (mRNP) (Figure 11).  Formation of mRNPs takes place 
cotranscriptionally.  The mRNA export adaptor proteins Npl3, Yra1, and Sub2 physically 
interact with Pol II along active ORFs and are transferred to the growing pre-mRNA chain 
during synthesis (KOHLER and HURT 2007; ROUGEMAILLE et al. 2008).  Yra1 and Sub2 mediate 
association of the assembling mRNP with the Mex67-Mtr2 export receptor complex.  Mex67-
Mtr2 physically interacts with the nuclear pore to facilitate movement of the mRNP through the 
channel (SANTOS-ROSA et al. 1998; SEGREF et al. 1997). 
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Figure 11.  The mRNA export pathway. 
mRNA is exported to the cytoplasm for transcription in complex with several proteins as a messenger 
ribonucleoprotein particle (mRNP).  mRNPs are generated cotranscriptionally; the Yra3, Sub2, and Npl3 mRNA 
export adaptor proteins associate with Pol II and the bodies of active genes.  These adaptor proteins associate with 
the pre-mRNA as it is being transcribed.  Following transcription termination, the mRNP is released from the 
polymerase.  Passage of the mRNP into the cytoplasm is facilitated by the Mex67-Mtr2 export receptor complex, 
which associates with the nuclear pore (NP).  Backtracking of mRNPs into the nucleus is inhibited by the helicase 
activity of Dbp5, which is believed to unravel mRNPs as they enter the cytoplasm.  The activity of Dbp5 is 
specifically stimulated in the cytoplasm by physical interaction with Gle1.  This figure is an adaptation of Figure 1 
in ROUGEMAILLE et al. 2008. 
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To prevent backtracking of the mRNP through the NPC, mRNPs are remodeled as they 
emerge into the cytoplasm by the helicase activity of Dbp5 (LUND and GUTHRIE 2005).  
Although Dbp5 can shuttle between the nucleus and cytoplasm, its helicase activity is only 
activated in the cytoplasm.  This is because activation of Dbp5 requires interaction with Gle1, 
which associates with filaments on the cytoplasmic side of the nuclear pore (ALCAZAR-ROMAN et 
al. 2006; WEIRICH et al. 2006).  Association with Gle1 tethers Dbp5 activity in a position to 
unravel mRNPs immediately upon entry into the cytoplasm to prevent backtracking of these 
particles into the nucleus.   
1.5 THE INOSITOL POLYPHOSPHATE SIGNALING PATHWAY AFFECTS 
TRANSCRIPTION 
Signaling pathways represent a primary means by which cells sense and respond to changing 
environmental stimuli.  A major signaling pathway utilized by eukaryotic organisms is the 
inositol polyphosphate signaling pathway.  Inositol, a 6-carbon ring that bears a hydroxyl group 
on each carbon, is imported into cells or is synthesized from glucose-6-phosphate through the 
enzymatic activity of inositol-1-phosphate synthase (Ino1 in S. cerevisiae) (ALCAZAR-ROMAN 
and WENTE 2008).  Inositol, which is essential for cell viability, is incorporated into membrane-
anchored lipids resulting in the formation of phosphatidylinositols (PIPs).  PIPs, which have 
recognized functions in vesicular trafficking and actin cytoskeleton rearrangements, can be 
phosphorylated in various arrangements. 
PIP2 (phosphatidylinositol 4,5 bisphosphate) is cleaved by phospholipase C (Plc1 in S. 
cerevisiae) to generate membrane-bound diacylglycerol and soluble inositol trisphosphate (IP3) 
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(Figure 12) (FLICK and THORNER 1993).  IP3 is phosphorylated by the Arg82 kinase to inositol 
tetrakisphosphate (IP4) and inositol pentakisphosphate (IP5) (SAIARDI et al. 1999).  IP5 is further 
phosphorylated to inositol hexakisphosphate (IP6) by the Ipk1 kinase (YORK et al. 1999).  
Although Arg82 and Ipk1 are localized to the nucleus, IPs are found throughout the cell 
(ALCAZAR-ROMAN and WENTE 2008).  Plc1 is necessary for a variety of cellular functions 
including survival in nutrient-limited conditions, transition from budding to pseudohyphal 
growth, sporulation, heat-tolerance, and response to osmotic shock; the IP signaling pathway has 
also been implicated in DNA repair and telomere homeostasis (ALCAZAR-ROMAN and WENTE 
2008; MICHELL et al. 2003).  These observations suggest that the inositol polyphosphate 
signaling pathway is involved in the cellular stress response. 
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Figure 12.  The inositol polyphosphate signaling pathway. 
Inositol is a 6-carbon ring (represented by the blue hexagons) that bears a hydroxyl group on each carbon (hydroxyl 
groups are not shown.  Plc1 cleaves the membrane-associated phospholipid PIP2 into IP3 and diacylglycerol (DAG; 
not shown).  Arg82 is a bifunctional kinase that phosphorylates IP3 to IP4 and IP5.  IP5 is further phosphorylated to 
IP6 by Ipk1.  Phosphate groups are represented by red dots.  This figure is an adaptation of Figure 2 in ALCAZAR-
ROMAN and WENTE 2008. 
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IPs are known to bind to various proteins, although no consensus sequence for an IP 
binding pocket has been identified (ALCAZAR-ROMAN and WENTE 2008).  The association of IPs 
with proteins has been proposed to modulate protein function in several ways:  IPs may function 
as essential structural cofactors, induce allosteric changes, or inhibit the binding of other ligands. 
 Many signaling pathways are known to impact gene expression, and the IP signaling 
pathway has several recognized connections to this activity.  The products of Arg82 and Ipk1 
catalytic activity have roles in chromatin remodeling and mRNA export and Arg82 is a subunit 
of the ArgR/Mcm1 transcription regulatory complex.  These roles for the IP signaling pathway 
are described in more detail in the following sections. 
1.5.1 Arg82 is required for normal expression of arginine metabolic genes 
Arg82 is known to associate with and stabilize Mcm1, a member of the MADS box transcription 
factor family (EL BAKKOURY et al. 2000).  Arg82 is, therefore, necessary for normal expression 
of Mcm1 targets, which include genes involved in the pheromone response.  Additionally, Arg82 
and Mcm1 associate with Arg80 and Arg81 to form the ArgR/Mcm1 transcription regulatory 
complex (EL BAKKOURY et al. 2000; MESSENGUY et al. 1991) (SHEARS 2000).  This complex 
binds to the promoters of 8 genes involved in arginine metabolism and regulates their expression.  
Five genes involved in arginine synthesis (ARG8, ARG3, ARG1, and the bifunctional ARG5,6) 
are repressed by ArgR/Mcm1 binding, while two genes involved in arginine catabolism (CAR1 
and CAR2) are induced in response to association of this complex.  Interestingly, Arg82 kinase 
activity does not appear to required for its role in expression of arginine metabolic genes 
(DUBOIS et al. 2000; EL ALAMI et al. 2003).  This observation suggests that Arg82 may possess 
functionality that is not related to the IP signaling pathway. 
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1.5.2 IP6 is necessary for mRNA export 
Mutations in PLC1, ARG82, and IPK1 were identified in a screen for factors that became 
essential in combination with a gle1-1 mutation (YORK et al. 1999).  As discussed in Section 
1.4.4, Gle1 is a cytoplasmic factor that interacts with Dbp5 and stimulates its helicase activity to 
facilitate the forward translocation of mRNP particles from the nucleus to the cytoplasm.  IP6 is 
required for Gle1-dependent stimulation of Dbp5 activity (ALCAZAR-ROMAN et al. 2006; 
KOHLER and HURT 2007; WEIRICH et al. 2006). The role of IP6 in mRNA export suggests that 
this process can be modulated in response to physiological stress. 
1.5.3 Chromatin remodeling is affected by inositol polyphosphates 
The IP signaling pathway has been implicated in the control of chromatin remodeling in several 
ways.  A genetic screen for mutations that impaired induction of the PHO5 gene, which is highly 
regulated by chromatin structure, identified a mutation in ARG82 (STEGER et al. 2003).  Further 
analysis demonstrated that nucleosomes, which are displaced from the PHO5 promoter upon 
activation, were not efficiently remodeled in the absence of Arg82 kinase activity.  The 
requirement for the kinase function of Arg82 suggests that effects on PHO5 chromatin 
remodeling are mediated through Arg82’s role in IP signaling and are likely not due to its 
function as a transcriptional regulator as a subunit of the ArgR/Mcm1 complex.   
This study further demonstrated that remodeling of chromatin structure at several 
phosphate responsive promoters is impaired by mutations in the SWI/SNF and INO80 chromatin 
remodeling complexes and that mutations in these factors also decreases expression of PHO5 
and PHO84.  In the absence of Arg82, SWI/SNF and INO80 fail to localize to the PHO84 
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promoter upon gene induction and INO80 is not recruited to the PHO5 promoter.  Interestingly, 
the Pho4 transcriptional activator is still efficiently recruited to PHO5 and PHO84 in the absence 
of Arg82, suggesting that regulation of SWI/SNF and INO80 recruitment by the IP signaling 
pathway takes place independent of transcription factor binding. 
An additional study demonstrated that IPs could modulate the activity of chromatin 
remodeling complexes in vitro.  IP4 and IP5, the products of Arg82 catalytic function, stimulated 
nucleosome sliding by SWI/SNF while IP6, the product of Ipk1 kinase activity, inhibited 
nucleosome repositioning by the INO80, ISW2, and the fly ISWI-containing NURF complexes 
(SHEN et al. 2003).  SWI/SNF, ISW2, and INO80 are required for normal expression of the INO1 
gene in S. cerevisiae (GOLDMARK et al. 2000; PETERSON et al. 1991; SHEN et al. 2000).  Deletion 
of PLC1 or ARG82, or mutation of the Arg82 catalytic domain, impaired INO1 induction (SHEN 
et al. 2003).  This observation suggests that the effects of IP4, IP5, and IP6 on chromatin 
remodeling complexes in vitro may have physiological relevance. 
The different effects of individual IPs on chromatin remodeling complexes implies that 
activity of IP signaling enzymes can be modulated to elicit distinct effects on gene expression.  
Interestingly, INO1 and the PHO genes are induced under conditions of nutrient limitations; 
therefore, the effects of mutations in IP signaling enzymes on expression of these genes further 
implicates the IP signaling pathway in the cellular stress response.  Genes involved in the cellular 
stress response are often poised for rapid activation and in several cases, chromatin remodeling 
complexes are associated with the promoters of these genes under repressing conditions (RANDO 
et al. 2003).  These genes may then be rapidly activated or inhibited in response to 
environmental stimuli by modulating the activity of enzymes in the IP signaling pathway. 
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1.6 THESIS AIMS 
The S. cerevisiae Paf1 transcription elongation complex contributes to normal transcription in 
multiple ways.  However, the mechanisms underlying Paf1 complex function remain largely 
unknown.  A major focus of my thesis research was to investigate the means by which the Rtf1 
subunit of the Paf1 complex carries out its known transcription-related functions.  Rtf1 
physically interacts with the ATP-dependent chromatin remodeling protein Chd1 and recruits it 
to active genes, promotes posttranslational modification of specific lysine residues in histones 
H2B and H3 along active ORFs, and mediates association of other Paf1 complex subunits with 
transcriptionally active regions.  Using a collection of sequential Rtf1 internal deletion mutants, I 
identified nonoverlapping regions of Rtf1 that were necessary for each of these processes.  These 
observations suggest that the known activities of Rtf1 are not completely interrelated.  I 
performed a more detailed analysis of the region of Rtf1 required for histone modification and 
found that this region of the protein was sufficient to promote Rtf1-dependent histone 
modifications when expressed in isolation and that the function of this region depended on 
several highly conserved residues.   
Furthermore, a screen for factors that become essential when RTF1 is deleted identified 
mutations in the IP signaling enzymes Plc1 and Arg82.  I sought to better understand the nature 
of the interaction between these factors.  I performed genetic analyses which demonstrated that 
deletion of ARG82 impaired cell growth in combination with loss of four subunits of the Paf1 
complex (Paf1, Ctr9, Rtf1, and Cdc73).  Additional genetic analyses established that deletion of 
ARG82 or PAF1 genetically interacted with disruptions of the same chromatin remodeling 
complexes.  These results established a connection between IP signaling, transcription 
elongation, and chromatin remodeling. 
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2.0  RTF1 IS COMPOSED OF DISCRETE FUNCTIONAL REGIONS 
2.1 INTRODUCTION 
The Paf1 complex colocalizes with actively transcribing Pol II (KROGAN et al. 2002b; 
POKHOLOK et al. 2002; PORTER et al. 2005; SIMIC et al. 2003) and orchestrates modifications to 
the chromatin template during transcription elongation.  In particular, the Rtf1 subunit of the 
Paf1 complex contributes to chromatin modification in several ways.  Rtf1 is necessary for the 
cotranscriptional monoubiquitylation of histone H2B at lysine 123 (H2B K123 Ub) along active 
ORFs by the Rad6 ubiquitin conjugating enzyme and the Bre1 ubiquitin ligase (NG et al. 2003b; 
WOOD et al. 2003b; XIAO et al. 2005).  H2B K123 Ub is a prerequisite for the subsequent 
methylation of histone H3 at lysine 4 (H3 K4 Me) and lysine 79 (H3 K79 Me) within active 
genes by the Set1 and Dot1 methyltransferases, respectively (BERNSTEIN et al. 2002; BRIGGS et 
al. 2001; SANTOS-ROSA et al. 2002; SUN and ALLIS 2002).  Therefore, these histone H3 
methylation marks are also Rtf1-dependent (KROGAN et al. 2003; NG et al. 2003b; NG et al. 
2003c).  Additionally, Rtf1 impacts chromatin structure through its physical interaction with the 
ATP-dependent chromatin remodeling protein Chd1.  Our lab has demonstrated that this physical 
interaction is necessary for the normal recruitment of Chd1 to active genes (SIMIC et al. 2003). 
 Although multiple transcription-related roles have been identified for Rtf1, the 
mechanism by which it functions in these processes remains unknown.  Rtf1’s primary amino 
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acid sequence contains no recognizable motifs or domains that provide insight into the 
mechanism by which it functions.  Therefore, a series of sequential deletions along the length of 
the protein was created in the Arndt lab to identify the functional regions of the protein.  I 
performed genetic and biochemical assays on these mutants to identify residues required for the 
various activities of Rtf1.  My results establish that discrete non-overlapping segments of Rtf1 
are necessary for recruitment of the ATP-dependent chromatin remodeling protein Chd1 to 
genes, promoting covalent modification of histones H2B and H3, recruitment to active ORFs, 
and association with other Paf1 complex subunits.  Transcription-related defects were observed 
when regions of Rtf1 that mediate histone modification or association with active genes were 
deleted, but disruption of the physical association between Rtf1 and other Paf1 complex subunits 
caused only subtle mutant phenotypes.  Together, our results indicate that Rtf1 influences 
transcription and chromatin structure through several independent functional domains and that 
Rtf1 may function independently of its association with other members of the Paf1 complex. 
2.2 MATERIALS AND METHODS 
2.2.1 Media and yeast strains 
Rich (YPD), synthetic complete (SC), synthetic minimal (SD), and 5-fluoroorotic acid (5-FOA) 
media were prepared as described previously (ROSE et al. 1990).  Where indicated, 6-azauracil 
was added to SC-Ura media at a final concentration of 50 μg/ml. 
S. cerevisiae strains used in these studies are listed in Table 1.  All strains, with the 
exceptions of OKA93 and PJ69-4A, are GAL2+ derivatives of S288C (WINSTON et al. 1995).  
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Transformation, mating, sporulation, and tetrad dissection were performed according to standard 
methods (ROSE et al. 1990).  Complete disruptions of RTF1 and CHD1 were created by a PCR-
based gene replacement method (AUSUBEL et al. 1988).  Constructs expressing HA-Rtf1Δ3 or 
HA-Rtf1Δ4 were integrated into the yeast chromosome to replace the endogenous RTF1 locus by 
a two-step gene replacement method (ROTHSTEIN 1991).  Tagging of Ctr9 at the carboxy-
terminus with six copies of the Myc epitope and Chd1 at the amino-terminus with three copies of 
the HA epitope was previously described (SIMIC et al. 2003; SQUAZZO et al. 2002). 
2.2.2 Plasmid construction 
Standard cloning techniques were used to construct all plasmids (AUSUBEL et al. 1988).  pLS20 
and pLS21-5 are derivatives of pRS314 (SIKORSKI and HIETER 1989) that express Rtf1 or triple 
HA-tagged Rtf1, respectively (STOLINSKI et al. 1997).  Site-directed mutagenesis (KUNKEL et al. 
1987) or PCR-based approaches were used to remove segments of the RTF1 coding region from 
pLS21-5 to create a series of sequential RTF1 internal deletion mutations, which are detailed in 
Figure 13A.  Each rtf1 deletion mutation was confirmed by DNA sequencing.  pKR37, which 
expresses HA-Rtf1Δ1, was digested with Nde1 to remove the triple HA-tag and religated to 
generate pPC61.  High-copy vectors used to overexpress HA-Rtf1 (pMW6) and HA-Rtf1Δ7 
(pMW7) were constructed by subcloning a SalI-SpeI fragment from pLS21-5 or pKR14 (the 
pLS21-5 derivative carrying HA-rtf1Δ7) into SalI-SpeI digested pRS426 (SIKORSKI and HIETER 
1989).  To create glutathione S-transferase (GST)-Rtf1 fusions, plasmid pJS2 was generated by 
introducing a BamHI site immediately upstream of RTF1 by site directed-mutagenesis of 
pKA61, which carries RTF1 on a 3.6 kb insert (STOLINSKI et al. 1997).  A plasmid expressing a 
fusion of GST to full-length Rtf1 (pJS4) was constructed by subcloning a 2.4 kb RTF1-
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containing BamHI/EcoRI fragment from pJS2 into BamHI/EcoRI digested pGEX-3X (SMITH 
and JOHNSON 1988).  pJS3, which expresses a GST fusion to the most amino-terminal 261 amino 
acids of Rtf1, was created by digesting pJS2 at the introduced BamHI and at a natural SmaI site 
in the RTF1 coding region and subcloning this fragment into BamHI/SmaI digested pGEX-3X.  
A plasmid expressing a GST fusion to the most carboxy-terminal 297 amino acids of Rtf1 (pJS1) 
was constructed by digesting pKA61 at the internal RTF1 SmaI site and at a downstream EcoRI 
site and cloning this 1.6 kb fragment into SmaI/EcoRI digested pGEX-3X.  pMW4, which 
expresses a GST fusion to Rtf1 segments 11 through 13, was created by amplifying the 3’ end of 
the RTF1 coding region from pJS1 to introduce a SmaI site adjacent to nucleotide 1306 of RTF1 
(corresponding to the start of amino acid 436).  PCR product was digested with SmaI and EcoRI 
and the resulting 1.1 kb fragment was cloned into SmaI/EcoRI digested pGEX-3X. 
2.2.3 Yeast growth assays 
Strains were grown to saturation at 30oC in appropriate media.  Cells were washed twice and 
serially diluted in sterile water.  Three microliters of each dilution were spotted on indicated 
media and incubated at 30oC. 
2.2.4 Sequence Alignment 
A BLAST search was conducted using S. cerevisiae Rtf1 protein sequence (GenBank accession 
#:  NP_011270.1) as the query.  Sequences corresponding to Rtf1 homologs in 
Schizosaccharomyces pombe (NP_595507.1), Caenorhabditis elegans (NP_505473.1), and 
Homo sapiens (NP_055953.1) were downloaded from the NCBI database.  A complete sequence 
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alignment was performed using Clustal X (JEANMOUGIN et al. 1998) and the resulting alignment 
was exported into JalView (http://www.jalview.org) to apply grayscale shading at a threshold 
value of 20% identity.  To search for proteins containing a similar sequence, amino acids 63-152 
of S. cerevisiae Rtf1 were used to query the nonredundant NCBI protein database in four 
iterations of a Psi-BLAST search. 
2.2.5 Immunoblotting analyses 
Transformants of KY404 containing pRS314, pRS424, pMW6, pMW7, pLS20, pLS21-5, or 
derivatives of pLS21-5 expressing each Rtf1 internal deletion mutant were grown to 
approximately 4 x 107 cells/mL in SC-Trp medium. Whole cell extracts were made by glass bead 
lysis essentially as described previously (SHIRRA et al. 2005) except that 
radioimmunoprecipitation assay (RIPA) buffer (50 mM HEPES, pH 7.9, 2 mM EDTA, 0.1% 
SDS, 0.1% sodium deoxycholate, 1% Triton X-100, and protease inhibitors) was used.  To 
examine expression of Rtf1 internal deletion mutants, 20 µg of extract was run on a 15% SDS-
PAGE gel and transferred to nitrocellulose membrane.  Membranes were probed with anti-HA 
(Boehringer Mannheim) or anti-L3 (VILARDELL and WARNER 1997) primary antibodies at a final 
concentration of 1:3000.  Sheep anti-mouse horseradish peroxidase (HRP)-conjugated secondary 
antibodies (GE Healthcare) were used at a 1:5000 dilution and the presence of immunoreactive 
proteins was visualized by enhanced chemiluminescence detection (Perkin Elmer).  Bulk levels 
of histone modifications were assayed similarly except that 30 µg of protein was analyzed using 
primary antibodies specific for H3 K4 Me3 (Abcam; 1:2000 dilution), H3 K79 Me2 (Upstate; 
1:2500 dilution), or total H3 (Upstate; 1:2000 dilution).  Donkey anti-rabbit HRP-conjugated 
secondary antibodies (GE Healthcare) were used at a 1:5000 dilution. 
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2.2.6 Analysis of histone H2B K123 monoubiquitylation 
Histone H2B K123 monoubiquitylation was measured using a protocol provided by William 
Tansey.  FY406, KY982, KY1216, and KY1217 were transformed with CEN/ARS/HIS3 
plasmids carrying HTA1/HTB1 or HTA1/FLAG-HTB1 (NG et al. 2002).  URA3-marked 
HTA1/HTB1 plasmids were eliminated by counterselection on 5-FOA medium.  Resulting strains 
were transformed with 2-micron, URA3-marked plasmids expressing untagged or HIS-tagged 
ubiquitin under control of the CUP1 promoter (pUb175 and pUb221, respectively; gift of Daniel 
Finley).  Transformants were grown to approximately 1 x 107 cells/ml in SC-His-Ura medium 
and expression of ubiquitin was then induced with a final concentration of 0.5 mM CuSO4 for 
4.5 h.  Whole cell extracts were made by glass bead lysis in Buffer A, pH 8.0 (6M guanidine-
HCl, 0.1 M sodium phosphate).  Extract (2 mg) was incubated with 250 µl 50% Ni-NTA agarose 
(Qiagen) at room temperature for 2 h.  Affinity precipitated proteins were washed, separated on a 
15% SDS-PAGE gel, and analyzed by immunoblotting using anti-FLAG (Sigma) or anti-HIS tag 
(Invitrogen) antibodies at a final concentration of 1:5000. 
2.2.7 Chromatin immunoprecipitation assays 
Transformants of KY452 or KY995 containing pRS314, pRS424, pLS20, pMW6, pMW7, 
pLS21-5, or derivatives of pLS21-5 and transformants of KY623 containing pRS314, pLS20, or 
pPC61, were grown in SC-Trp medium to approximately 1 x 107 cells/mL.  Chromatin 
preparation and treatment were performed essentially as described previously (SHIRRA et al. 
2005).  Sonicated chromatin was incubated overnight with anti-HA or anti-Myc conjugated 
agarose (Santa Cruz Biotechnology) to immunoprecipitate HA-Rtf1, HA-Chd1 or Ctr9-Myc.  
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PCR was performed using primers that amplify segments in the 5’ ORFs of PYK1 (+195/381; 
ATG = +1), CLN2 (+126/373; ATG = +1), or TEF2 (+40/291; ATG = +1).  Reactions were 
multiplexed with control primers that amplify an intergenic region of chromosome VIII 
(coordinates:  535129/535268).  Two dilutions of input and immunoprecipitated DNA were 
amplified in the presence of [α-32P]dATP (Perkin Elmer) and Platinum Taq DNA polymerase 
(Invitrogen).  PCR products were separated on 6% native polyacrylamide gels and signals were 
visualized and quantitated with a Fujifilm FLA-5100 phosphorimager and MultiGauge software.  
Signals from input and immunoprecipitated DNA were normalized to the chr VIII control signal 
and relative association of Rtf1, Chd1, or Ctr9 at each locus was determined by dividing the 
average of the two immunoprecipitated samples by the average of the two input samples. 
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Table 1.  Saccharomyces cerevisiae strains used in Chapter 2 
Straina Genotype 
FY406 MATa (hta1-htb1)Δ::LEU2 (hta2-htb2)Δ::TRP1 his3Δ200 lys2-128δ 
leu2Δ1 ura3-52 trp1Δ63 [pSAB6= HTA1-HTB1/CEN/ARS/URA3] 
OKA93 MATα rtf1Δ::kanMX4 TEL-VR::URA3 ura3-52 trp1- 
KY100 MATa spt15-122 his4-917δ lys2-173R2 ura3-52 ade8 
KY284 MATα his4-917δ ura3-52 trp1Δ63 
KY343 MATa rtf1Δ::URA3 his4-917δ lys2-173R2 leu2Δ1 ura3-52 trp1Δ63 
KY386 MATα spt15-122 rtf1Δ::URA3 his4-917δ lys2-173R2 ura3-52 leu2Δ1 ade8 
KY404 MATa rtf1Δ::LEU2 his4-912δ lys2-128δ leu2Δ1 ura3-52 trp1Δ63 
KY432 MATa rtf1-1 his4-917δ lys2-173R2 leu2Δ1 ura3-52 trp1Δ63 
KY440 MATα spt15-122 rtf1-1 his4-917δ lys2-173R2 leu2Δ1 ade8 
KY452 MATa rtf1Δ::URA3 his3Δ200 lys2-173R2 ura3-52 trp1Δ63 
KY457 MATa rtf1Δ::URA3 leu2Δ1 ura3-52 trp1Δ63 
KY619 MATa rtf1Δ::ARG4 his4-912δ lys2-173R2 leu2Δ1 trp1Δ63 arg4-12 
KY623 MATα rtf1Δ ::LEU2 3XHA-CHD1 his4-912δ lys2-128δ leu2Δ1 ura3-52 
trp1Δ63 
KY638 MATα spt15-122 his4-917δ lys2-173R2 ura3-52 
KY639 MATa spt15-122 chd1Δ::URA3 his4-917δ leu2Δ1 ura3-52 trp1Δ63 
KY640 MATa his4-917δ ura3-52 
KY641 MATα chd1Δ::URA3 his4-917δ lys2-173R2 leu2Δ1 ura3-52 trp1Δ63 
KY680 MATα 3XHA-rtf1Δ1 his4-917δ lys2-173R2 leu2Δ1 ura3-52 
KY982 MATa rtf1Δ::kanMX4 (hta1-htb1)Δ::LEU2 (hta2-htb2)Δ::TRP1 his3Δ200 
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lys2-128δ leu2Δ1 ura3-52 trp1Δ63 [pSAB6= HTA1-
HTB1/CEN/ARS/URA3] 
KY995 MATα rtf1Δ::URA3 CTR9-6XMYC::LEU2  his3Δ200 leu2Δ(0 or 1) 
ura3(Δ0 or -52) trp1Δ63 
KY1216 MATa rtf1Δ3 (hta1-htb1)Δ::LEU2 (hta2-htb2)Δ::TRP1 his3Δ200 lys2-
128δ leu2Δ1 ura3-52 trp1Δ63 arg4-12 [pSAB6= HTA1-
HTB1/CEN/ARS/URA3] 
KY1217 MATa rtf1Δ4 (hta1-htb1)Δ::LEU2 (hta2-htb2)Δ::TRP1 his3Δ200 lys2-
128δ leu2Δ1 ura3-52 trp1Δ63 arg4-12 [pSAB6= HTA1-
HTB1/CEN/ARS/URA3] 
KY1265 MATa spt15-122 3XHA-rtf1Δ1 his4-917δ lys2-173R2 ura3-52 ade8 
a FY406 was generated in the laboratory of Fred Winston. 
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2.3 RESULTS 
2.3.1 Conserved regions of Rtf1 direct normal transcription 
Although Rtf1 homologs are found in many eukaryotes, the primary amino acid sequences of 
these proteins contain no recognizable functional domains or motifs and the mechanism by 
which this protein affects transcription remains unknown.  To begin dissecting the functional 
regions of Rtf1, a series of sequential internal deletions across the RTF1 coding region was 
constructed in the Arndt lab.  These internal deletion mutations express HA-epitope tagged 
mutant versions of Rtf1 that lack between 23 and 52 amino acids (Figure 13A) from CEN/ARS 
plasmids.  I performed immunoblot analysis to demonstrate that all Rtf1 internal deletion 
mutants were expressed (Figure 13B) and verified by serial dilution analysis that cell growth was 
not impaired by any of the mutations on control medium (Figure 14, right panel). 
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Figure 13.  Rtf1 internal deletion mutants.   
(A)  Schematic representation of amino acids removed by rtf1 internal deletion mutations.  Each Rtf1 mutant protein 
is amino-terminally tagged with a triple HA epitope.  (B)  Immunoblot analysis of wild-type and mutant Rtf1 protein 
levels.  Extracts were prepared from an rtf1Δ strain (KY404) transformed with CEN/ARS plasmids that express the 
indicated HA-tagged Rtf1 derivatives.  Immunoblots were probed with anti-HA antibody and, as a loading control, 
anti-L3.  The faster migrating band observed in most lanes in the anti-HA immunoblot is likely a product of 
proteolysis, which we frequently observe in extracts prepared by glass bead lysis, but is less pronounced in extracts 
prepared by a rapid boiling method (data not shown). 
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I first utilized the Rtf1 internal deletion mutants to explore which regions of the protein 
are responsible for the transcription defects observed when Rtf1 is absent from the cell.  Deletion 
of RTF1 causes the suppressor of Ty (Spt-) phenotype (STOLINSKI et al. 1997); that is, it 
suppresses the transcriptional effects of promoter insertion mutations caused by a yeast 
retrotransposon Ty or its long terminal repeat (δ).  In particular, I examined the Spt- phenotype of 
rtf1 deletion strains that contain his4-912δ, a HIS4 allele where a Ty δ element is positioned 37 
bp upstream of the native TATA box (ROEDER and FINK 1982).  Transcriptional effects at this 
locus were assayed by growth on medium lacking histidine; growth on this medium indicates an 
Spt- phenotype.  Deletion of regions 2, 3, 4, or 13 of Rtf1 caused a weak Spt- phenotype, while 
deletion of region 5 caused a moderate Spt- phenotype (Figure 14, left panel).  In contrast, a 
significantly stronger Spt- phenotype was observed when regions 6, 7, 8, or 9 were removed.  To 
rule out the possibility that the severe phenotype caused by these deletions arose from 
mislocalization of the mutant proteins, indirect immunofluorescence assays were performed 
(K.L. Roinick and K.M. Arndt, data not shown).  These experiments demonstrated that Rtf1 
internal deletion mutants 6, 7, 8, and 9 localized to the nucleus, where wild-type Rtf1 is known 
to reside (STOLINSKI et al. 1997). 
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Figure 14.  Deletions of discrete regions of Rtf1 cause phenotypes associated with transcriptional 
defects. 
Ten-fold serial dilutions, ranging from 1 x 108 cells/mL to 1 x 104 cells/mL, of an rtf1Δ strain (KY619) expressing 
the indicated Rtf1 derivatives were spotted on SD-His-Trp medium to examine the Spt- phenotype, SC-Ura-Trp 
medium containing 50 μg/mL 6-AU to assess 6-AU sensitivity, or SC-Trp medium as a control for growth.  Plates 
were incubated at 30oC for 5 days. 
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 Deletion of RTF1 also causes sensitivity to the base analog 6-azauracil (6-AU) (COSTA 
and ARNDT 2000), a drug that lowers intracellular nucleotide pools by inhibiting enzymes in the 
ribonucleotide synthesis pathway (EXINGER and LACROUTE 1992).  Sensitivity to 6-AU is 
considered an indicator of defects in transcription elongation because Pol II is believed to 
become more dependent on accessory factors to overcome elongation impediments under low 
nucleotide conditions.  My analysis demonstrated that removal of regions 6, 7, or 8 from Rtf1 
caused strong sensitivity to 6-AU, while deletion of regions 3, 4, and 9 caused moderate 
sensitivity (Figure 14, center panel). 
Interestingly, loss of any single region of RTF1 did not cause an effect equal to a 
complete RTF1 disruption for either phenotype tested, suggesting that each internal deletion 
mutant retains some functionality.  This raises the possibility that Rtf1 may be composed of 
distinct functional parts.  I performed an alignment of Rtf1 homologs from four species, which 
revealed a total of 26 invariant residues.  All of these invariant amino acids reside in either 
regions 3-4 (8 invariant residues) or 6-9 (18 invariant residues) (Figure 15).  These conserved 
sections of the protein overlap with those that cause the most severe Spt- and 6-AUS phenotypes 
when deleted.  Together, these observations suggest that Rtf1 requires two clusters of highly 
conserved amino acids to direct normal transcription in vivo. 
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Figure 15.  Rtf1 homologs contain two clusters of highly conserved residues.   
An alignment of Rtf1 protein sequences from four different species is shown.  Conserved residues are highlighted in 
gray, with darker shades indicating a greater degree of conservation.  Black and gray lines above the S. cerevisiae 
sequence denote Rtf1 regions 3-4 and 6-9, respectively.   
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2.3.2 A region near the amino-terminus of Rtf1 mediates physical interaction with Chd1 
The observation that removal of discrete amino acid clusters from Rtf1 caused transcription 
defects led us to investigate whether these residues are responsible for any of Rtf1’s known 
functions.  The Arndt lab has previously demonstrated that Rtf1 physically associates with the 
ATP-dependent chromatin remodeling protein Chd1 and determined that this interaction is 
mediated by region 1 of Rtf1 (residues 3-30) (COSTA 2001).  Rtf1 is required for normal 
recruitment of Chd1 to active ORFs (SIMIC et al. 2003) and I examined whether Rtf1 region 1 
contributed to this association.  I performed chromatin immunoprecipitation (ChIP) assays on 
wild type, rtf1Δ1, and rtf1Δ strains expressing HA-tagged Chd1.  Association of Rtf1 was 
analyzed at the 5’ ends of two ORFs:  PYK1, a highly expressed gene where association of the 
Paf1 complex has been detected previously (QIU et al. 2006), and TEF2, where we have 
previously demonstrated a role for Rtf1 in the recruitment of Chd1 (SIMIC et al. 2003).  My 
results show that deletion of region 1 of Rtf1 significantly reduced association of Chd1 at the 5’ 
ORFs of PYK1 and TEF2, although the effect was not as severe as that observed when RTF1 was 
completely absent (Figure 16) suggesting that additional regions of Rtf1 may contribute to 
stabilizing the interaction of Chd1 with chromatin. 
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Figure 16.  The amino-terminus of Rtf1 is required for recruitment of Chd1 to active genes. 
ChIP analysis of Chd1 recruitment to active ORFs in rtf1 mutants.  HA-Chd1 and associated DNA were 
immunoprecipitated from extracts of a formaldehyde-treated rtf1Δ strain (KY623) that had been transformed with an 
empty vector or plasmids that express untagged wild-type Rtf1 or Rtf1∆1.  An untagged Chd1 strain (KY452) 
expressing untagged wild-type Rtf1 (pLS20) was used as a control.  Association of Chd1 at the 5’ ORFs of PYK1 
(A) or TEF2 (B) was assessed by PCR.  The mean of three independent experiments with standard error is shown.  
Signal from strains expressing full-length Rtf1 is set to 1. 
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A previous study in the Arndt lab identified a function for Rtf1 region 1 (STOLINSKI et al. 
1997).  An Rtf1 mutant with a substitution of phenylalanine for leucine at position 11 (Rtf1-1) 
was identified as a suppressor of the Spt- phenotype caused by spt15-122, a mutation in the gene 
encoding the TATA-binding protein (TBP).  The TBP mutant encoded by spt15-122, TBP-
L205F, exhibits altered DNA binding specificity in vitro and in vivo (ARNDT et al. 1992).  
Previous analysis in the lab demonstrated that Rtf1-1 also impairs the physical interaction 
between Rtf1 and Chd1 (COSTA 2001).  The observation that the Rtf1-1 mutant protein interacted 
poorly with Chd1 suggested that suppression of spt15-122 by certain RTF1 mutations was due to 
a disruption of the Rtf1-Chd1 interaction.  This possibility was tested by examining the effect of 
mutations that interfere with the Rtf1-Chd1 interaction on the Spt- phenotype of spt15-122 in a 
strain carrying his4-917δ, a HIS4 allele where a Ty δ element is inserted between the native 
TATA box and the transcription start site (ROEDER and FINK 1982).  Previous work in the lab 
determined that chd1∆ and rtf1-1 strongly suppressed the Spt- phenotype of the spt15-122 
mutation, similar to the effect of an rtf1 null allele (COSTA 2001; STOLINSKI et al. 1997).  I 
extended this analysis to demonstrate that rtf1Δ1 also suppresses this phenotype (Figure 17).  
These observations suggest that while disrupting the Rtf1-Chd1 interaction does not cause 
noticeable transcription-related phenotypes in a wild-type strain (Figure 17), it may have effects 
on chromatin structure that become apparent in a TBP mutant strain. 
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Figure 17.  Mutations that disrupt the Rtf1-Chd1 interaction suppress a TBP mutant.   
Mutations in RTF1 or CHD1 suppress the Spt- phenotype of an spt15-122 strain.  KY343, KY386, KY638, KY639, 
KY640, and KY641 (top row) or KY100, KY284, KY432, KY440, KY680, and KY1265 (bottom row) were grown 
on YPD medium and transferred by replica printing to SC complete as a control or SC-His medium to examine the 
Spt- phenotype.  Plates were incubated at 30oC for 3 days.   
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2.3.3 Conserved regions of Rtf1 are required for Rtf1-dependent histone modifications 
and telomeric silencing 
I next sought to determine which residues are essential for Rtf1 to direct covalent modification of 
lysine residues in histones H2B and H3.  I began by examining the effects of the Rtf1 internal 
deletion mutants on histone H3 methylation.  Immunoblot analysis demonstrated that Rtf1 
regions 3 and 4 are essential for dimethylation and trimethylation of histone H3 K4 and 
dimethylation of histone H3 K79 (Figure 18A and data not shown).  I also observed a slight 
reduction of these modifications when regions 6, 7, 8, or 9 were eliminated from Rtf1.  
Interestingly, the regions of Rtf1 that are required for histone methylation correspond to the most 
highly conserved portions of the protein (Figure 15). 
 97 
 
Figure 18.  Conserved regions of Rtf1 are essential for Rtf1-dependent histone modifications and 
telomeric silencing.   
(A)  Immunoblot analysis of Rtf1-dependent histone methylation in strains expressing the Rtf1 internal deletion 
mutants.  Extracts from an rtf1Δ strain (KY404) expressing the indicated Rtf1 derivatives were probed with 
antibodies specific for H3 K4 Me3, H3 K79 Me2, and total H3.  An anti-L3 immunoblot was performed as a loading 
control.  Me3 = trimethylation; Me2 = dimethylation.  (B) Analysis of H2B K123 ubiquitylation levels in Rtf1 
mutants defective for histone methylation.  FY406, KY982, KY1216, and KY1217 were transformed with plasmids 
expressing untagged or HIS-tagged ubiquitin and a plasmid expressing wild type or FLAG-tagged histone H2B.  
The HIS-tagged protein fraction from each strain was isolated and analyzed by immunoblot using an anti-FLAG 
antibody to detect FLAG-H2B (top panel).  An anti-HIS tag immunoblot was also performed (lower panel) to 
demonstrate expression and enrichment of HIS-ubiquitin (HIS-Ub) in the expected strains.  (C)  Analysis of 
telomeric silencing in strains expressing Rtf1 internal deletion mutants.  Ten-fold serial dilutions, ranging from 1 x 
108 cells/mL to 1 x 104 cells/mL, of an rtf1Δ strain (OKA93) expressing the indicated Rtf1 derivatives and 
containing an ectopic URA3 gene integrated proximal to the telomere on the right arm of chromosome V were 
spotted on SC-Ura-Trp medium containing 5-FOA to assess telomeric silencing defects or SC-Trp medium as a 
control for growth.  Plates were incubated at 30oC for 4 days. 
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Rtf1 is also required for monoubiquitylation of histone H2B K123 (NG et al. 2003b; 
WOOD et al. 2003b).  Because removal of Rtf1 region 3 or 4 eliminates H3 K4 and K79 
methylation, modifications that lie downstream of H2B K123 Ub, I examined the state of H2B 
K123 Ub in strains expressing these Rtf1 mutants.  This modification was analyzed in strains 
expressing HIS-tagged ubiquitin (HIS-Ub) and FLAG-tagged histone H2B (FLAG-H2B).  
Expression of FLAG-H2B and HIS-Ub was confirmed by immunoblot analysis (data not shown 
and Figure 18B).  Ubiquitylated proteins from yeast extracts were captured on Ni-NTA agarose, 
separated by SDS-PAGE, and analyzed by immunoblotting for the presence of FLAG-H2B.  I 
detected ubiquitylated H2B in wild-type cells, but not in cells where RTF1 had been deleted or 
replaced with rtf1Δ3 or rtf1Δ4 (Figure 18B).  This observation demonstrates that Rtf1-dependent 
histone ubiquitylation is mediated by the same 90 amino acids (residues 63-152; regions 3 and 4) 
as Rtf1-dependent histone methylation. 
Rtf1 and its downstream histone modifications are required for normal telomeric 
silencing (KROGAN et al. 2003; NG et al. 2003b).  To assess which regions of Rtf1 affect 
telomeric silencing, I analyzed the effects of the Rtf1 internal deletion mutants on expression of 
an ectopic copy of URA3 integrated proximal to the telomere on the right arm of chromosome V 
(TEL-VR::URA3).  URA3 expression causes toxicity on media containing 5-fluoroorotic acid (5-
FOA).  When telomeric silencing is active, transcription from TEL-VR::URA3 is repressed and 
cell growth is largely unaffected by 5-FOA.  However, mutations that compromise telomeric 
silencing derepress TEL-VR::URA3, resulting in growth inhibition or cell death on 5-FOA 
containing media.  I found that deletion of Rtf1 regions 3, 4, 6, 7, 8, or 9 eliminated cell growth 
on media containing 5-FOA in a TEL-VR::URA3 strain (Figure 18C, left panel).  Therefore, the 
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regions of Rtf1 that affect telomeric silencing correspond to the same regions that eliminate or 
reduce Rtf1-dependent histone modifications. 
2.3.4 Association of Rtf1 with active ORFs requires a conserved central region 
Rtf1 occupies active ORFs coincident with Pol II.  I performed ChIP assays on strains expressing 
the Rtf1 internal deletion mutants to investigate which regions of Rtf1 are required for its 
association with active ORFs.  Association of Rtf1 was analyzed at the 5’ ends of PYK1 and 
CLN2, a gene that requires the Paf1 complex for normal expression (KOCH et al. 1999).  My 
results show that deletion of segments 6, 7, or 8 reduced association of Rtf1 at the 5’ ORFs of 
PYK1 and CLN2 to background levels observed in untagged or rtf1Δ strains (Figure 19A and B).  
A strong reduction in association of Rtf1 at these loci was also observed when Rtf1 region 9 was 
absent.  Deletion of Rtf1 regions 3 and 4, which are required for Rtf1-dependent histone 
modifications, caused approximately a two-fold reduction of Rtf1 association with PYK1, but 
this effect was not observed for CLN2.  These observations suggest that a large central region of 
Rtf1, spanning amino acids 201-350, is essential for recruitment of Rtf1 to the two genes tested 
and amino acids 351-395 contribute significantly to this interaction. 
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Figure 19.  A central conserved region mediates association of Rtf1 with active ORFs and influences 
protein stability.   
(A) and (B) ChIP analysis of Rtf1 association with active ORFs.  HA-tagged Rtf1 mutants and associated DNA were 
immunoprecipitated from extracts of a formaldehyde-treated rtf1Δ strain (KY452) that expressed the indicated Rtf1 
derivatives.  Association of wild-type or mutant Rtf1 proteins with the 5’ ORFs of PYK1 (A) or CLN2 (B) was 
assessed by PCR.  The mean of three independent experiments with standard error is shown.  Signal from strains 
expressing HA-tagged full-length Rtf1 is set to 1. (C) Effects of Rtf1Δ7 overexpression on protein levels and histone 
modifications.  20 μg of extract from an rtf1Δ strain (KY404) expressing the indicated Rtf1 derivatives from low-
copy (CEN/ARS = C/A) or high-copy (2μ) plasmids were subjected to immunoblot analysis with antibodies specific 
for the HA epitope, H3 K4 Me3, H3 K79 Me2 and total H3.  An anti-L3 immunoblot was performed as a loading 
control. (D) ChIP analysis to assess effects of Rtf1Δ7 overexpression on association with active ORFs.  Analysis 
was performed as described in (A) and (B) on extracts from KY452 transformed with plasmids expressing the 
indicated Rtf1 derivatives from C/A or 2μ plasmids.  (E)  Overexpression of Rtf1Δ7 does not suppress transcription-
related phenotypes.  Ten-fold serial dilutions, ranging from 1 x 108 cells/mL to 1 x 104 cells/mL, of an rtf1Δ strain 
(KY619) expressing the indicated Rtf1 derivatives from C/A or 2μ plasmids were spotted on SD-His-Trp medium to 
examine the Spt- phenotype, SC-Ura-Trp medium containing 50 μg/mL 6-AU to assess 6-AU sensitivity, or SC-Trp 
medium as a control for growth.  Plates were incubated at 30oC for 5 days. 
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Immunoblot analysis of the Rtf1 internal deletion mutants indicates that expression of 
Rtf1 deletions 6, 7, 8, and 9 is somewhat reduced in comparison to full-length Rtf1 (Figure 
13B.), raising the possibility that the effects I observe when regions 6-9 are deleted may be a 
consequence of reduced protein levels.  To address this possibility, I expressed Rtf1Δ7 from a 
high-copy yeast vector and asked whether increased levels of the mutant protein reduced the 
severity of its effects.  I found that overexpression of Rtf1∆7 increased its levels to those 
observed for wild-type Rtf1 that was expressed from a CEN/ARS (low copy) vector (Figure 
19C), but did not increase association of Rtf1Δ7 with the 5’ ORF of PYK1 (Figure 19D) or 
suppress the transcription-related or histone modification defects observed in an rtf1Δ7 strain 
(Figure 19C and E).  These results support the idea that amino acids 201-395 are important for 
recruitment of Rtf1 to active genes and indicate that this association contributes to protein 
function and stability. 
2.3.5 Rtf1 interacts with other Paf1 complex components through its carboxy-terminus 
Rtf1 is a component of the five-member Paf1 transcription elongation complex.  To identify the 
regions of Rtf1 that are necessary for its association with other Paf1 complex components, I 
immunoprecipitated the Rtf1 internal deletion mutants with an anti-HA antibody and co-
immunoprecipitation of Paf1 or Myc-tagged Ctr9 was measured by immunoblot analysis (Figure 
20A).  I found that Paf1 and Ctr9 co-immunoprecipitated with full-length Rtf1 and Rtf1 internal 
deletion mutants 1 through 11.  The slight decrease in the amounts of Paf1 and Ctr9 co-
immunoprecipitated from strains expressing Rtf1 internal deletion mutants 6, 7, 8, and 9 is likely 
related to the reduced expression of these Rtf1 mutants (Figure 13B).  However, when the most 
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carboxy-terminal segments of Rtf1, regions 12 or 13, were deleted, co-immunoprecipitation of 
Paf1 and Ctr9 was greatly reduced. 
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Figure 20.  The carboxy-terminus of Rtf1 mediates physical interaction with other Paf1 complex 
subunits.   
(A) Co-immunoprecipitation analyses of Rtf1 internal deletion mutants and other Paf1 complex subunits.  Extracts 
from an rtf1Δ strain (KY995) expressing Ctr9-Myc and the indicated Rtf1 derivatives were subjected to 
immunoprecipitation with an anti-HA antibody.  The precipitated fraction was analyzed by immunoblotting using 
anti-Myc, anti-Paf1, or anti-HA antibodies.  (B)  Paf1 and Ctr9 bind to the carboxy-terminus of Rtf1.  GST alone or 
GST fusions to full-length Rtf1 (GST-Rtf1), the amino-terminal half of Rtf1 (GST N-Rtf1), the carboxy-terminal 
half of Rtf1 (GST Rtf1-C), or Rtf1 segments 11 through 13 (GST Rtf1(11-13)) were purified from bacteria and 
incubated with yeast extract from an rtf1∆ strain (KY457) for GST pull-down assays.  Bound proteins were detected 
by immunoblotting using anti-Myc and anti-Paf1 antibodies.  (C)  ChIP analysis of Ctr9-Myc in Rtf1 internal 
deletion mutant strains.  Myc-tagged Ctr9 and associated DNA were immunoprecipitated from extracts of a 
formaldehyde-treated rtf1Δ strain (KY995) expressing Ctr9-Myc and the indicated Rtf1 derivatives.  Association of 
Ctr9-Myc with the 5’ ORF of PYK1 was assessed by PCR.  The mean of three independent experiments with 
standard error is shown.  Signal from transformants expressing HA-tagged full-length Rtf1 is set to 1. 
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To further test the importance of the Rtf1 carboxy-terminus in Paf1 complex assembly, I 
purified bacterially-expressed GST fusions to full-length Rtf1, the amino-terminal half of Rtf1, 
the carboxy-terminal half of Rtf1, or the extreme carboxy-terminus of Rtf1 (regions 11 through 
13) and examined the ability of these fusions to bind Paf1 or Myc-tagged Ctr9 in yeast lysates.  I 
found that Paf1 and Ctr9 bound GST fusions to full-length Rtf1, the carboxy-terminal half of 
Rtf1, and the extreme carboxy-terminus of Rtf1 (Figure 20B).  However, a GST fusion to the 
amino-terminal half of Rtf1 showed essentially no interaction with Paf1 or Ctr9.  Together, these 
observations indicate that the extreme carboxy-terminus of Rtf1 is both necessary and sufficient 
to mediate interaction with other components of the Paf1 complex. 
A previous report demonstrated that Paf1 complex components fail to associate with 
active ORFs in a strain completely lacking Rtf1 (MUELLER et al. 2004).  I therefore decided to 
use our specific mutations to test whether disruption of the physical interaction between Rtf1 and 
the Paf1 complex is sufficient to eliminate recruitment of other Paf1 complex components to 
active ORFs.  ChIP analyses were performed on a strain expressing Myc-tagged Ctr9 and a 
subset of the Rtf1 internal deletion mutants.  I found that regions of Rtf1 required for the 
interaction with Chd1 (region 1) or histone modification (region 3) had only a modest effect on 
Ctr9 association at the PYK1 gene (Figure 20C).  However, removal of region 6, which is 
required for association of Rtf1 with active ORFs, or region 13, which is responsible for the 
interaction of Rtf1 with other Paf1 complex components, reduced Ctr9 association at PYK1 
essentially to the level observed in an rtf1 null strain.  Surprisingly, Ctr9 associates with the 5’ 
ORF of PYK1 at near wild-type levels in a strain expressing Rtf1Δ12.  This observation suggests 
that a weak physical interaction between Rtf1Δ12 and Ctr9 exists in vivo and that this interaction 
can be detected once it has been stabilized by formaldehyde crosslinking.  These results support 
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the conclusion that Rtf1 is required to tether the Paf1 complex to active ORFs.  Additionally, I 
observed that deletion of region 13 from Rtf1 slightly reduces its occupancy on PYK1 and CLN2 
(Figure 19), suggesting that other Paf1 components may play a reciprocal, though minor, role in 
stabilizing association of Rtf1 with active ORFs. 
2.4 CONCLUSIONS 
Using a collection of sequential rtf1 deletion mutations, I demonstrated that discrete 
nonoverlapping segments of Rtf1 are required for recruitment of Chd1 to active genes, histone 
modification, association of Rtf1 with active ORFs, and interaction with other Paf1 complex 
subunits.  These regions of the protein have been given designations which reflect their 
functionality:  Chd1-interaction domain (CID), histone modification domain (HMD), ORF-
association region (OAR), and the Paf1 complex interaction domain (PID), respectively.  I 
observed that distinct transcriptional effects resulted from disruption of individual functions of 
Rtf1 (Figure 21).  Combined with the observation that a complete deletion of RTF1 causes more 
severe phenotypes than mutations that eliminate only one of its activities (Figure 14), these data 
suggest that the functions of Rtf1 are not entirely interdependent. 
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Figure 21.  Rtf1 is composed of functionally distinct regions.   
A schematic diagram of Rtf1 indicating the relative size of each Rtf1 internal deletion (numbered boxes) is shown.  
Regions of Rtf1 affecting each of the indicated processes or phenotypes are specified by colored lines.  The width of 
the line represents the degree of phenotype or effect that was observed. 
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My analyses and other data from the Arndt lab indicate that amino acids 3-30 of Rtf1 
(region 1) are required for physical interaction with Chd1 and for normal association of Chd1 
with active genes.  Although I observed no transcription-related defects when region 1 was 
deleted in an otherwise wild-type strain, previous work in the lab has demonstrated that rtf1-1, 
which results in substitution of phenylalanine for a leucine at position 11, and chd1 and rtf1 null 
alleles suppress the Spt- phenotype of the spt15-122 mutation (COSTA 2001; STOLINSKI et al. 
1997).  I report here that this effect is also caused by rtf1Δ1.  This result indicates that the 
interaction between Rtf1 and Chd1 is important for proper chromatin function particularly when 
the cell is sensitized to small changes in nucleosome positioning or stability, such as in a TBP 
mutant strain. 
I also demonstrated that amino acids 63 through 152 of Rtf1, which correspond to regions 
3 and 4, are required for monoubiquitylation of H2B K123 and methylation of histone H3 K4 
and K79.  Regions 3 and 4 of Rtf1 contain several highly conserved residues, but a Psi-BLAST 
search did not identify similar domains in other proteins.  This suggests that regions 3 and 4 of 
Rtf1 stimulate the activity of the enzymes that promote Rtf1-dependent histone mechanisms 
(Rad6, Set1, and Dot1) by a unique conserved mechanism. 
Rtf1-dependent histone modifications were also moderately reduced by deletion of 
regions 6-9, which span amino acids 201-395.  My analyses show that residues in these regions 
are important for association of Rtf1 with active ORFs.  In addition to its role in normal Rtf1-
dependent histone modification levels, the association of Rtf1 with chromatin, and presumably 
transcribing Pol II, appears to be required for its full stability and for normal telomeric silencing. 
All amino acids that are invariant across the four Rtf1 homologs examined in Figure 15 
reside in either regions 3-4, which are required for histone modification, or in regions 6-9, which 
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regulate localization of Rtf1 to active ORFs.  I also observe that the most severe transcription-
related phenotypes result from deletion of these regions of the protein, indicating that directing 
cotranscriptional modification of histones is a critical means by which Rtf1 exerts its effects on 
transcription.   
Finally, I demonstrated that the carboxy-terminus of Rtf1, defined by region 13, is 
necessary and sufficient for the interaction between Rtf1 and other Paf1 complex subunits.  
Consistent with a prior study, I confirmed that interaction with Rtf1 mediates recruitment of Paf1 
and Ctr9 to active ORFs (MUELLER et al. 2004).  Remarkably, disruption of the physical 
interaction between Rtf1 and the Paf1 complex causes only a mild Spt- phenotype (Figure 14) 
and the known biochemical functions of Rtf1 remain largely intact.  This observation suggests 
that Rtf1 retains function, independent of stable association with the Paf1 complex.   
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3.0  CONSERVED RESIDUES IN THE RTF1 HISTONE MODIFICATION DOMAIN 
DIRECT HISTONE H2B UBIQUITYLATION AND H3 METHYLATION 
3.1 INTRODUCTION 
In Section 2.3.3, I demonstrated that a 90 amino acid segment of Rtf1 mediates its roles in 
histone H2B monoubiquitylation, histone H3 K4 di- and trimethylation, and histone H3 K79 
dimethylation.  The region of Rtf1 required to promote these histone modifications spans amino 
acids 63 through 152 (regions 3 and 4) of the full-length protein.  I have termed this protein 
region the histone modification domain (HMD) to reflect its functionality.   
The Rtf1 HMD contains eight residues in a 33 amino acid span that are invariant across 
Saccharomyces cerevisiae, Schizosaccharomyces pombe, Homo sapiens, and Caenorhabditis 
elegans (Figure 15).  Although the HMD is conserved, its primary amino acid sequence does not 
resemble any recognized domains or motifs that imply the mechanism by which it functions; I, 
therefore, sought to explore this mechanism in several ways.   
First, I isolated substitution mutations in conserved residues of the HMD and investigated 
their effects on the known functions for this region of the protein.  Surprisingly, I found that 
different HMD substitution mutations had unique effects on Rtf1-dependent histone 
modifications.  I also tested the effects of these mutations on transcription and chromatin-related 
phenotypes that result when RTF1 is completely deleted.  Interestingly, the results of these 
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analyses indicate that HMD substitution mutations often have similar effects on these 
phenotypes, despite their differential effects on Rtf1-dependent histone modifications.  However, 
phenotypic effects of the HMD substitution mutations sometimes differ from those caused by an 
rtf1 null mutation or partial deletions of the HMD.  These results suggest that modifying the 
HMD and removing it are not functionally equivalent. 
Additionally, I determined that the HMD alone was sufficient to promote Rtf1-dependent 
histone methylation in a strain where RTF1 had been deleted.  Intriguingly, the HMD did not 
need to be specifically targeted to DNA or to active genes to elicit this activity.  Together, these 
results suggest that promoting histone modification is an intrinsic property of the HMD and that 
its function does not require a stable interaction with active genes.   
3.2 MATERIALS AND METHODS 
3.2.1 Media and yeast strains 
Media were prepared and standard genetic methods were performed as described in Section 
2.2.1.  S. cerevisiae strains used in these studies are listed in Table 2.  All strains are GAL2+ 
derivatives of S288C (WINSTON et al. 1995).  Constructs expressing HA-Rtf1 102-104A, HA-
Rtf1 108-110A, or HA-Rtf1 F80V F123S, which are tagged at the amino-terminus with three 
copies of the HA epitope, were integrated into the yeast chromosome to replace endogenous 
RTF1 by a two-step gene replacement method (ROTHSTEIN 1991). 
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3.2.2 Plasmid construction 
Standard cloning techniques were used to construct all plasmids (AUSUBEL et al. 1988).  pLS20 
and pLS21-5 are derivatives of pRS314 (SIKORSKI and HIETER 1989) that express Rtf1 or triple 
HA-tagged Rtf1, respectively (STOLINSKI et al. 1997).  pKR27 and pKR28 express HA-Rtf1∆3 
and HA-Rtf1∆4, respectively, and were created as part of the Rtf1 internal deletion series as 
described in Section 2.2.2.  Alanine substitution mutations in the Rtf1 HMD were created by 
site-directed mutagenesis using the QuikChange system from Stratagene.  Using pLS21-5 as the 
template plasmid, three separate plasmids were created by this method:  pJB1, which expresses 
HA-Rtf1 102-104A; pJB2, which expresses HA-Rtf1 108-110A, and pJB3, which expresses HA-
Rtf1 120-121A.  These mutations cause changes in the native amino acids at the corresponding 
numerical positions, i.e. 102-104, to alanines.  The presence of the specified mutations in each 
plasmid was confirmed by DNA sequencing. 
An amino-terminal Gal4 DNA binding domain fusion to full-length Rtf1 (GBD-Rtf1) is 
expressed from pLS28; construction of this plasmid is described in SIMIC et al. 2003.  pLS28 is 
based on pGBT9 (Clontech), which expresses untagged GBD (corresponding to amino acids 1-
147 of full-length Gal4.)  pMW8 expresses an amino-terminal fusion of GBD to amino acids 63 
through 152 of full-length Rtf1 (GBD-HMD); a single Myc tag is present between the GBD and 
HMD; this plasmid was created by amplifying the HMD coding sequence (nucleotides 187 
through 456 of full-length RTF1) from pLS21-5 using primers that add an NdeI site to the 5’ end 
and two stop codons and an EcoRI site to the 3’ end.  The resulting PCR product was digested 
with the appropriate enzymes and ligated into NdeI/EcoRI digested pGBKT7.  pGBKT7 
(Clontech) expresses the GBD tagged with a single Myc epitope at the carboxy-terminus (GBD-
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Myc).  pMW16 and pMW17 express GBD-myc fusions to amino acids 63 through 152 of Rtf1 
F123S (GBD-F123S-HMD) and Rtf1-102-104A (GBD-102-104A-HMD), respectively.  pMW16 
was created by amplifying the HMD coding region from pDS1, which expresses full-length HA-
Rtf1 F123S, and pMW17 was created by amplifying the HMD coding sequence from pJB1.  A 
GBD-Myc fusion to the Rtf1 108-110A HMD (pMW15) was created, but no expression of this 
fusion protein could be detected in whole cell extracts (data not shown). 
3.2.3 Error prone mutagenesis of the RTF1 HMD coding sequence 
To create random substitution mutations in the Rtf1 HMD, a PCR product encompassing 
nucleotides -23 through +1008 of RTF1 was generated using Promega Taq DNA polymerase, a 
low fidelity DNA polymerase, under low nucleotide conditions (50µM each dNTP).  The 
resulting PCR product was transformed into KY960 along with pKR27 that was digested with 
BglII and SmaI to remove nucleotides 190 through 783 (regions 3 through 6).  Because the PCR 
product contains slightly greater than 200 bp overlaps upstream and downstream of the deleted 
region, homologous recombination should result in integration of the PCR product into the 
digested plasmid (MUHLRAD et al. 1992).  Repaired plasmids are TRP1 marked and can be 
selected on medium lacking tryptophan (SC-Trp).  KY960 is deleted for the genomic copies of 
RTF1 and RKR1, but is kept viable due to the presence of pKA69, which carries RTF1 on a 
URA3-marked plasmid.  Trp+ transformants were exposed to medium containing 5FOA to 
counterselect for pKA69; transformants that were Trp+, but sensitive to 5FOA, were further 
characterized.  Null mutations were ruled out due to the degree of Spt- phenotype they caused; an 
rtf1 null mutation causes a strong Spt- phenotype in a his4-912δ strain, while the effect of partial 
deletions of the HMD on this phenotype is relatively mild (Figure 14).  Candidate plasmids that 
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caused a mild Spt- phenotype were isolated and sequenced.  Two plasmids that were isolated in 
this screen, pKB1 (HA-rtf1 F80V F123S) and pKB2 (HA-rtf1 E119K F123S) were used in 
studies detailed in this chapter. 
3.2.4 Yeast growth assays 
Strains were grown to saturation at 30oC in appropriate media.  Cells were washed twice and 
serially diluted in sterile water.  Three microliters of each dilution were spotted on indicated 
media and incubated at 30oC. 
3.2.5 Immunoblotting analyses 
With the exception of the extracts analyzed in Figure 23C, all extracts were prepared by glass 
bead lysis in RIPA buffer and analyzed as described in Section 2.2.5.  Extracts prepared from 
KY404 transformed with pLS21-5, pRS314, pKR27, pKR28, pJB1, pJB2, pJB3, pKB1, pKB2, 
and pLS20 that had been grown in SC-Trp medium were analyzed in Figure 22B; extracts 
prepared from KY279, KY1418, KY404, KY1193, KY1194, and KY1195 that had been grown 
in YPD were analyzed in Figure 23B; and extracts prepared from MHY119 transformed with 
pGBT9, pGBKT7, pLS20, pLS28, pMW8, pMW16, or pMW17 that had been grown in SC-Trp 
medium were analyzed in Figure 26 and Figure 29.  30 µg of extract from each strain was run on 
a 15% SDS-polyacrylamide gel and proteins were transferred to nitrocellulose for immunoblot 
analysis.  An antibody specific for H3 K4 dimethylation (H3 K4 Me2; Upstate) was used at 
1:2500 dilution and an anti-Rtf1 antibody (SQUAZZO et al. 2002) was used at a 1:3000 dilution.  
Antibodies specific for glucose-6-phosphate dehydrogenase (G6PDH; 1:100,000; Sigma) or L3 
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(described in Section 2.2.5) were used to demonstrate that equivalent amounts of protein were 
loaded in each lane.  All other antibodies were described in Section 2.2.5. 
 Extracts from KY1418, KY1194, and KY1195 were also prepared by a rapid boiling 
method to assess total H3 levels.  Cells were grown in YPD to approximately 3 x 107 cells/mL 
and a volume equal to approximately 4.5 x 107 cells was centrifuged to remove growth media.  
The cell pellet was resuspended in 20 µL sample buffer (80mM Tris-Cl pH 6.8, 2% SDS, 10% 
glycerol, 0.01% bromophenol blue, 1% β-mercaptoethanol, and 1mM phenylmethylsulfonyl-
fluoride) and boiled for 2 minutes.  Cells were frozen in liquid nitrogen, and then thawed and 
vortexed at maximum speed in the presence of 0.12g acid-washed glass beads.  80 µL of 
additional sample buffer were added, extracts were boiled for an additional 3 minutes, and a 
volume equivalent to 1 x 107 cells was loaded on a 15% SDS-polyacrylamide gel.  Proteins were 
transferred to nitrocellulose and analyzed with the indicated antibodies. 
3.2.6 Analysis of histone H2B K123 monoubiquitylation 
Histone H2B K123 monoubiquitylation was measured using the protocol described in Section 
2.2.6 and strains FY406 (RTF1), KY982 (rtf1∆), KY1458 (HA-RTF1), MHY213 (HA-rtf1 102-
104A), MHY215 (HA-rtf1 108-110A), and KY1462 (HA-rtf1 F80V F123S) expressing untagged 
or HIS-tagged ubiquitin and wild type or FLAG-tagged histone H2B.  An anti-Ub (gift of 
Richard Gardner; 1:50 dilution) immunoblot was performed to demonstrate expression of HIS-
Ub in the appropriate strains following enrichment with Ni-NTA agarose. 
 117 
3.2.7 Chromatin immunoprecipitation assays 
Chromatin was isolated and immunoprecipitated as described in Section 2.2.7.  MHY119 
transformed with pGBT9, pGBKT7, pLS20, pLS28, pMW8, pMW16, or pMW17 was analyzed 
in these experiments.  Anti-Myc immunoprecipitation was performed as described in Section 
2.2.7.  Other immunoprecipitations were performed overnight at 4oC with primary antibodies 
specific for H3 K4 trimethylation (H3 K4 Me3; Abcam), H3 K79 dimethylation (H3 K79 Me2; 
Upstate), total H3 (Upstate), or the largest subunit of Pol II (8WG16; Covance).  Immune 
complexes were captured by incubating with Protein A-coupled sepharose for histone antibody 
immunoprecipitations (Amersham Biosciences) and Protein G-coupled sepharose (Amersham 
Biosciences) for 8WG16 immunoprecipitations.  Association of these factors was analyzed at 
two loci:  the GAL7 UAS (-298/-92; ATG = +1) and the 5’ end of PYK1 (+195/381; ATG = +1).  
All PCR reactions were multiplexed with control primers that amplify a nontranscribed region in 
the right arm of telomere VI (TEL-VIR; coordinates: 269487/269624).  IP/input was calculated as 
described in Section 2.2.7.  IP/input values from the GAL7 UAS or PYK1 ORF are normalized to 
background signal observed with TEL-VIR primers; a ratio equal to “1” indicates no enrichment 
of the immunoprecipitated factors at the GAL7 UAS or PYK1 ORF over that observed at the 
TEL-VIR.  Signals for H3 K4 Me3 and H3 K79 Me2 were not normalized to TEL-VIR control 
primers because histones in this region are modified at low levels in strains containing a WT 
HMD.  TEL-VIR signal is, therefore, not equivalent across all strains used in this analysis and is 
unsuitable for normalization; specific signals are instead normalized to the amount of total H3 
present at the locus being examined.  
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Table 2.  Saccharomyces cerevisiae strains used in Chapter 3 
Straina Genotype 
FY406 MATa (hta1-htb1)Δ::LEU2 (hta2-htb2)Δ::TRP1 his3Δ200 lys2-128δ 
leu2Δ1 ura3-52 trp1Δ63 [pSAB6= HTA1-HTB1/CEN/ARS/URA3] 
KY279 MATa leu2Δ1 ura3-52 trp1Δ63 
KY404 MATa rtf1∆::LEU2 his4-912δ lys2-128δ leu2Δ1 ura3-52 trp1Δ63 
KY619 MATa rtf1∆::ARG4 his4-912δ lys2-173R2 leu2Δ1 trp1Δ63 arg4-12 
KY960 MATa rtf1∆::LEU2 rkr1∆::kanMX4 his4-912δ lys2-128δ leu2Δ1 ura3-52 
trp1Δ63 [pKA69 = RTF1/CEN/ARS/URA3] 
KY982 MATa rtf1∆::kanMX4 (hta1-htb1)Δ::LEU2 (hta2-htb2)Δ::TRP1 his3Δ200 
lys2-128δ leu2Δ1 ura3-52 trp1Δ63 [pSAB6= HTA1 
HTB1/CEN/ARS/URA3] 
KY1010 MATα his4-912δ lys2-128δ ade8 
KY1116 MATa GAL1pr-FLO8-HIS3::kanMX his3Δ200 lys2-128δ leu2Δ1 ura3-52 
trp1Δ63 
KY1193 HA-rtf1 102-104A his3Δ200 lys2-128δ leu2Δ1 ura3-52 trp1Δ63 ade8 
KY1194 HA-rtf1 108-110A his3Δ200 lys2-128δ leu2Δ1 ura3-52 ade8 
KY1195 HA-rtf1 F80V-F123S his3Δ200 lys2-128δ leu2Δ1 ura3-52 trp1Δ63 ade8 
KY1207 MATa rtf1∆::ARG4 GAL1pr-FLO8-HIS3::kanMX his3Δ200 (LYS2 or lys2-
173R2) leu2Δ1 ura3-52 arg4-12 
KY1208 MATa HA-rtf1∆3 GAL1pr-FLO8-HIS3::kanMX his3Δ200 lys2-128δ 
leu2Δ1 ura3-52 
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KY1209 MATa HA-rtf1∆4 GAL1pr-FLO8-HIS3::kanMX his3Δ200 lys2-128δ 
leu2Δ1 ura3-52 ade8 
KY1210 MATa HA-rtf1102−104Α GAL1pr-FLO8-HIS3::kanMX his3Δ200 lys2-
128δ leu2Δ1 ura3-52 arg4-12 
KY1211 MATα HA-rtf1108−110Α GAL1pr-FLO8-HIS3::kanMX his3Δ200 lys2-
128δ leu2Δ1 ura3-52  
KY1212 MATa HA-rtf1 F80V F123S GAL1pr-FLO8-HIS3::kanMX his3Δ200 lys2-
128δ leu2Δ1 ura3-52 ade8 
KY1226 MATα TEL-VR::URA3 ura3-52 
KY1227 MATα rtf1∆::kanMX TEL-VR ::URA3 lys2-128δ leu2Δ1 ura3-52 trp1Δ63 
KY1418 MATα HA-RTF1 his3Δ200 lys2-128δ leu2Δ1 ura3-52 trp1Δ63 
KY1458 MATα HA-RTF1 (hta1-htb1)Δ::LEU2 (hta2-htb2)Δ::TRP1 his3Δ200 lys2-
128δ leu2Δ1 ura3-52 trp1Δ63 [pSAB6= HTA1 HTB1/CEN/ARS/URA3] 
KY1462 MATα HA-rtf1 F80V F123S (hta1-htb1)Δ::LEU2 (hta2-htb2)Δ::TRP1 
his3Δ200 lys2-173R2 leu2Δ1 ura3-52 trp1Δ63 ade8 [pSAB6= HTA1 
HTB1/CEN/ARS/URA3] 
KY1506 MATα HA-rtf1∆3 his4-912δ lys2-128δ ade8 
KY1508 MATa HA-rtf1∆4 his4-912δ lys2-128δ leu2Δ1 trp1Δ63 
KY1510 MATα HA-rtf1 102-104A his4-912δ lys2-128δ leu2Δ1 trp1Δ63 
KY1511 MATα HA-rtf1 108-110A his4-912δ lys2-128δ trp1Δ63 ade8 
KY1512 MATa HA-rtf1 F80V F123S his4-912δ lys2-128δ leu2Δ1 ade8 
MHY119 MATa rtf1∆::kanMX4 gal4∆::LEU2 lys2-128δ leu2Δ1 ura3-52 trp1Δ63 
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MHY188 MATa HA-rtf1∆3 TEL-VR::URA3 his4-912δ lys2-128δ leu2Δ1 ura3-52 
trp1Δ63 
MHY190 MATα HA-rtf1∆4 TEL-VR::URA3 his4-912δ lys2-128δ leu2Δ1 ura3-52 
MHY192 MATα HA-rtf1 102−104Α TEL-VR::URA3 his4-912δ lys2-128δ leu2Δ1 
ura3-52 
MHY194 MATα HA-rtf1 108−110Α TEL-VR::URA3 his4-912δ lys2-128δ leu2Δ1 
ura3-52 trp1Δ63 
MHY197 MATα HA-rtf1 F80V F123S TEL-VR::URA3 his4-912δ lys2-128δ leu2Δ1 
ura3-52 trp1Δ63 
MHY213 MATα HA-rtf1 102-104A (hta1-htb1)Δ::LEU2 (hta2-htb2)Δ::TRP1 
his3Δ200 lys2-173R2 leu2Δ1 ura3-52 trp1Δ63 [pSAB6= HTA1 
HTB1/CEN/ARS/URA3] 
MHY215 MATα HA-rtf1 108-110A (hta1-htb1)Δ::LEU2 (hta2-htb2)Δ::TRP1 
his3Δ200 lys2-173R2 leu2Δ1 ura3-52 trp1Δ63 [pSAB6= HTA1 
HTB1/CEN/ARS/URA3] 
a FY406 was generated in the laboratory of Fred Winston. 
 121 
3.3 RESULTS 
3.3.1 Point mutations were generated in the Rtf1 HMD by biased and unbiased methods 
To explore the mechanism by which the Rtf1 HMD functions, I utilized two strategies to create 
mutations in this region.  In a biased approach, site-directed mutagenesis was used to replace 
several highly conserved residues in the HMD with alanines.  The HMD contains eight residues 
that are invariant across S. cerevisiae, S. pombe, H. sapiens, and C. elegans (Figure 15).   These 
invariant residues reside in a 33 amino acid stretch spanning residues 88 through 120.  I created 
three separate substitution mutations in this region:  rtf1 102-104A, rtf1 108-110A, and rtf1 120-
121A.  These particular mutations were chosen between these residues flank the border between 
regions 3 and 4 of Rtf1.  Each mutation changes at least one invariant residue and a neighboring 
residue to alanines, resulting in the neutralization of a charged patch (Figure 22A). 
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Figure 22.  Substitution of conserved residues in the Rtf1 HMD affects H3 K4 trimethylation.  
(A)  Primary amino acid sequence of the Rtf1 HMD.  The sequence of the S. cerevisiae Rtf1 HMD, corresponding to 
residues 63 through 152 of full-length Rtf1, is shown.  Residues that are conserved across S. cerevisiae, S. pombe, 
H. sapiens, and C. elegans are shown in red.  Black bars above the sequence denote clusters of charged residues that 
were mutated to alanines by site-directed mutagenesis; each mutation is referred to by its amino acid position 
followed by an “A”, which signifies that the native residues have been replaced with alanines.  Substitutions of the 
residues shown in blue were isolated in a genetic screen, as described in the text; the specific change that was 
isolated is indicated below the altered residue. (B)  Immunoblot analysis of H3 K4 trimethylation levels in strains 
with substitution mutations in the Rtf1 HMD.  Extracts from an rtf1∆ strain (KY404) expressing the indicated Rtf1 
derivatives were probed with antibodies specific for H3 K4 Me3 and total H3.  An anti-L3 immunoblot was 
performed as a loading control and an anti-HA blot was performed to demonstrate approximately equal expression 
of HA-tagged wild type Rtf1 and mutant Rtf1 proteins harboring mutations in the HMD.  The faster migrating band 
observed in most lanes in the anti-HA immunoblot is likely a product of proteolysis, which we frequently observe in 
extracts prepared by glass bead lysis, but is less pronounced in extracts prepared by a rapid boiling method (data not 
shown). 
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Furthermore, I performed an unbiased genetic screen to isolate additional mutations in 
the Rtf1 HMD.  A deletion of RTF1 is synthetically lethal in a cell that also lacks RKR1, which 
encodes a nuclear ubiquitin ligase (BRAUN et al. 2007).  Previous work in the Arndt lab has 
demonstrated that this synthetic lethality results from the combined loss of Rtf1-dependent H2B 
ubiquitylation and an unidentified compensatory function that is mediated by Rkr1.  I amplified a 
DNA fragment containing the HMD coding sequence using error-prone PCR to introduce 
random mutations.  The resulting PCR products, along with a linearized TRP1-marked plasmid 
carrying triple HA-tagged RTF1 that had been digested to remove the HMD coding sequence, 
were transformed into a strain where the genomic copies of RTF1 and RKR1 had been deleted.  
This strain was kept viable with a URA3-marked plasmid carrying wild type RTF1, which could 
be counterselected by growing these cells on media containing 5-FOA.  Colonies that grew on 
media lacking tryptophan, but became inviable following exposure to 5-FOA, likely contained 
repaired plasmids harboring copies of rtf1 with mutations in the HMD, since loss of Rtf1-
dependent H2B ubiquitylation is lethal in the absence of Rkr1.  rtf1 null mutations were ruled out 
based on the strength of Spt- phenotype; a strong Spt- phenotype is associated with a null allele 
while HMD mutations cause a weak Spt- phenotype (Figure 14).  Two HMD mutations were 
identified in this screen:  rtf1 F80V F123S and rtf1 E119K F123S (Figure 22A).  Although these 
residues are not invariant across the four Rtf1 homologs analyzed in Figure 15, the phenylalanine 
at position 123 in S. cerevisiae is conserved as a non-polar hydrophobic amino acid in the other 
three species examined. 
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3.3.2 Conserved residues in the Rtf1 HMD differentially affect H2B ubiquitylation and 
H3 methylation 
I first tested the effects of the HMD point mutations on Rtf1-dependent histone modifications.  
Initially, I performed immunoblot analysis with an antibody specific for H3 K4 trimethylation on 
extracts prepared from an rtf1∆ strain that had been transformed with plasmids carrying each of 
the five rtf1 HMD point mutations:  rtf1 102-104A, rtf1 108-110A, rtf1 120-121A, rtf1 F80V 
F123S, and rtf1 E119K F123S.  The resulting HMD mutant proteins are HA-tagged and I 
confirmed their expression is equivalent to wild type Rtf1 by anti-HA immunoblot analysis 
(Figure 22B). I also demonstrated that several of the HMD mutations do not impair cell growth 
on complete medium (Figure 24; right panel) and that the resulting mutant proteins were 
recruited normally to the 5’ end of CLN2 (data not shown).  These results indicate that mutation 
of the HMD does not result in a gross misfolding of the resulting proteins.   I found that four of 
the five HMD point mutations, with the exception of rtf1 120-121A, eliminated or greatly 
reduced H3 K4 trimethylation (Figure 22B). 
To further characterize the consequences of these mutations, I integrated three of the 
alleles that affected H3 K4 trimethylation, rtf1 102-104A, rtf1 108-110A, and rtf1 F80V F123S, 
into the genome to replace wild type RTF1.  Because I had observed that these mutations 
affected H3 K4 trimethylation, I next determined their effect on the upstream ubiquitylation of 
H2B at K123.  I analyzed this modification using a strain that expressed HIS-Ub and FLAG-
H2B, as described in Section 2.3.3.  Interestingly, I found that rtf1 108-110A and rtf1 F80V 
F123S eliminated this modification, while it was essentially unaffected in an rtf1 102-104A strain 
(Figure 23A).  I confirmed that the effect of rtf1 108-110A and rtf1 F80V F123S on H2B K123 
ubiquitylation was not a consequence of decreased H2B levels by performing an anti-FLAG 
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immunoblot on whole cell extracts prepared from these strains and observed that equal or greater 
amounts of FLAG-H2B were extracted from HMD mutant strains when compared to a wild type 
strain (data not shown.) 
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Figure 23.  Conserved residues in the Rtf1 HMD differentially affect Rtf1-dependent histone 
modifications.  
(A) Analysis of H2B K123 ubiquitylation levels in Rtf1 HMD substitution mutant strains.  FY406 (RTF1), KY982 
(rtf1∆), KY1458 (HA-RTF1), MHY213 (HA-rtf1 102-104A), MHY215 (HA-rtf1 108-110A), and KY1462 (HA-rtf1 
F80V F123S) were transformed with plasmids expressing untagged or HIS-tagged ubiquitin and plasmids expressing 
wild type or FLAG-tagged histone H2B as their only source of histone H2B.  The HIS-tagged protein fraction from 
each strain was isolated and analyzed by immunoblot using an anti-FLAG antibody to detect FLAG-H2B (top 
panel).  An anti-ubiquitin (anti-Ub) immunoblot was also performed (lower panel) to demonstrate expression and 
enrichment of HIS-ubiquitin (HIS-Ub) in the expected strains.  (B) Immunoblot analysis of Rtf1-dependent histone 
methylation in Rtf1HMD substitution mutant strains.  Extracts were prepared from KY279 (RTF1), KY1418 (HA-
RTF1), KY404 (rtf1∆), KY1193 (HA-rtf1 102-104A), KY1194 (HA-rtf1 108-110A), and KY1195 (HA-rtf1 F80V 
F123S) by glass bead lysis and probed with antibodies specific for H3 K4 Me3, H3 K4 Me2, H3 K79 Me2, and total 
H3.  An anti-G6PDH immunoblot was performed as a loading control and an anti-HA immunoblot was performed to 
demonstrate equivalent expression of HA-Rtf1 and Rtf1 HMD substitution mutant proteins.  (C) Analysis of total 
H3 levels in extracts prepared from select Rtf1 HMD substitution mutant strains by a rapid boiling method.  Rapid 
boiling extracts were prepared from KY1418 (HA-RTF1), KY1195 (HA-rtf1 F80V F123), and KY1194 (HA-rtf1 
108-110A) and probed with antibodies specific for H3 K4 Me3, H3 K79 Me2, and total H3. 
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Due to the unexpected observation that unique HMD mutations had distinct effects on 
H2B ubiquitylation, I sought to perform a more thorough evaluation of the effects of these 
mutations on Rtf1-dependent H3 methylation.  I prepared extracts from strains where rtf1 102-
104A, rtf1 108-110A, or rtf1 F80V F123S had been integrated to replace the genomic copy of 
RTF1 and performed immunoblot analysis using antibodies specific for di- or trimethylated H3 
K4 or dimethylated H3 K79.  As expected, the HMD mutations which eliminated H2B K123 Ub 
(rtf1 108-110A and rtf1 F80V F123S) also eliminated all three H3 methylation marks that were 
examined (Figure 23B).  However, rtf1 102-104A, which did not affect H2B K123 
ubiquitylation, specifically eliminates only H3 K4 trimethylation.  Together, these results 
indicate that distinct conserved residues in the HMD differentially affect H2B ubiquitylation and 
H3 K4 trimethylation. 
3.3.3 rtf1 108-110A and rtf1 F80V F123S may alter histone-DNA contacts 
Another surprising observation made from the immunoblot analysis shown in Figure 23B is that 
rtf1 108-110A and rtf1 F80V F123S decrease the amount of total H3 present in whole cell 
extracts prepared by glass bead lysis (Figure 23B).  However, I demonstrated that the effects of 
these mutations on Rtf1-dependent histone modifications are not simply a consequence of 
decreased H3 expression by repeating this immunoblot analysis on extracts prepared from HA-
RTF1, rtf1 108-110A, and rtf1 F80V F123S strains by a rapid boiling method; when extracts are 
prepared in this manner, H3 K4 trimethylation and H3 K79 dimethylation are still dramatically 
decreased in rtf1 108-110A and rtf1 F80V F123S strains even though the amount of total H3 
extracted under these conditions is equal to that observed in the HA-RTF1 strain (Figure 23C).   
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A major difference between the two extract preparation methods is that the rapid boiling 
method lacks a centrifugation step that is performed during glass bead lysis.  During this 
centrifugation step, intact genomic DNA is likely discarded along with any histones that are still 
associated.  This suggests that the histone population being analyzed in extracts prepared by 
glass bead lysis represents free histones and histones which were dislodged from DNA during 
extract preparation.  Because it appears that total histone H3 protein levels are unaffected by rtf1 
108-110A and rtf1 F80V F123S mutations, my observations may instead suggest that these HMD 
mutations alter histone-DNA contacts or affect the balance of histones associated with DNA and 
in free pools.  This effect is not likely due exclusively to the loss of H2B K123 ubiquitylation, 
because this modification is also absent from an rtf1∆ strain, where wild type levels of total H3 
are extracted by glass bead lysis (Figure 23B).  The different effects of rtf1 108-110A and rtf1 
F80V F123S mutations on extraction of total H3 when compared to an rtf1 null mutation may 
instead indicate that these HMD mutations represent gain-of-function alleles. 
3.3.4 Point mutations in the Rtf1 HMD cause defects in transcription 
I demonstrated that defects in transcription, as measured by the Spt- phenotype and sensitivity to 
the base analog 6-azauracil (6-AU), are caused by partial deletions of the HMD coding sequence:  
rtf1∆3 and rtf1∆4 (Figure 14).  I repeated this analysis to investigate whether Rtf1 HMD 
substitution mutations also cause transcription-related phenotypes.  In contrast to an rtf1 null 
mutation or partial HMD deletions, the HMD point mutations cause no discernible Spt- 
phenotype in a strain containing the his4-912δ allele (Figure 24; center panel).  However, the 
HMD mutations caused the same degree of 6-AU sensitivity as partial HMD deletions (Figure 
 131 
24; left panel).  Because sensitivity to 6-AU is an indicator of a transcription elongation defect, 
this result supports a role for the Rtf1 HMD in proper transcription elongation. 
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Figure 24.  Rtf1 HMD substitution mutations cause phenotypes associated with transcription defects. 
Ten-fold serial dilutions, ranging from 1 x 108 cells/mL to 1 x 104 cells/mL, of KY1010 (RTF1), KY619 (rtf1∆), 
KY1506 (HA-rtf1∆3), KY1508 (HA-rtf1∆4), KY1510 (HA-rtf1 102-104A), KY1511 (HA-rtf1 108-110A), and 
KY1512 (HA-rtf1 F80V F123S) were spotted on SC-Ura medium containing 50 μg/mL 6-AU to assess 6-AU 
sensitivity, SD-His medium to examine the Spt- phenotype, or SC Complete medium as a control for growth.  Plates 
were incubated at 30oC for 4 days. 
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3.3.5 Mutations in the Rtf1 HMD allow aberrant transcription initiation from cryptic 
promoters internal to coding regions and the telomeres  
In addition to the transcription-related defects that occur in its absence, deletion of RTF1 is also 
known to result in several phenotypes indicative of effects on normal chromatin function.  As 
described in Section 2.3.3, loss of Rtf1 results in ineffective transcriptional silencing of the 
telomeres, a process which is highly sensitive to disruptions in global histone modification 
patterns.  I analyzed the effectiveness of telomeric silencing in strains carrying the TEL-
VR::URA3 telomeric silencing reporter and integrated versions of rtf1 102-104A, rtf1 108-110A, 
or rtf1 F80V F123S.  I demonstrated that these HMD mutations prevent growth on media 
containing 5-FOA, comparable to the effect observed when RTF1 is completely deleted or when 
the HMD is partially removed (Figure 25A).  Interestingly, rtf1 120-121A, the only rtf1 HMD 
mutation that did not affect H3 K4 trimethylation in my initial analysis (Figure 22B), also did not 
affect telomeric silencing (data not shown.)  This result very closely links Rtf1’s roles in histone 
modification and telomeric silencing. 
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Figure 25.  Substitution mutations in the Rtf1 HMD cause phenotypes associated with defects in 
chromatin structure. 
(A)  Analysis of telomeric silencing in strains expressing Rtf1 HMD substitution mutants.  Ten-fold serial dilutions, 
ranging from 1 x 108 cells/mL to 1 x 104 cells/mL, of KY1226 (RTF1), KY1227 (rtf1∆), MHY188 (HA-rtf1∆3), 
MHY190 (HA-rtf1∆4), MHY192 (HA-rtf1 102-104A), MHY194 (HA-rtf1 108-110A), and MHY197 (HA-rtf1 F80V 
F123S) were spotted on SC-Ura medium containing 5-FOA to assess telomeric silencing defects or SC Complete 
medium as a control for growth.  Plates were incubated at 30oC for 3 days.  (B)  Substitution mutations in the Rtf1 
HMD allow aberrant initiation from a cryptic promoter within the FLO8 open reading frame.  Top; Schematic of the 
GAL1pr-FLO8-HIS3 reporter (PRATHER 2005).  GAL1pr = GAL1 promoter; FLO8cr = FLO8 cryptic internal 
promoter.  Bottom; Ten-fold serial dilutions (1 x 108 - 1 x 104 cells/mL) of KY1116 (RTF1), KY1207 (rtf1∆), 
KY1208 (HA-rtf1∆3), KY1209 (HA-rtf1∆4), KY1210 (HA-rtf1 102-104A), KY1211 (HA-rtf1 108-110A), and 
KY1212 (HA-rtf1 F80V F123S) were spotted on SC-His + galactose medium to induce and monitor expression of 
the reporter and SC Complete medium as a control for growth.  Plates were incubated at 30oC for 7 days.  The 
GAL1pr-FLO8-HIS3 reporter was kindly provided by Fred Winston. 
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Rtf1 is also required to suppress internal initiation from a cryptic promoter within the 
FLO8 gene (WINSTON, F.; unpublished communication).  This internal promoter is expressed 
when chromatin structure across the FLO8 gene is disrupted, as is thought to occur in strains 
with mutations in certain transcription and chromatin-related factors.  Effects on internal 
initiation from FLO8 can be monitored using a reporter strain where the HIS3 gene, which 
encodes an enzyme in the histidine biosynthesis pathway, is integrated into the FLO8 reading 
frame downstream of the internal promoter; because FLO8 is expressed at low levels, the native 
FLO8 promoter was replaced with the highly inducible GAL1 promoter (GAL1 pr; Figure 25B) 
(PRATHER 2005).  Expression from the internal promoter can then be monitored by growing 
GAL1pr-FLO8-HIS3 reporter strains on galactose-containing media that lacks histidine.  I used 
this reporter to demonstrate that rtf1 102-104A, rtf1 108-110A, and rtf1 F80V F123S result in 
internal initiation at FLO8 at a level equivalent to that observed when RTF1 is completely 
deleted (Figure 25B).  Interestingly, this effect is more severe than that caused by partial HMD 
deletions.  This result indicates that substitution of conserved residues in the HMD is not 
functionally equivalent to completely removing these residues from the protein. 
3.3.6 The Rtf1 HMD is sufficient to promote Rtf1-dependent histone modifications 
I have established that the Rtf1 HMD is necessary for Rtf1-dependent histone modifications; I 
next sought to determine if it was also sufficient.  To this end, I created a fusion of the Rtf1 
HMD, encompassing residues 63 through 152 of the full-length protein, to the DNA binding 
domain of the Gal4 transcriptional activator (GBD-HMD).  This construct also contains a single 
Myc epitope between the GBD and HMD.  As controls, I also created a fusion of the Rtf1 102-
104A HMD to GBD (GBD-102-104A-HMD) and a GBD fusion to an HMD containing a single 
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F123S substitution (GBD-F123S-HMD).  I focused on the F123S substitution because it was 
isolated multiple times in the error-prone mutagenesis screen described in Section 3.2.3.  I 
performed immunoblot analysis on extracts prepared from an rtf1∆ gal4∆ strain that had been 
transformed with plasmids expressing the GBD-HMD fusions.  All three GBD-HMD fusions 
were expressed and recognized by an anti-Rtf1 antibody (Figure 26).  I also analyzed expression 
of these fusions from the same extracts using an anti-Myc antibody; expression of GBD-Myc, 
GBD-HMD and GBD-F123S-HMD was detected in these extracts at nearly equivalent levels.  
However, GBD-102-104A-HMD could not be detected with an anti-Myc antibody in whole cell 
extracts (Figure 26).  This is likely the result of the lower expression level of this protein when 
compared with expression of the other GBD fusions, as is observed in the anti-Rtf1 immunoblot 
analysis.  Interestingly, all three GBD-HMD fusions impair growth of wild type, rtf1∆, and rtf1∆ 
gal4∆ strains when compared to the same strains expressing GBD-Myc alone (data not shown).  
This result may suggest that the GBD-HMD fusions function as dominant-negatives, potentially 
by sequestering another factor involved in histone modification. 
  
 138 
 
 
Figure 26.  Expression of GBD-HMD fusion proteins. 
Extracts were prepared from an rtf1Δ gal4∆ strain (MHY119) transformed with 2µ plasmids that express the 
indicated GBD constructs or pLS20, a CEN/ARS plasmid that expresses untagged full-length Rtf1.  Immunoblots 
were performed on these extracts with anti-Rtf1 and anti-Myc antibodies to assess expression of the GBD-HMD 
fusions and, as a loading control, anti-G6PDH. 
   
 139 
The motivation for creating the GBD-HMD fusions was to determine whether they were 
sufficient to induce Rtf1-dependent histone modifications when recruited to Gal4 binding sites 
present at a nontranscribed region of the genome.  I performed ChIP assays on chromatin 
extracted from an rtf1∆ gal4∆ strain expressing GBD-Myc, untagged GBD, untagged Rtf1, full-
length GBD-Rtf1, or each of the three GBD-HMD fusions.  I determined whether H3 K4 
trimethylation was present in these strains at the upstream activating sequence (UAS) of GAL7, 
which contains two Gal4 binding sites (Figure 27A) (LORCH and KORNBERG 1985).  I 
determined that GBD-Myc and the three GBD-HMD fusions were recruited to this site, although 
wild type GBD-HMD is recruited at significantly higher levels than mutant GBD-HMD fusions 
or the GBD-myc control protein (Figure 27B).  Chromatin utilized in these experiments was 
prepared from strains grown in glucose, a condition under which GAL7 is transcriptionally 
inactive.  I confirmed that Pol II was present at this locus at levels roughly equivalent to that 
observed at the telomeres, which are known to be transcriptionally silent (Figure 27C) 
(GOTTSCHLING et al. 1990).  Expression of these fusion proteins also did not significantly affect 
levels of total histone H3 present at the GAL7 UAS (Figure 27D). 
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Figure 27.  The Rtf1 HMD is sufficient to induce H3 K4 trimethylation at the GAL7 UAS. 
(A) Schematic of the GAL7 promoter region.  The GAL7 promoter contains a UAS with two 17 bp Gal4 binding 
sites, GAL4-1 and GAL4-2, contained in a region spanning approximately 150 bp through 260 bp upstream of the 
translation start site.  The region amplified in the GAL7 UAS ChIP studies spans coordinates -298/-92 upstream of 
GAL7.  (B) through (E) ChIP analyses of the effects of GBD-HMD fusions at the GAL7 UAS.  Antibodies specific 
for the Myc epitope (B), the largest subunit of Pol II (8WG16) (C), total H3 (D), and H3 K4 Me3 (E) were used to 
immunoprecipitate these factors and associated DNA from a formaldehyde-treated rtf1∆ gal4∆ strain (MHY119) 
that had been transformed with 2µ plasmids expressing the indicated GBD or Rtf1 derivatives.  Association of the 
indicated proteins or levels of histone modifications were assessed by PCR. Results in (B) and (C) are shown as a 
ratio of the signal observed at the GAL7 promoter to the signal derived from a nontranscribed region in the right 
telomere of chromosome VI (TEL-VIR).  Values in (D) and (E) are not normalized to TEL-VIR.  GAL7 UAS signal 
derived from the H3 K4 Me3 samples (E) was normalized to total H3 levels (E) at the same position.   The mean of 
three independent experiments with standard error is shown. 
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My analyses indicated that H3 K4 trimethylation at the GAL7 UAS was increased three-
fold in strains expressing GBD-HMD when compared to strains expressing GBD alone or GBD-
Myc (Figure 27E).  GBD-102-104A-HMD and GBD-F123S-HMD caused no detectable increase 
in H3 K4 trimethylation at this locus, consistent with the effect of these mutations in whole cell 
extracts.  This result indicates that promoting Rtf1-dependent histone modifications is an 
intrinsic property of the HMD. 
 However, I also observed that full-length Rtf1 induced substantial levels of H3 K4 
trimethylation at this locus, regardless of whether it was expressed as a GBD fusion or untagged 
(Figure 27E).  The presence of this modification at the GAL7 UAS in a strain expressing 
untagged Rtf1 is unexpected because GAL7 should be inactive under these conditions and Rtf1-
dependent histone modifications are typically found in transcriptionally active regions.  This may 
indicate that transcription has recently occurred at this locus, or is currently occurring at a very 
low level, because H3 K4 trimethylation is known to be highly stable even several hours 
following the cessation of transcription (NG et al. 2003c). 
Another explanation for the presence of H3 K4 trimethylation at this locus is that Rtf1 
may not need to be recruited to DNA to induce Rtf1-dependent histone modifications.  The 
GAL7 UAS may be particularly poised to become modified in this way as long as a functional 
Rtf1 HMD is present in the cell.  Precedence for the idea that Rtf1 does not require targeting to 
active genes to promote histone modifications can be found in my previous observation that 
when the region of Rtf1 that mediates its association with active genes (regions 6 through 9; 
Figure 19) is mutated, global levels of Rtf1-dependent histone methylation are relatively 
unaffected (Figure 18A).   
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To determine whether the HMD needed to be recruited to DNA to elicit Rtf1-dependent 
histone modifications, I examined the presence of these modifications at the 5’ end of PYK1, a 
location which does not harbor Gal4 binding sites, in the same strains analyzed in the GAL7 
UAS studies.  PYK1 is constitutively expressed at high levels and I observed ten- to twenty-five-
fold greater association of Pol II at the 5’ end of PYK1 than at the telomeres in all strains 
examined (Figure 28A).  Due to the high expression level of PYK1, Rtf1-dependent histone 
modifications should be present within its 5’ coding region in strains expressing full-length Rtf1.  
Accordingly, higher levels of H3 K4 trimethylation are observed at this locus in strains 
expressing untagged Rtf1 or GBD-Rtf1 than are seen in strains expressing GBD alone (Figure 
28B).  Full-length Rtf1 is known to associate with the 5’ end of PYK1 (WARNER et al. 2007).  
However, the GBD-HMD fusions and control proteins should not associate with this locus due to 
the absence of the Rtf1 OAR and Gal4 binding sites; I verified that these proteins were not 
enriched in the 5’ end of PYK1 (Figure 28C).  Total H3 levels at the 5’ end of PYK1 are also not 
dramatically impacted by expression of different Rtf1 constructs (Figure 28D); the most 
significant effect is a slightly greater than two-fold increase in total H3 levels at this locus in a 
strain expressing GBD-102-104A-HMD compared to a strain expressing wild type Rtf1. 
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Figure 28.  The Rtf1 HMD does not require targeting to DNA to induce Rtf1-dependent histone 
modifications. 
 ChIP analyses of the effects of GBD-HMD fusions at the 5’ end of PYK1.  Antibodies specific for the largest 
subunit of Pol II (8WG16) (A), H3 K4 Me3 (B), the Myc epitope (C), total H3 (D), and H3 K79 Me2 (E) were used 
to immunoprecipitate these factors and associated DNA from a formaldehyde-treated rtf1∆ gal4∆ strain (MHY119) 
that had been transformed with 2µ plasmids expressing the indicated GBD or Rtf1 derivatives.  Association of the 
indicated proteins or levels of histone modifications are assessed by PCR. Results in (A) and (C) are shown as a 
ratio of the signal observed at the 5’ end of PYK1 to the signal derived from a nontranscribed region in the right 
telomere of chromosome VI (TEL-VIR).  Values in (B), (D), and (E) are not normalized to TEL-VIR.  PYK1 signal 
derived from the H3 K4 Me3 and H3 K79 samples (B and E) was normalized to total H3 levels at the same position.  
The mean of three independent experiments with standard error is shown. 
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Surprisingly, GBD-HMD induces H3 K4 trimethylation to the same extent at the 5’ end 
of PYK1 as was observed at the GAL7 UAS (Figure 28B).  I observed a similar induction of H3 
K79 dimethylation at this locus in strains expressing untagged Rtf1, GBD-Rtf1, and GBD-HMD 
(Figure 28E).  The increase in H3 K4 trimethylation and H3 K79 dimethylation observed at the 
5’ end of PYK1 in strains expressing GBD-HMD was not seen in strains expressing GBD fusions 
to the 102-104A or F123S HMDs.  rtf1 102-104A did not affect bulk H3 K79 dimethylation 
levels in whole cell extracts and the effect on this modification observed in this analysis is likely 
a consequence of the low expression level of the GBD-102-104A-HMD fusion protein. 
To determine if the GBD-HMD fusions could affect Rtf1-dependent histone 
modifications on a global scale, I performed immunoblot analysis with antibodies specific for H3 
K4 trimethylation and H3 K79 dimethylation on whole cell extracts from an rtf1∆ gal4∆ strain 
expressing GBD alone, GBD-Myc, full-length Rtf1, or the three GBD-HMD fusions.  
Interestingly, I observed nearly wild type levels of H3 K79 dimethylation and a modest 
restoration of H3 K4 trimethylation in the GBD-HMD strain, while these modifications were 
absent from GBD-102-104A-HMD and GBD-F123S-HMD strains (Figure 29).  Together, the 
results of my PYK1 ChIP analysis and the immunoblot analysis described here support the idea 
that the Rtf1 HMD possesses inherent activity and that it does not need to be specifically 
recruited to DNA to promote Rtf1-dependent histone modifications. 
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Figure 29.  The Rtf1 HMD can partially restore global Rtf1-dependent histone modifications. 
Extracts were prepared from an rtf1Δ gal4∆ strain (MHY119) transformed with 2µ plasmids that express the 
indicated GBD constructs or pLS20, a CEN/ARS plasmid that expresses untagged full-length Rtf1.  Immunoblots 
were probed with antibodies specific for H3 K4 Me3 and H3 K79 Me2 to assess the levels of these modifications in 
the indicated extracts.  A  total H3 immunoblot was performed to demonstrate effects on these modifications are not 
due to a significant change in histone H3 expression and an anti-G6PDH immunoblot was performed as a loading 
control. 
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3.4 CONCLUSIONS 
Rtf1 has been implicated in several transcription-related functions, but the mechanisms by which 
it participates in these processes remain undefined.  My previous analyses identified a region of 
Rtf1, now termed the HMD, which is necessary for its role in the covalent modification of 
histones that are present in the bodies of transcriptionally active genes.  The experiments 
described in this chapter were aimed at better characterizing the HMD to begin exploring the 
mechanism by which Rtf1 promotes histone modification. 
 I created substitution mutations in several conserved residues in the HMD and assessed 
the effects of these alterations on histone modification.  Interestingly, I found that different 
substitution mutations in the HMD resulted in unique effects on Rtf1-dependent histone 
modifications.  This result indicates that the Rtf1 HMD may promote histone H2B lysine 123 
monoubiquitylation and histone H3 K4 trimethylation by unique mechanisms.    
Because I had previously observed that partially deleting the HMD led to transcription-
related phenotypes (Figure 14), I explored the effects of the HMD substitution mutations on 
these phenotypes.  I found that all three mutations tested, rtf1 102-104A, rtf1 108-110A, and rtf1 
F80V F123S, caused sensitivity to 6-AU.  However, the HMD substitution mutations caused no 
obvious Spt- phenotype.   
 A complete deletion of RTF1 also causes several phenotypes associated with defects in 
chromatin structure.  I demonstrated that these phenotypes, loss of telomeric silencing and 
aberrant internal initiation from within the FLO8 open reading frame, are also caused by rtf1 
102-104A, rtf1 108-110A, and rtf1 F80V F123S.  Effects on telomeric silencing reflect a global 
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disruption of histone modifications patterns, while internal initiation from a cryptic promoter 
within the FLO8 open reading frame is a read-out of an effect on chromatin structure at this 
specific locus.   These results therefore suggest that HMD substitution mutations lead to 
chromatin defects on both global and local scales. 
 Interestingly, aberrant initiation from the FLO8 internal promoter and the Spt- phenotype 
both reflect the ability of the transcription machinery to gain access to abnormal transcriptional 
start sites.  Rtf1-dependent histone modifications are found specifically within ORFs, where the 
FLO8 internal promoter is located.  The Spt- phenotype measures the ability to suppress 
insertions at specific promoters, which are devoid of Rtf1-dependent histone modifications.  
Because the Rtf1 HMD substitution mutations also display sensitivity to 6-AU, a phenotype 
associated with transcription elongation defects, these results may suggest that mutations in the 
Rtf1 HMD specifically affect chromatin structure within ORFs.  Mutations in various elongation 
factors, including an rtf1 null allele, are known to cause strong Spt- phenotypes.  Therefore, it 
remains likely that the Spt- phenotype is influenced by effects on transcription elongation.  
However, the effect of Rtf1 on this phenotype appears to be mediated by a function other than its 
role in histone modification.  
 Despite their differential effects on Rtf1-dependent histone modifications, HMD 
substitution mutations always result in equivalent phenotypic effects.  This may indicate that H3 
K4 trimethylation is particularly important to prevent defects in transcription elongation and 
chromatin structure, since this is the only modification absent in all HMD substitution mutants 
tested in the phenotypic analysis.  Interestingly, HMD substitution mutations sometimes result in 
phenotypes that are different from those caused by an rtf1 null mutation or partial HMD 
deletions, suggesting that mutating the HMD and removing it are not functionally equivalent. 
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 Finally, I found that expressing only the residues encompassing the HMD as a fusion to 
the Gal4 DNA binding domain (GBD-HMD) was sufficient to elicit a three-fold induction of H3 
K4 trimethylation at the GAL7 UAS, where this fusion protein is recruited by Gal4 binding sites, 
indicating that promoting histone modifications is an intrinsic property of the HMD.  
Surprisingly, I found that expression of the GBD-HMD also induced H3 K4 trimethylation and 
H3 K79 dimethylation at the 5’ end of PYK1, where GBD-HMD binding is not detected, and at 
least partially restored both of these modifications in whole cell extracts.  These observations 
indicate that the HMD does not need to be specifically recruited to DNA to elicit histone 
modifications.  Overall, the analyses described in this chapter indicate that Rtf1’s role in histone 
modification can be attributed to a number of highly conserved residues in the HMD and that 
these residues differentially contribute to H2B ubiquitylation and H3 K4 trimethylation.  In 
addition to being necessary for Rtf1-dependent histone modifications, the HMD is also sufficient 
for this function and may not require targeting to active genes to elicit this activity. 
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4.0  THE PAF1 COMPLEX IS CONNECTED TO CHROMATIN REMODELING 
THROUGH GENETIC INTERACTIONS WITH THE INOSITOL POLYPHOSPHATE 
SIGNALING CASCADE 
4.1 INTRODUCTION 
A screen for factors that became essential for viability when RTF1 was deleted identified 
several transcription-related factors and suggested a role for Rtf1 in transcription (COSTA and 
ARNDT 2000).  The same screen also identified mutations in the genes that code for the first two 
enzymes in the inositol polyphosphate (IP) signaling cascade:  PLC1 and ARG82 (Figure 12) 
(COSTA 2001).  Plc1 catalyzes the conversion of phosphatidylinositol 4,5-bisphosphate to 
diacylglycerol and inositol trisphosphate (IP3) (FLICK and THORNER 1993).  Arg82 converts 
nuclear IP3 to tetrakis- and pentakisphosphorylated derivatives (IP4 and IP5) (SAIARDI et al. 
1999).  Because several factors that were identified as essential in the absence of RTF1 were 
ultimately linked to transcription elongation, the function of Plc1 and Arg82 may also be 
connected to this process. 
In addition to this possible connection to transcription elongation, disruption of the IP 
signaling cascade has been implicated in several other nuclear processes including chromatin 
remodeling and mRNA export.  IP4 and IP5, the direct products of Arg82 activity, stimulate the 
SWI/SNF chromatin remodeling complex to mobilize nucleosomes in vitro (SHEN et al. 2003).  
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A separate study reported that the chromatin structure of the PHO5 promoter was not efficiently 
remodeled and the SWI/SNF and INO80 complexes were poorly recruited to the promoter of 
PHO84 in the absence of Arg82 (STEGER et al. 2003).  Additionally, mutations in PLC1 and 
ARG82 were recovered in a screen for factors that become essential in combination with a 
temperature-sensitive version of Gle1, an mRNA export factor that associates with the nuclear 
pore complex (YORK et al. 1999).  Further analysis demonstrated that mutations in PLC1 and 
ARG82 result in a striking accumulation of polyadenylated transcripts in the nucleus, suggesting 
that these mutations severely disrupt export of mRNA to the cytoplasm. 
I investigated whether these known nuclear functions for the IP signaling cascade were 
responsible for the synthetic lethality observed when PLC1 and ARG82 are mutated in an RTF1 
deletion strain.  Because a complete deletion of PLC1 causes a severe growth defect, I performed 
these analyses using arg82∆ strains.  I found that the absence of Arg82 strongly impaired the 
growth of several strains lacking known elongation factors, including four of the five subunits of 
the Paf1 complex.  An arg82∆ paf1∆ strain was inviable; I determined that this lethality was not 
the result of an enhanced defect in mRNA export, but instead was likely due to interactions 
between Paf1, Arg82, and specific chromatin remodeling complexes.  These results suggest that 
IP signaling, transcription elongation factors, and ATP-dependent chromatin remodeling 
cooperate to support normal cell growth. 
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4.2 MATERIALS AND METHODS 
4.2.1 Genetic methods 
S. cerevisiae strains used in these studies are listed in Table 3.  All strains are GAL2+ derivatives 
of S288C (WINSTON et al. 1995).  Complete disruptions of RTF1, PAF1, CTR9, CDC73, LEO1, 
SPT4, DST1, SET1, BRE1, ARG82, ISW1, ISW2, CHD1, INO80, ARP8, SNF2, and SWR1 were 
created by a PCR-based gene replacement method (AUSUBEL et al. 1988).  spt5-194 is a 
temperature sensitive mutation in the essential SPT5 gene. 
Mating, sporulation, and tetrad dissection were performed according to standard methods 
(ROSE et al. 1990).  Null mutations are marked by the incorporation of an auxotrophic marker in 
place of the native gene (Table 3).  Following sporulation and dissection, sorting of marked 
deletions is assayed by replica printing to a series of media that lacks individual amino acids or 
nucleic acids; the auxotrophic profile of each spore can be determined by this method.  Synthetic 
lethality of double mutants is inferred when spores containing marker genes for both knockouts 
sorting in a genetic cross are consistently not recovered.  If both knockouts in a cross are marked 
by the same nutritional marker, the progeny of tetrads that sort 2:2 for growth on media lacking 
the corresponding nutrient (nonparental ditypes) are analyzed; the two spores capable of growth 
in the absence of this nutrient are surmised to contain both deletions.  spt5-194 is not marked by 
a nutritional marker; sorting of this mutation is followed by its known strong Spt- phenotype in a 
strain containing his4-912δ.  dst1∆ was followed by sensitivity to mycophenolic acid. 
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4.2.2 Analysis of mRNA export 
mRNA export analyses were conducted as described in (MURPHY et al. 1996) except that oligo-
dT(30) prelabeled with digoxigenin (IDT) and Antidigoxigenin-rhodamine Fab fragments 
(Boehringer Mannheim) were used and strains were grown at 30oC.  KY660 (wild type), KY804 
(paf1∆), MHY82 (ipk1∆ paf1∆), KY875 (ipk1∆), and KY743 (arg82∆) were used in these 
analyses. 
4.2.3 Northern analysis 
KY292 (wild type), KY802 (paf1∆), KY930 (rtf1∆), MHY63 (arg82∆), KY508 (snf2∆), MHY88 
(arp8∆), MHY57 (ino80∆), MHY75 (isw1∆), KY884 (isw2∆), KY632 (chd1∆), KY907 (set1∆), 
and KY968 (bre1∆) were grown to approximately 1 x 107 cells/ml in YPD.  RNA isolation and 
Northern analyses were performed as described previously (SWANSON et al. 1991).  [α-
32P]dATP-labeled DNA hybridization probes were prepared by random prime labeling of VTC3, 
SPL2, or SCR1 PCR products that had been amplified from yeast genomic DNA.  SCR1 encodes 
a cytoplasmic RNA that is transcribed by RNA Polymerase III (HANN and WALTER 1991) and is 
used as a loading control. 
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Table 3.  Saccharomyces cerevisiae strains used in Chapter 4 
Strain Genotype 
ECY57 
KY292 
MATα paf1∆::kanMX leu2∆0 ura3∆0 
MATa his4-912δ lys2-128δ leu2Δ1 ura3-52 trp1Δ63 
KY404 MATa rtf1∆::LEU2 his4-912δ lys2-128δ leu2Δ1 ura3-52 trp1Δ63 
KY452 MATa rtf1∆::URA3 his3∆200 lys2-173R2 ura3-52 trp1Δ63 
KY508 MATa snf2∆::HIS3 his3∆200 lys2-128δ leu2Δ1 ura3-52 
KY528 MATα dst1∆::HISG his4-912δ lys2-128δ leu2Δ1 ura3-52 
KY583 MATa chd1∆::HIS3 his3∆200 lys2-128δ leu2Δ1 ura3-52 trp1Δ63 
KY632 MATα chd1∆::URA3 his3∆200 lys2-128δ leu2Δ1 ura3-52 
KY678 MATα ctr9∆::kanMX4 his3∆200 lys2-128δ leu2Δ1 ura3-52 
KY688 MATa cdc73∆::kanMX4 lys2∆0 ura3Δ0 trp1Δ63 
KY715 MATa spt5-194 his3∆200 leu2Δ1 ura3-52 
KY740 MATα arg82∆::URA3 leu2∆0 ura3Δ0 trp1Δ63 met15Δ0 
KY741 MATa arg82∆::URA3 his3∆200 leu2∆0 ura3Δ0 trp1Δ63 met15Δ0 
KY742 MATα arg82∆::URA3 leu2∆0 ura3Δ0 met15Δ0 
KY743 MATa arg82∆::URA3 his3∆200 leu2∆0 ura3Δ0 
KY744 MATα arg82∆::URA3 his3∆200 leu2∆0 ura3Δ0 met15Δ0 
KY758 MATa spt4∆::HIS3 his3∆200 lys2-128δ leu2Δ1 ura3-52 trp1Δ63 
KY802 MATa  paf1∆::URA3 his3∆200 lys2-173R2 ura3(∆0 or -52) 
KY804 MATα paf1∆::URA3 his3∆200 leu2Δ(0 or 1) ura3(∆0 or -52) 
KY806 MATa  leo1∆::URA3 his3∆200 lys2-173R2 ura3-52 
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KY875 MATa  ipk1∆::HIS3 his3∆200 lys2-173R2 leu2∆1 ura3-52 trp1Δ63 
KY879 MATα arp8∆::HIS3 his3∆200 lys2-173R2 leu2Δ1 ura3-52 trp1Δ63 
KY884 MATa isw1∆::HIS3 his3∆200 lys2-173R2 leu2Δ1 ura3-52 trp1Δ63 
KY885 MATα isw2∆::HIS3 his3∆200 lys2-128δ leu2Δ1 ura3-52 ade8 
KY901 MATα isw1∆::HIS3 his3∆200 lys2-128δ leu2Δ1 ura3-52 trp1Δ63 
KY907 MATa set1∆::HIS3 his3∆200 lys2-128δ leu2Δ1 ura3-52 
KY930 MATα rad6∆::URA3 lys2-128δ ura3-52 
KY968 MATa bre1∆::kanMX4 his3∆200 ura3-52 
KY972 MATα swr1∆::kanMX4 his3∆200 lys2-128δ leu2Δ1 ura3-52 
MHY8 MATa arp8∆::HIS3 his3∆200 lys2-128δ leu2Δ1 ura3-52 trp1Δ63 ade8 
MHY57 MATa ino80∆::HIS3 his3∆200 his4-912δ  lys2-173R2 leu2Δ1 ura3-52 
MHY63 MATα arg82∆::URA3 his3∆200 leu2Δ(0 or 1) ura3(∆0 or -52) 
MHY66 MATa paf1∆::URA3 his3∆200 leu2Δ( 0 or 1) ura3(∆0 or -52) trp1Δ63 
MHY75 MATa isw1∆::HIS3 his3∆200 lys2-128δ leu2Δ1 ura3-52 
MHY82 MATα ipk1∆::HIS3 paf1∆::URA3 his3∆200 ?lys2-173R2? leu2Δ( 0 or 1) 
ura3(∆0 or -52) trp1Δ63 
MHY86 MATa paf1∆::URA3 his3∆200 leu2Δ( 0 or 1) ura3(∆0 or -52) ade8 
MHY88 MATa arp8∆::HIS3 his3∆200 lys2-128δ leu2Δ( 0 or 1) ura3(∆0 or -52) 
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4.3 RESULTS 
4.3.1 arg82∆ genetically interacts with mutations in several known elongation factors 
To determine whether the genetic interaction resulting from combination of mutations in 
IP signaling enzymes and deletion of RTF1 was specific, I crossed an arg82 null strain by strains 
harboring deletions in the genes encoding each subunit of the Paf1 complex:  PAF1, CTR9, 
RTF1, CDC73, and LEO1.  Deletion of ARG82 results in synthetic lethality when combined with 
paf1 or ctr9 null mutations (Figure 30A and B and Table 4) and combination of an ARG82 
deletion with rtf1 or cdc73 null mutations resulted in considerable synthetic cell sickness (Figure 
30C and D and Table 4).  Although an arg82∆ leo1∆ strain displayed only a minor growth defect 
(Figure 30E and Table 4), the strong genetic interactions I observe between an arg82 null 
mutation and deletion of four of the five genes encoding Paf1 complex subunits suggest that the 
connection between the IP signaling cascade and transcription elongation is not specifically 
mediated through Rtf1. 
The severity of the genetic interaction between rtf1 and arg82 null mutations differs from 
the results of the original genetic screen where combination of an RTF1 deletion with a point 
mutation in ARG82 (arg82-383) was lethal (COSTA 2001).  This disparity may reflect differences 
in the genetic background of the strains used in these analyses or may indicate that deletion of 
ARG82 is not equivalent to arg82-383.   
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Figure 30.  arg82∆ genetically interacts with deletions of the genes encoding Paf1 complex subunits. 
Yeast strains of opposite mating type were mated, sporulated, and dissected on YPD.  Strains used for each 
individual cross are indicated in the legend to Table 4.  Each vertical row contains the four spores derived from 
meiosis of a single diploid yeast cell.  Plates were incubated at 30oC for 4 days.  Because the deletions of ARG82 
and LEO1 are both marked by URA3, only nonparental ditypes tetrads are shown (E). 
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Table 4.  Genetic interactions between arg82∆ and mutations in known elongation factors 
Strain Relative growth rate 
arg82∆ +++++ 
dst1∆ arg82∆ +++++ 
leo1∆ arg82∆ ++++ 
rtf1∆ arg82∆ ++ 
cdc73∆ arg82∆ ++ 
spt5-194 arg82∆ + 
spt4∆ arg82∆ + 
paf1∆ arg82∆ - 
ctr9∆ arg82∆ - 
 
The growth rate for an arg82∆ strain was arbitrarily set to “+++++”; an arg82∆ alone causes an intermediate growth 
defect when compared to a wild type strain, although this effect is no longer noticeable on dissection plates after 2 
days growth at 30oC.  The growth rates of double mutants were determined by analyzing the progeny of the 
following crosses:  leo1∆ arg82∆ = KY806 X KY744; dst1∆ arg82∆ = KY741 X KY678; rtf1∆ arg82∆ = KY404 X 
KY740; cdc73∆ arg82∆ = KY688 X KY740; spt5-194 arg82∆ = KY715 X KY742; spt4∆ arg82∆ = KY758 X 
KY744; paf1∆ arg82∆ =KY742 X ECY57; ctr9∆ arg82∆ = KY741 X KY528. 
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I next investigated whether mutations in IP signaling enzymes interacted specifically with 
mutations in the Paf1 complex or whether the growth effects caused by combination of mutations 
in these factors might be indicative of a functional relationship between IP signaling and 
transcription elongation.  I crossed an arg82∆ strain by strains harboring mutations in SPT4 and 
SPT5, which encode the subunits of the Spt4/Spt5 transcription elongation complex, or a deletion 
of DST1, which encodes a transcription elongation factor (TFIIS) that reactivates stalled Pol II 
by stimulating cleavage of nascent transcripts.  I observed strong synthetic sickness in arg82∆ 
spt4∆ and arg82∆ spt5-194 strains, but observed no obvious genetic interaction between arg82∆ 
and dst1∆ (Figure 31 and Table 4).  This result suggests that while the connection between IP 
signaling and transcription elongation is not restricted specifically to mutation of the Paf1 
complex, it is also not a general phenomenon that results from all disruptions of transcription 
elongation factors. 
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Figure 31.  arg82∆ genetically interacts with mutations in the Spt4/5 elongation complex, but not 
TFIIS. 
Yeast strains of opposite mating type were mated, sporulated, and dissected on YPD.  Strains used for each 
individual cross are indicated in the legend to Table 4.  Each vertical row contains the four spores derived from 
meiosis of a single diploid yeast cell.  Plates were incubated at 30oC for 4 days. 
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4.3.2 Enzymes that function downstream of Arg82 are not essential in the absence of Paf1 
or Rtf1 
The products of Arg82 kinase activity, IP4 and IP5, are further phosphorylated by two additional 
kinases, Ipk1 and Kcs1.  Ipk1 phosphorylates IP5 to IP6 (YORK et al. 1999) and Kcs1 converts 
IP4 and IP6 to pyro-phosphorylated forms (SAIARDI et al. 1999).  To determine if the Paf1 
complex was required in all instances of disruptions in the IP signaling pathway, I created 
deletions of IPK1 and KCS1 and crossed the null strains by paf1∆ and rtf1∆ strains.  I observed 
no major effects on growth of the resulting double mutant strains (data not shown).  This result 
indicates that the connection between transcription elongation and IP signaling is specifically 
associated with Plc1 or Arg82 or the products of their enzymatic activity. 
4.3.3 The synthetic lethality caused by the combined loss of ARG82 and PAF1 is not the 
result of an enhanced defect in mRNA export. 
Mutations in PLC1 and ARG82 are known to result in a failure to properly export polyadenylated 
transcripts from the nucleus (YORK et al. 1999).  To determine if the synthetic lethality observed 
in an arg82∆ paf1∆ strain might be the result of a combined effect on mRNA export, I examined 
the consequences of deleting PAF1 on this process.  The efficiency of mRNA export was 
assessed in fixed cells following in situ hybridization of a digoxigenin-labeled oligo-dT probe to 
the polyadenylated tails of mRNA.  Hybridized probe was then detected with a rhodamine-
labeled antidigoxigenin antibody and visualized on a fluorescence microscope.  As expected, an 
arg82∆ strain displayed a striking accumulation of polyadenylated transcripts in the nucleus 
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(Figure 32).  However, paf1 null cells display diffuse cellular staining that is virtually 
indistinguishable from that observed in wild type cells, indicating that mRNA export was largely 
unaffected by this mutation (Figure 32).  Deletion of RTF1 or CDC73 also does not result in a 
noticeable effect on mRNA export (data not shown).  These results suggest that the inviability of 
an arg82∆ paf1∆ strain likely cannot be attributed to a combinatorial effect on mRNA export. 
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Figure 32.  The inviability of an arg82∆ paf1∆ strain is not due to an enhanced defect in mRNA 
export. 
The efficiency of mRNA export was assessed in fixed cells by in situ hybridization of a digoxigenin-labeled oligo-
dT probe to polyadenylated (polyA) RNA followed by detection with a rhodamine-labeled antidigoxigenin antibody.  
DAPI was used to visualize the location of nuclei. 
 166 
However, deletion of Paf1 complex subunits is known to result in a decrease in the 
average length of polyadenylated tails on RNA transcripts (MUELLER et al. 2004).  This suggests 
that the absence of a strong nuclear signal in the mRNA export analysis of a paf1∆ strain may 
not reflect wild type levels of mRNA export, but instead be a simple consequence of the inability 
of the oligo-dT probe to hybridize as efficiently to abnormally short polyadenylated tails.  To 
address this possibility, I performed mRNA export analysis on an ipk1∆ paf1∆ double mutant 
strain.  Mutation of IPK1 is known to cause a defect in mRNA export, similar to the effect 
observed in arg82 mutant strains (YORK et al. 1999).  A prominent signal is observed in the 
nuclei of ipk1∆ paf1∆ cells (Figure 32), suggesting that the reduction in polyadenylated tail 
length caused by deletion of PAF1 does not affect the efficiency of this assay. 
4.3.4 paf1∆ and arg82∆ genetically interact with mutations in the INO80, SWI/SNF, and 
SWR1 chromatin remodeling complexes 
Inositol polyphosphates can modulate the activity of several ATP-dependent chromatin 
remodeling complexes in S. cerevisiae, including the INO80 and SWI/SNF complexes (SHEN et 
al. 2003).  Additionally, the INO80 and SWI/SNF complexes are not efficiently recruited to the 
PHO84 promoter and nucleosomes at the PHO5 promoter are not efficiently remodeled in 
arg82Δ cells (STEGER et al. 2003).  To investigate whether the inviability of an arg82∆ paf1∆ 
strain is the result of an enhanced impact on chromatin remodeling, paf1Δ cells were crossed by 
disruptions of all known nonessential chromatin remodeling complexes in S. cerevisiae:  INO80, 
ISW1, ISW2, CHD1, SWI/SNF, and SWR1.  Due to the requirement of the RSC complex for 
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viability, genetic interaction between deletion of PAF1 and mutations in this complex were not 
analyzed.   
The results of these crosses demonstrated that a paf1 null mutation was synthetically 
lethal with deletions of SWR1, the catalytic subunit of the SWR1 complex, and ARP8, a 
component of the INO80 complex that is not found in other known chromatin remodeling 
complexes (Figure 33A and B and Table 5).  An ino80 null mutation causes severe sickness on 
its own (data not shown) and, therefore, was not used in my genetic analyses.  Additionally, a 
deletion of PAF1 resulted in severe sickness when combined with deletions of ISW1 or SNF2, 
the catalytic subunits of the ISW1 and SWI/SNF chromatin remodeling complexes, respectively 
(Table 5).  No obvious genetic interaction was observed in paf1∆ chd1∆ strains or paf1∆ isw2∆ 
strains; CHD1 and ISW2 encode the catalytic subunits of chromatin remodeling complexes by 
the same names (Table 5). 
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Figure 33.  paf1∆ genetically interacts with disruptions in chromatin remodeling complexes. 
Yeast strains of opposite mating type were mated, sporulated, and dissected on YPD.  Strains used for each cross are 
indicated in the legend to Table 5.  Each vertical row contains the four spores derived from meiosis of a single 
diploid yeast cell.  Plates were incubated at 30oC for 4 (A) or 3 (B) days. 
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Table 5.  paf1∆ or arg82∆ genetically interact with disruptions of chromatin remodeling 
complexes 
Chromatin 
remodeling 
complex 
Subunit 
deleted 
Growth defect 
when crossed 
by paf1∆ 
Growth defect 
when crossed 
by arg82∆ 
CHD1 chd1∆ none none 
ISW1 isw1∆ severe none 
ISW2 isw2∆ none none 
SWI/SNF snf2∆ severe lethal 
INO80 arp8∆ lethal lethal 
SWR1 swr1∆ lethal intermediate 
 
paf1∆ and arg82∆ both cause growth defects on their own when compared to a wild type cell; the growth categories 
shown are relative to the normal growth of a paf1∆ or arg82∆ strain.  The growth rates of double mutants were 
determined by analyzing the progeny of the following crosses:  chd1∆ paf1∆ = KY583 X KY804; chd1∆ arg82∆ = 
KY583 X KY744; isw1∆ paf1∆ = MHY86 X KY901; isw1∆ arg82∆ = KY741 X KY901; isw2∆ paf1∆ = KY884 X 
KY804; isw2∆ arg82∆ = KY741 X KY885; snf2∆ paf1∆ = KY508 X KY804; arp8∆ paf1∆ = MHY8 X KY804; 
arp8∆ arg82∆ = KY741 X KY879; swr1∆ paf1∆ = MHY66 X KY972; swr1∆ arg82∆ = KY452 X KY972.  snf2∆ 
arg82∆ double mutants were previously reported to be inviable (SHEN et al. 2003). 
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Deletion of ARG82 is known to cause synthetic lethality in a cell lacking SNF2 (SHEN et 
al. 2003).  To more extensively analyze the connection between Arg82 and chromatin 
remodeling complexes, I introduced an arg82 null mutation into strains harboring mutations in 
integral subunits of the other nonessential chromatin remodeling complexes.  I found that arg82∆ 
arp8∆ double mutants were inviable (Figure 34A and Table 5).  Loss of ARG82 also resulted in 
synthetic sickness when combined with a deletion of SWR1 (Figure 34B), while no discernible 
genetic interaction was obvious in crosses between an arg82∆ strain and strains lacking CHD1, 
ISW1, or ISW2 (Table 5).  Additionally, I performed genetic analyses which revealed that 
deletion of ARG82 caused no growth defect in strains lacking SET1, which encodes the H3 K4 
methyltransferase, or BRE1, the gene for the ubiquitin ligase required for H2B K123 
ubiquitylation (data not shown).  This suggests that Arg82 is not required for normal cell growth 
when chromatin structure is impacted by the loss of histone modifications, but instead appears to 
be specifically connected to chromatin remodeling. 
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Figure 34.  arg82∆ genetically interacts with disruptions in chromatin remodeling complexes. 
Yeast strains of opposite mating type were mated, sporulated, and dissected on YPD.  Strains used for each cross are 
indicated in the legend to Table 5.  Each vertical row contains the four spores derived from meiosis of a single 
diploid yeast cell.  Plates were incubated at 30oC for 3 days. 
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 Together, the results detailed in this section demonstrate that, when combined with 
disruptions of chromatin remodeling complexes, deletion of ARG82 caused a similar pattern to 
that observed when PAF1 is absent.  Three of the four chromatin remodeling complexes 
(SWI/SNF, INO80, and SWR1) that were necessary for normal cell growth in the absence of 
PAF1 were also required when ARG82 was deleted.  These genetic results imply that IP 
signaling and transcription elongation may work in parallel with a common set of chromatin 
remodeling complexes. 
4.3.5 Expression of several genes is affected by loss of Paf1, Arg82, or mutations in the 
INO80 and SWI/SNF chromatin remodeling complexes 
To further investigate the connection between IP signaling, transcription elongation, and ATP-
dependent chromatin remodeling, I investigated whether factors involved in these processes were 
required for expression of common targets.  Genes whose expression was known to be 
compromised in strains containing disruptions of chromatin remodelers were chosen as 
candidates.  Expression of one such candidate gene, SPL2 (OHDATE et al. 2003), is virtually 
eliminated in cells containing disruptions of the INO80 or SWI/SNF complexes or deletion of 
PAF1, and its expression is reduced in arg82Δ and rtf1∆ strains (Figure 35A).  Transcription of a 
second candidate gene, VTC3, was essentially absent from snf2∆ and ino80∆ strains and was 
severely compromised by deletion of PAF1, RTF1, ARG82, and ARP8 (Figure 35B).  Chromatin 
remodelers that caused no growth defects when disrupted in both paf1∆ strains and arg82∆ 
strains (ISW1, ISW2, CHD1), or deletion of genes encoding histone modifying enzymes (SET1 
or BRE1), did not impact expression of these genes.  These similar effects on expression of at 
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least two common genes further imply a specific relationship between the Paf1 complex, IP 
signaling, and the INO80 and SWI/SNF chromatin remodeling complexes.   
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Figure 35.  The Paf1 complex, Arg82, and the INO80 and SWI/SNF chromatin remodeling complexes 
are necessary for normal expression of SPL2 and VTC3. 
Expression of SPL2 (A) and VTC3 (B) was analyzed by Northern analysis.  10 µg of total RNA from strains 
harboring the indicated deletions was analyzed with probes specific for SPL2 or VTC3 and, after stripping, SCR1 
levels were assessed on the same filter as a loading control. 
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Surprisingly, deletion of SWR1, which was synthetically lethal in the absence of Paf1 or 
Arg82, does not impact expression of VTC3 or SPL2.  This may reflect the known function of the 
SWR1 complex as primarily required to facilitate the incorporation of the Htz1 histone variant in 
gene promoters whereas INO80 and SWI/SNF are primarily believed to reposition existing 
nucleosomes (MIZUGUCHI et al. 2004; SHEN et al. 2003).  The genes examined in this analysis, 
VTC3 and SPL2, may require nucleosome repositioning for expression, but not Htz1 
incorporation.  If I extended this analysis to explore effects on genes that are known to require 
Htz1 deposition for normal expression, I would likely uncover common target genes that are 
affected by swr1∆, paf1∆, and arg82∆. 
4.4 CONCLUSIONS 
Previous work in the Arndt lab identified a synthetic lethal interaction between mutation of a 
transcription elongation factor, Rtf1, and two enzymes that function in the inositol polyphosphate 
signaling cascade, Plc1 and Arg82.  While many connections between signaling pathways and 
transcription have been previously described, the effect is often manifested at the level of 
transcription initiation.  The discovery of an interaction between the IP signaling cascade and the 
Paf1 transcription elongation complex implies that signaling pathways may also exert control 
during the elongation stage of transcription.   
Because deletion of PLC1 results in a severe growth defect, my studies were focused 
primarily on investigating the contribution of ARG82 to this synthetic lethality.  Arg82 is known 
to have at least three nuclear functions:  transcriptional control of arginine-responsive genes as a 
subunit of the ArgR/Mcm1 transcriptional regulatory complex; involvement in the proper export 
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of mRNA from the nucleus, and effects on the activity of several chromatin remodeling 
complexes.  I ruled out effects on Arg82’s role as a transcriptional regulator as the likely cause of 
the synthetic lethality with rtf1∆ by demonstrating that deletion of ARG80, which encodes an 
additional subunit of the ArgR/Mcm1 complex, caused no growth defect in an rtf1∆ strain (data 
not shown).  Furthermore, I demonstrated that deletion of multiple subunits of the Paf1 complex 
(PAF1, CDC73, or RTF1) did not affect mRNA export.  This result indicates that the synthetic 
lethality caused by simultaneous mutation of RTF1 and ARG82 is not the result of a combined 
effect on mRNA export. 
My genetic results suggest that the IP signaling cascade is connected to transcription 
elongation through its known interactions with several ATP-dependent chromatin remodeling 
complexes.  Synthetic lethality is thought to result when two or more parallel processes that elicit 
a common essential function are simultaneously disrupted.  Synthetic lethal interactions or strong 
effects on cell growth resulted from combinatorial deletions of factors involved in IP signaling 
(Arg82), transcription elongation (Paf1), and chromatin remodeling (Arp8, Snf2, and Swr1) 
(Figure 36).  This result may imply that all three of these processes function in parallel; however, 
my genetic results demonstrate that a cell cannot tolerate the simultaneous loss of any two of 
these functions.   
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Figure 36.  Genetic interactions between Paf1, Arg82, and chromatin remodeling complexes. 
A schematic is shown representing genetic interactions that were observed between the indicated factors; the 
thickness of the line indicates the degree of interaction that was observed with the thickest lines signifying lethality; 
a paf1 null allele showed a strong genetic interaction in a strain with an ISW1 deletion, but no interaction was 
observed between arg82∆ and isw1∆. 
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Additionally, individual disruption of the Paf1 complex, Arg82, or the INO80 and 
SWI/SNF chromatin remodeling complexes has a marked effect on at least two genes that are 
known to require proper chromatin remodeling for normal expression.  This observation, in 
combination with my genetic data, may instead suggest that Arg82 and Paf1 both contribute to 
the normal function of the INO80, SWI/SNF, and SWR1 chromatin remodeling complexes.  
When both IP signaling and the Paf1 complex are concurrently disrupted, this may lead to 
widespread effects on chromatin remodeling that are too severe to support transcription at a level 
necessary to support cell viability.  While the INO80, SWI/SNF, and SWR1 complexes are not 
essential when disrupted individually, deletion of the catalytic subunits of the INO80 or 
SWI/SNF complexes cause substantial growth defects.  It is, therefore, likely that simultaneously 
inactivating or dampening the activity of all three of these chromatin remodeling complexes 
would have severe consequences for normal cell function. 
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5.0  DISCUSSION AND FUTURE DIRECTIONS 
5.1 RTF1 IS COMPOSED OF FUNCTIONALLY DISTINCT REGIONS 
A large number of accessory factors participate in mRNA synthesis by facilitating the 
recruitment and modification of Pol II, the cotranscriptional processing of the nascent transcript, 
the progression of Pol II along ORFs, and transcription termination.  Accessory proteins that 
carry out distinct cotranscriptional events, such as transcript cleavage, can be recruited to 
discrete segments of a gene (BENTLEY 2005).  In contrast, the Paf1 complex associates along the 
entirety of active ORFs (KIM et al. 2004a; MUELLER et al. 2004; SIMIC et al. 2003), suggesting 
that it functions throughout transcript elongation.  My results indicate that the Paf1 complex 
component Rtf1 utilizes several independent mechanisms to orchestrate alterations to the 
chromatin template during gene expression.  Using a collection of sequential rtf1 deletion 
mutations, I demonstrated that discrete nonoverlapping segments of the protein are required for 
recruitment of Chd1 to active genes, histone modification, association with active ORFs, and 
physical interaction with the Paf1 complex; these regions of the protein have been given 
designations that reflect their functionalities:  CID (Chd1-interaction domain), HMD (histone 
modification domain), OAR (ORF-association region), and PID (Paf1 complex interaction 
domain).   
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I observed that distinct transcriptional effects resulted from disruption of individual 
functions of Rtf1 (Figure 21).  Combined with the observation that a complete deletion of RTF1 
causes more severe phenotypes than mutations that eliminate only one of its activities, these data 
suggest that the functions of Rtf1 are not entirely interdependent.  Additionally, I observed that 
the most severe transcription-related phenotypes were caused by deletions in the HMD or OAR, 
which correspond to the most highly conserved regions of the protein; this observation suggests 
that promoting cotranscriptional histone modification is a critical means by which Rtf1 directs 
transcription.   
Deletion of sequences required for either histone methylation or ORF association causes 
similar 6-AU sensitivity, but disruption of the association of Rtf1 with ORFs causes a more 
severe Spt- phenotype.  This observation suggests that association of Rtf1 with active genes is 
required for a function in addition to H2B K123 ubiquitylation or H3 K4 and K79 methylation.  
Another indication that the 6-AU and Spt- phenotypes measure, at least partly, distinct functions 
of Rtf1 comes from the observation that Rtf1Δ5 causes a moderate Spt- phenotype but no 
sensitivity to 6-AU (Figure 14).  Despite the Spt- phenotype resulting from deletion of this 
region, none of Rtf1’s known functions are compromised in the absence of region 5; this may 
indicate that Rtf1 participates in an additional transcription-related function that has not been 
identified. 
The OAR is the most highly conserved region of Rtf1; it contains 18 of the 26 residues 
that are invariant across S. cerevisiae, S. pombe, H. sapiens, and C. elegans (Figure 15).  
Recently, the structure of the corresponding region in human Rtf1 has been solved by NMR (DE 
JONG et al. 2008).  Interestingly, the structure of a subdomain within the human OAR shows 
structural similarity to a number of nucleic acid binding proteins, including the PAZ domains of 
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Dicer and Argonaut (proteins involved in RNA interference), the Tudor domains of Sm and 
SMN proteins (proteins involved in assembly and function of the spliceosome), and bacterial 
transcription elongation factors including NusG.  This observation led the authors to test whether 
Rtf1 possessed DNA binding activity; they found that the human Rtf1 OAR could bind single 
stranded DNA in vitro, but that it did not interact with double stranded DNA or RNA under 
similar conditions.  The authors, therefore, proposed that the OAR may have a role in stabilizing 
the transcription “bubble” where the template and nontemplate strands of DNA have separated 
during active transcription. 
Due to the conservation observed between the human and S. cerevisiae OAR domains, it 
will be beneficial to our understanding of Rtf1’s function to determine whether the S. cerevisiae 
OAR also interacts with single stranded DNA.  It is also possible that the OAR may be capable 
of interacting with double stranded DNA or RNA in the context of the full length protein, or in 
vivo.  Rtf1 is known to physically interact with the Spt4/Spt5 transcription elongation complex, 
which mediates interaction of Rtf1 with Pol II.  In light of my observation that the OAR is 
necessary for association of Rtf1 with active genes, it will be interesting to determine whether 
this region of the protein is also necessary for its physical interaction with the Spt4/Spt5 complex 
and/or Pol II and if these interactions are disturbed following treatment with DNase.  
Alternatively, the structure of the human Rtf1 OAR also resembled the structures of several 
proteins that contained Tudor domains, which have been proposed to possess histone methyl-
lysine binding properties.  No interaction was observed between the human OAR domain and 
un- or di-methylated H3 K4 (DE JONG et al. 2008), but it remains possible that the OAR of S. 
cerevisiae may bind mono- or tri- methylated H3 K4 or that it may interact with methylated H3 
K36 or K79. 
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Previous analyses in the Arndt lab demonstrated that physical interaction with Chd1 is 
disrupted by deleting amino acids 3-30 of Rtf1 (region 1; CID) or by substituting phenylalanine 
for leucine at position 11 (Rtf1-1) (COSTA 2001; WARNER et al. 2007).  I demonstrated that the 
rtf1∆1 mutation reduces association of Chd1 at the 5’ ORFs of PYK1 and TEF2 (Figure 16), 
implying that the physical interaction between these two factors contributes to the normal 
recruitment of Chd1 to active genes.  However, removing the CID from Rtf1 does not decrease 
Chd1 recruitment to the same extent as a complete RTF1 deletion.  This observation suggests 
that another function of Rtf1 may also contribute to Chd1 association with active genes.  A likely 
candidate for this additional function is the role of Rtf1 in promoting histone modifications.  S. 
cerevisiae Chd1 has been demonstrated to bind dimethylated H3 K4 through the second of the 
two chromodomains present near its N-terminus (PRAY-GRANT et al. 2005).  Because H3 K4 
Me2 is an Rtf1-dependent histone modification that marks active ORFs, the HMD of Rtf1 may 
contribute to association of Chd1 with active genes by promoting the placement of this 
modification.  However, conflicting reports exist regarding the validity of the physical 
interaction between S. cerevisiae Chd1 and H3 K4 Me2.  An additional study failed to detect 
interaction of the S. cerevisiae Chd1 chromodomains with H3 K4 Me2 and demonstrated that S. 
cerevisiae lacks several key functional residues that mediate the known interaction between 
human CHD1 and an H3 K4 Me2 peptide (OKUDA et al. 2007).  Therefore, it may be useful to 
test the effect of all Rtf1 internal deletion mutants on the interaction of Chd1 with active genes. 
Although I observed no transcription-related defects when the CID was deleted in an 
otherwise wild-type strain, the Arndt lab has previously shown that rtf1-1 or deletion of RTF1 or 
CHD1 suppresses the Spt- phenotype of the spt15-122 mutation (STOLINSKI et al. 1997).  I report 
here that this effect is also caused by rtf1Δ1.  The similar effects of mutations in RTF1 and 
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CHD1 in an spt15-122 strain suggest that these factors elicit similar effects on chromatin 
structure.  The interaction between Rtf1 and Chd1 may, therefore, be important for proper 
chromatin function particularly when the cell is sensitized to small changes in nucleosome 
positioning or stability, such as in a TBP mutant strain. 
Additionally, I observed that the carboxy-terminus of Rtf1, defined by region 13 (PID), is 
necessary and sufficient for the interaction between Rtf1 and other Paf1 complex subunits.  It is 
surprising that Rtf1∆13 has apparently wild-type stability, because previous studies revealed a 
ten- to twenty- fold reduction in Rtf1 levels in crude extracts from paf1∆ and ctr9∆ strains 
(MUELLER et al. 2004; PORTER et al. 2005).  My results indicate that a stable physical interaction 
with the Paf1 complex is not required for Rtf1 stability or that residues within Rtf1 that confer 
instability are deleted from the Rtf1∆13 mutant protein.  Consistent with a prior study, I 
demonstrated that interaction with Rtf1 mediates recruitment of Paf1 and Ctr9 to active ORFs 
(MUELLER et al. 2004).   
Remarkably, disruption of the physical interaction between Rtf1 and the Paf1 complex 
causes only a mild Spt- phenotype and the known biochemical functions of Rtf1 remain largely 
intact.  This observation suggests that Rtf1 retains function, independent of stable association 
with the Paf1 complex.  In agreement with this idea, Rtf1 does not copurify with the human Paf1 
complex (ROZENBLATT-ROSEN et al. 2005; YART et al. 2005; ZHU et al. 2005) and the carboxy-
terminus is poorly conserved (Figure 15).  Human Rtf1 may only interact with other Paf1 
complex subunits while associated with chromatin or the human Paf1 complex may execute 
some functions independently of ORF association, as previously suggested from studies in yeast 
(MUELLER et al. 2004).  Alternatively, Cdc73, which also promotes association of Paf1 and Ctr9 
with active genes in yeast (MUELLER et al. 2004), may be the sole Paf1 complex subunit required 
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for this function in humans.  The observation that only mild transcription-related phenotypes 
result when the CID or PID is removed from Rtf1 may also indicate that Rtf1 performs an 
additional unidentified role in the cell that is not transcription-related; the interaction between 
Rtf1 and Chd1 and/or other subunits of the Paf1 complex may ultimately be found to be 
important in this unidentified process. 
The goal of analyzing the Rtf1 internal deletion mutants was to gain insight into the 
mechanism by which this protein functions.  Through these analyses, I have demonstrated that 
the known roles of Rtf1 are mediated by distinct functional regions.  At least 3 of these 
functional segments, the CID, OAR, and the PID, appear to be necessary to mediate protein-
protein (or potentially protein-DNA) interactions.  The Paf1 complex is believed to function as a 
platform for the recruitment of accessory factors during transcription elongation, and my data 
provide additional support for this idea in regard to the Rtf1 subunit of this complex.  The 
exchange of interacting factors, allosteric changes in Rtf1’s structure, or posttranslational 
modifications may control the association of Rtf1 with its binding partners.  Alternatively, a 
catalytic role for Rtf1 itself cannot be completely ruled out.  Structural analyses on full-length 
Rtf1 may reveal similarities to known enzymatic domains. 
5.2 THE HISTONE MODIFICATION DOMAIN OF RTF1 IS NECESSARY AND 
SUFFICIENT TO PROMOTE RTF1-DEPENDENT HISTONE MODIFICATIONS 
My analyses of the Rtf1 internal deletion series also revealed that a 90 amino acid segment 
spanning residues 63 through 152 (HMD) was necessary to promote Rtf1-dependent 
monoubiquitylation of histone H2B at K123 and methylation of histone H3 at K4 and K79.  The 
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dependence of both H2B K123 Ub and its downstream histone methylation marks on a relatively 
small region of Rtf1 implied that the primary role of Rtf1 in histone modification may be to 
promote H2B K123 Ub.  However, I created substitution mutations in the Rtf1 HMD and 
observed unique effects on Rtf1-dependent histone modifications; rtf1 108-110A and rtf1 F80V 
F123S eliminated all Rtf1-dependent histone modifications tested (H2B K123 Ub, di- and 
trimethylation of H3 K4 and dimethylation of H3 K79), while rtf1 102-104A affected only H3 
K4 Me3.  These results suggested that Rtf1 may promote distinct Rtf1-dependent histone 
modifications by separate mechanisms. 
However, it remains possible that the primary role of the HMD is to specifically promote 
H2B K123 Ub.  In contrast to eliminating H2B K123 Ub, the rtf1 102-104A mutation may 
instead alter the genome-wide pattern of this modification.  The progression of H3 K4 Me2 to H3 
K4 Me3 may be particularly sensitive to proper patterns of H2B K123 Ub, and this effect may 
account for the specific loss of this modification in an rtf1 102-104A strain.  ChIP analyses to 
explore the distribution of H2B K123 Ub within active genes will be useful in exploring this 
possibility.  It is also possible that Rtf1 controls the deubiquitylation of H2B K123 Ub; 
deubiquitylation of H2B K123 has been demonstrated to be necessary for H3 K4 Me (WYCE et 
al. 2004).  Examining association of the H2B deubiquitylating enzymes Ubp8 and Ubp10 with 
active genes in strains expressing Rtf1 HMD substitution mutations may reveal a role for Rtf1 in 
the recruitment of these enzymes. 
Alternatively, factors have previously been identified that are necessary for the 
progression of H3 K4 Me2 to H3 K4 Me3; these factors include Not4, a subunit of the Ccr4-Not 
mRNA production and processing complex, and the Cps35, Cps40 and Cps60 subunits of the 
COMPASS complex (which contains the Set1 H3 K4 methyltransferase) (LEE et al. 2007; 
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MULDER et al. 2007; SCHNEIDER et al. 2005).  Determining whether rtf1 102-104A impairs the 
recruitment or activity of these factors may provide insight into the specific effect of this 
mutation on H3 K4 Me3.  It has been reported previously that deletion of RTF1 causes a more 
severe effect on H3 K4 Me1 than is observed in the absence of Rad6 (the ubiquitin conjugating 
enzyme necessary for H2B K123 Ub) (DEHE et al. 2005).  This observation supports the idea that 
Rtf1 may have effects on the activity of the Set1 methyltransferase that are independent of its 
role in H2B K123 Ub. 
The effectiveness of transcriptional silencing at the telomeres is tightly linked to global 
patterns of histone modifications.  Deletion of RTF1 is known to disrupt this process (KROGAN et 
al. 2003; NG et al. 2003b) and I have demonstrated that partial deletion of the HMD or 
substitution mutations in this region that affect Rtf1-dependent histone modifications also 
compromise telomeric silencing.  I also observed loss of telomeric silencing when regions of the 
Rtf1 OAR were deleted, even though these mutations led to only a minor decrease in H3 K4 Me3 
while other Rtf1-dependent H3 methylation marks remained at wild type levels.  While these 
results may indicate that telomeric silencing is dramatically affected by slight perturbations in 
global histone modification patterns, it is more likely a reflection of the sensitivity of the TEL-
VR::URA3 reporter.  To more accurately measure transcriptional activity at the telomeres, 
Northern blots could be performed to assess levels of URA3 expression from the telomeric 
silencing reporter in strains harboring Rtf1 HMD mutations. 
Additionally, I tested the effects of Rtf1 HMD mutations on three other transcription- or 
chromatin-related phenotypes:  sensitivity to the base analog 6-AU, the Spt- phenotype, and 
internal initiation from the FLO8 locus.  All HMD mutations tested (rtf1∆3, rtf1∆4, rtf1 102-
104A, rtf1 108-110A, and rtf1 F80V F123S) caused similar sensitivity to 6-AU, indicating that 
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these mutations lead to a defect in transcription elongation.  Partial deletions of the HMD (rtf1∆3 
and rtf1∆4) resulted in a very weak Spt- phenotype, but no effect on this phenotype is observed 
in strains expressing Rtf1 HMD substititution mutations.  Conversely, the Rtf1 HMD substitution 
mutations allowed internal initiation from a cryptic promoter in the FLO8 locus at a level 
equivalent to that observed for a complete deletion of RTF1, while partial deletions of the HMD 
led to a weaker effect on this phenotype.   
The FLO8 internal initiation phenotype and the Spt- phenotype have both been proposed 
to indicate that chromatin structure has been disrupted, allowing access to aberrant 
transcriptional start sites (KAPLAN et al. 2003).  The FLO8 internal promoter lies within the 
ORF, where Rtf1-dependent histone modifications are known to localize.  Conversely, the Spt- 
phenotype typically results from utilizing alternate transcriptional start sites within the promoter, 
which is devoid of most Rtf1-dependent histone modifications.  Mutations in the Rtf1 HMD 
allow internal initiation from FLO8, but cause a very mild or no Spt- phenotype; these 
observations may suggest that the HMD contributes mainly to the function of chromatin within 
active ORFs. 
Another interesting observation made from these phenotypic studies is that partial 
deletions and substitution mutations in the HMD are not always functionally equivalent.  I also 
observed that several HMD substitution mutations led to a decrease in the amount of total H3 
that could be extracted from these strains; this effect is not caused by partial deletions of the 
HMD.  These observations may indicate that Rtf1 substitution mutations are gain of function 
mutations that alter histone-DNA contacts.  Consistent with the idea that the Paf1 complex may 
affect nucleosome stability on active genes, absence of Paf1 complex subunits results in an 
increase in levels of histone H3 present in the 5’ ORFs of several genes (DEHE et al. 2005; 
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MARTON and DESIDERIO 2008).  This increase in total histone H3 levels correlates with a 
decrease in levels of Pol II associated with the GAL1 locus following induction and leads to 
decreased GAL1 mRNA levels at 90 minutes post-induction (MARTON and DESIDERIO 2008; 
XIAO et al. 2005).  ChIP analyses to determine if rtf1 108-110A and rtf1 F80V F123S, which 
both decreased the amount of total H3 present in whole cell extracts prepared by glass bead lysis, 
increase the level of total H3 present in the GAL1 ORF upon gene induction will be useful in 
determining if Rtf1’s role in histone modification contributes to nucleosome dynamics during 
transcription activation.  It will also be interesting to determine if the Rtf1 CID contributes to 
histone eviction during the activation of gene transcription. 
Similar studies to explore the effects of Rtf1 substitution mutations on H2A and H2B 
levels present in active ORFs following gene induction should also be performed.  H2A/H2B 
dimers are more readily evicted from nucleosomes during transcription and may, therefore, be 
more strongly affected than histone H3 in the proposed ChIP analyses.  Interestingly, the yFACT 
histone chaperone complex that contributes to H2A/H2B dynamics during transcription 
physically interacts with the Paf1 complex (SQUAZZO et al. 2002).  It will be interesting to 
determine if yFACT requires the Rtf1 HMD for recruitment to recently induced genes or whether 
the HMD and yFACT physically interact. 
I demonstrated that expressing the Rtf1 HMD as a fusion to the Gal4 DNA binding 
domain (HMD-GBD) in an rtf1∆ strain could restore global levels of H3 K79 Me2 to those 
present in a wild type strain; expression of this construct also restored a modest level of global 
H3 K4 Me3 in an rtf1∆ background and induced a 3-fold increase in this modification at the 
GAL7 UAS under repressing conditions.  These observations demonstrated that promoting Rtf1-
dependent histone methylation is an intrinsic property of the HMD.  Future experiments to 
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explore whether the HMD is also sufficient to promote H2B K123 Ub will further clarify the 
function of this region of Rtf1. 
The ultimate goal of this experiment was to determine if the HMD could induce histone 
modifications in the absence of the transcription machinery.  Although the GAL7 locus should be 
silent under the conditions used in these experiments, it is possible that a low level of 
transcription is occurring under these conditions.  Integration of Gal4 binding sites into an 
intergenic region and the inactive PRM1 gene is currently underway.  ChIP analysis to determine 
if Rtf1-dependent histone modifications are induced at these regions by expression of HMD-
GBD will provide more conclusive data. 
I also observed that expression of the HMD-GBD induced H3 K4 Me3 and H3 K79 Me2 
in the 5’ end of the PYK1 ORF, a locus at which Gal4 binding sites have not been detected.  This 
raises the possibility that Rtf1 may not need to be directly targeted to DNA to promote histone 
modification.  Rtf1 may perhaps possess the ability to modify histones that are not incorporated 
into DNA.   
To investigate this possibility, several experimental adjustments and additional lines of 
experimentation must be pursued.  The HMD-GBD constructs used in these analyses were 
overexpressed from 2µ vectors.  Because the HMD is fused to a DNA binding domain, 
overexpression of this fusion protein may allow nonspecific interaction with DNA on a genome-
wide basis.  This may lead to a diffuse, transient association of the HMD-GBD fusion throughout 
the genome at levels below the limits of detection of the ChIP assay.  To address this issue, ChIP 
assays to determine if Rtf1-dependent histone modifications can be restored in an rtf1∆ 
background should be repeated utilizing constructs that express the HMD-GBD fusions from low 
copy vectors or inducible promoters to achieve lower expression levels of the fusion protein. 
 190 
Additionally, the HMD alone can be expressed to determine if the absence of a DNA-
binding domain affects the ability of this domain to induce Rtf1-dependent histone 
modifications.  Preliminary NMR structural analyses indicate that the HMD is largely structured 
(collaboration between the laboratories of Dr. Andy VanDemark and Dr. Angela Gronenborn; 
personal communication); therefore, the HMD alone should be stably expressed in vivo.  In the 
event that expression of the HMD alone cannot be achieved, it can be fused to a protein tag that 
does not possess DNA-binding activity, such as GFP.  If Rtf1-dependent histone modifications 
are still induced in strains expressing HMD alone or HMD-GFP from low copy vectors, this 
would provide more convincing evidence that Rtf1 does not need to be associated with DNA to 
promote histone modification. 
An alternative possibility is that the HMD itself possesses DNA binding activity; this 
activity may no longer be regulated when the HMD is overexpressed and is not present in the 
context of the full-length protein.  This possibility could be tested by subjecting the HMD to the 
DNA-binding analyses that were performed to demonstrate that the human Rtf1 OAR possessed 
single stranded DNA binding activity (DE JONG et al. 2008).  If DNA-binding activity is 
identified for the HMD, this may indicate that Rtf1 participates in histone modification by 
directly contacting DNA; this interaction may increase the accessibility of histone tails to histone 
modifying enzymes. 
Although the HMD may interact with DNA, the possibility that it mediates protein-
protein interactions should also be explored.  Rtf1 is known to be necessary for the normal 
recruitment of the Set1-containing COMPASS complex and Rad6 to active genes (KROGAN et al. 
2003; NG et al. 2003c; XIAO et al. 2005).  It is also possible that the HMD physically interacts 
with the histones, histone deubiquitylating enzymes, or histone demethylases.  Directed studies 
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to determine whether the HMD interacts directly with these factors, or with the yFACT histone 
chaperone complex, should provide useful information.  The HMD may also interact with an 
intermediate factor that leads to the recruitment of these histone modifying enzymes.  Several 
unbiased protein purification studies are currently underway to determine if HMD-interacting 
factors can be identified.  The possibility that the HMD functions enzymatically also cannot be 
conclusively ruled out.  Completion of the HMD structural analyses may reveal similarity to a 
known enzymatic fold, or other recognizable protein domain, and should significantly aid the 
investigation into understanding the mechanism by which Rtf1 directs histone modification at 
active genes. 
5.3 GENETIC INTERACTIONS IMPLY CONNECTIONS BETWEEN THE 
INOSITOL POLYPHOSPHATE SIGNALING PATHWAY, TRANCRIPTION 
ELONGATION, AND CHROMATIN REMODELING 
A screen for factors that become essential in the absence of Rtf1 uncovered mutations in several 
proteins that function during transcription elongation (COSTA and ARNDT 2000); this screen 
provided the first link between Rtf1 and transcription elongation.  Interestingly, the same screen 
also identified mutations in Plc1 and Arg82, the first two enzymes in the inositol polyphosphate 
signaling pathway.  The genetic interaction between mutations in these enzymes and Rtf1 
suggested that IP signaling may also be connected to transcription elongation.  To further 
investigate this phenomenon, I performed a series of genetic crosses to assess whether the 
genetic interaction between mutations in ARG82 and RTF1 was specific.  I found that deletion of 
ARG82 resulted in synthetic lethality or strong growth defects when combined with individual 
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deletions of four of the five members of the Paf1 complex; synthetic lethality resulted from 
combining a deletion of ARG82 with a deletion of PAF1 or CTR9.  I also observed genetic 
interactions between deletion of ARG82 and mutations in the Spt4/Spt5 complex.  Together, 
these results further implied a connection between IP signaling and transcription elongation.   
It is known that the Spt4/Spt5 complex is required for recruitment of the Paf1 complex to 
active genes (QIU et al. 2006), which may indicate that the link between IP signaling and 
transcription elongation may be mediated specifically through the Paf1 complex.  It may be 
useful to extend this genetic analysis to determine if deletion of ARG82 causes growth defects 
when combined with mutations in other known elongation factors, such as CTK1, FCP1, and the 
subunits of the yFACT complex, that have not been shown to affect the recruitment of the Paf1 
complex to active genes.  Additionally, the results of crosses between deletion of ARG82 and 
mutations in the Bur1/Bur2 transcription elongation complex, which is known to affect 
association of the Paf1 complex with active ORFs, will provide further information concerning 
the connections between IP signaling and transcription elongation. 
Arg82 is known to have at least three nuclear functions; it participates in the control of 
arginine-responsive genes as a subunit of the ArgR/Mcm1 transcriptional regulatory complex 
(BECHET et al. 1970), affects the activity and recruitment of several ATP-dependent chromatin 
remodeling complexes (SHEN et al. 2003; STEGER et al. 2003), and is necessary for the export of 
mRNA from the nucleus (YORK et al. 1999).  My analyses demonstrated that the role of Arg82 
as a transcriptional regulator or its function in mRNA export are likely not responsible for the 
synthetic lethality observed when ARG82 and PAF1 are simultaneously deleted.  Arg82’s role as 
a transcriptional regulator is independent of its kinase function (DUBOIS et al. 2000).  To more 
conclusively demonstrate that the kinase function of Arg82 is specifically required in the absence 
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of PAF1, the effect of combining a deletion of PAF1 with a mutation in the Arg82 kinase domain 
should be evaluated. 
Additionally, it will be interesting to determine which function of the Paf1 complex is 
necessary in the absence of Arg82.  This could be assessed by combining a deletion of ARG82, 
or the Arg82 kinase-dead mutant, with the Rtf1 internal deletion mutants.  The results of this 
analysis would determine which of Rtf1’s functions is necessary for normal cell growth when 
ARG82 is disrupted.  Paf1 and Ctr9 are known to have roles in trimethylation of histone H3 K36 
and phosphorylation of elongating Pol II on Ser2 of CTD repeats (CHU et al. 2007; MUELLER et 
al. 2004).  Genetic analyses to determine if the loss of Set2 (the H3 K36 methyltransferase) or 
Ctk1 (the CTD Ser2 kinase) cause growth defects in the absence of functional Arg82 kinase 
activity will also be informative. 
The IP signaling pathway was linked to the activity of several chromatin remodeling 
complexes, including the INO80 and SWI/SNF complexes (SHEN et al. 2003; STEGER et al. 
2003).  I, therefore, expanded my genetic analyses to determine whether mutations in Arg82 or 
the Paf1 complex genetically interacted with disruptions of nonessential chromatin remodeling 
complexes.  Strong synthetic genetic interactions are observed between deletion of PAF1 or 
ARG82 and disruption of the INO80, SWI/SNF, or SWR1 chromatin remodeling complexes.  
Disruption of these factors, with the exception of the SWR1 complex, was also found to impact 
expression of SPL2 and VTC3.  Interestingly, the IP signaling pathway, the Paf1 complex, and 
the SWI/SNF complex have all been implicated in the cellular stress response (FLICK and 
THORNER 1993; PORTER et al. 2002; SHIVASWAMY and IYER 2008).  The connection between 
these 3 pathways may indicate that the cellular stress response is tightly controlled during all 
stages of transcription. 
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Several mechanisms could account for the synthetic lethality observed between factors 
involved in IP signaling, transcription elongation, and chromatin remodeling.  All three 
processes may function in parallel for normal cell growth; this scenario is unlikely due to the 
pairwise synthetic lethality observed between disruptions in any two of these processes.  
Alternatively, the Paf1 complex and IP signaling may both contribute to the normal function of 
chromatin remodeling enzymes; when both transcription elongation and IP signaling are 
disrupted, chromatin remodeling is ineffective and results in cell inviability.  A third possibility 
is that the IP signaling pathway affects chromatin remodeling and these two processes work in 
parallel to the effect of the Paf1 complex on transcription elongation; simultaneous disruption of 
transcription elongation and chromatin remodeling could result in severe effects on gene 
expression, which would have a dramatic effect on cell growth. 
 ChIP analyses will be useful in further investigating the connections between IP 
signaling, chromatin remodeling, and transcription elongation.  It will be interesting to determine 
whether chromatin remodeling complexes are recruited to the ORFs of active genes; this may 
indicate that chromatin remodeling complexes directly affect transcription elongation.  Candidate 
genes for these analyses will include VTC3 and SPL2; expression of these genes was affected by 
deletion of ARG82, PAF1, or components of the INO80 and SWI/SNF chromatin remodeling 
complex.  Defects in expression of INO1 or recruitment of the INO80 and SWI/SNF to the 
promoters of several  phosphate-responsive genes were identified in arg82∆ strains (STEGER et 
al. 2003); therefore, these genes would also represent ideal candidates for the proposed ChIP 
analyses.  Additionally, it may be interesting to analyze the association of chromatin remodeling 
complexes with the bodies of heat-shock responsive genes.  BRG1, the ATPase component of 
the human SWI/SNF complex, has been demonstrated to associate with both the promoter and 
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ORF of the hsp70 gene following activation (COREY et al. 2003).   If the INO80 and/or 
SWI/SNF complexes are found to associate with the bodies of genes in these analyses, the 
dependence of this association on the Paf1 complex should then be assessed; the results of these 
experiments should indicate whether the Paf1 complex has a direct effect on chromatin 
remodeling during transcription elongation. 
 The Paf1 complex has been demonstrated to be necessary for the eviction of histones 
from the GAL1 locus upon gene activation (MARTON and DESIDERIO 2008).  It would be 
interesting to determine whether mutation of Arg82 or the INO80 and SWI/SNF complexes 
result in a similar defect.  The Paf1 complex has several known connections to histone 
modification.  A combined effect on histone modification and chromatin remodeling could result 
in the inability to sufficiently modify chromatin structure to allow gene expression to take place 
at levels necessary to support cell viability.  In agreement with this idea, synthetic lethal 
interactions have been reported between mutations in the SAGA histone acetyltransferase 
complex and the SWI/SNF chromatin remodeling complex (ROBERTS and WINSTON 1997). 
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